Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,anion transmembrane transporter activity (GO:0008509),-0.6820245597317719,-1.8900410688096683,0.018633540372670808,0.30898529230008653,0.214,5/12,12.10%,ABCG2;SLC39A8;SLC22A6;SLC26A11;SLC4A2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.7733847715655163,1.8863609817086855,0.0,0.05528254627201749,0.054,6/21,13.21%,FGF20;FGF9;FGF10;FRS2;KL;NPTN
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.7639077769354381,1.7516150506808905,0.00425531914893617,0.480208558718796,0.583,1/15,0.14%,PLA2G5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.8023631111220053,1.7036762315856746,0.0076103500761035,0.6587055937157338,0.822,1/10,0.02%,DPYSL4
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5834795267790667,1.7016633649553177,0.0,0.5073813356999571,0.832,11/73,11.05%,FSHR;S1PR2;LTB4R2;VIPR2;OPRK1;HCRTR2;GPR37;BDKRB2;LGR4;PTH1R;HCRTR1
prerank,phosphatidate phosphatase activity (GO:0008195),0.7702216224712854,1.6970578549288338,0.002844950213371266,0.4347644316985782,0.85,8/13,15.83%,LPIN1;PLPPR2;LPIN3;LPIN2;PLPP3;PLPPR5;PLPP4;PLPP5
prerank,diacylglycerol kinase activity (GO:0004143),-0.6664265708847618,-1.688812655081798,0.006230529595015576,1.0,0.805,7/11,12.04%,DGKH;AGK;DGKB;DGKE;DGKZ;DGKD;DGKG
prerank,CXCR chemokine receptor binding (GO:0045236),0.7889477468583634,1.687941304904349,0.0028129395218002813,0.4097779701067059,0.88,2/11,4.50%,YARS1;CXCL12
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.6815862886298608,1.6864600610570395,0.005141388174807198,0.35726178208236,0.887,9/22,12.39%,ILF3;CPEB1;KHSRP;ZFP36L1;EXOSC8;RBMS3;DHX36;NUDT21;HNRNPA0
prerank,filamin binding (GO:0031005),0.778702970255333,1.679921119088455,0.004573170731707317,0.3370829834128524,0.898,1/11,0.02%,DPYSL4
prerank,solute:sodium symporter activity (GO:0015370),0.6584583101465016,1.6583714280630093,0.008728179551122194,0.3874983751872864,0.95,4/27,5.03%,SLC4A4;SLC4A5;SLC5A3;SLC20A2
prerank,hormone activity (GO:0005179),0.5964401653615129,1.6524614176435033,0.0022026431718061676,0.37301663848966377,0.963,5/54,3.71%,APLN;IGF1;EDN3;GNRH1;PTHLH
prerank,exoribonuclease activity (GO:0004532),0.7450905368320837,1.6275227263847352,0.02167630057803468,0.4559745303453153,0.988,5/12,6.42%,EXOSC1;EXOSC3;EXOSC7;EXOSC2;EXOSC8
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6658716741276844,-1.6264716246050492,0.016853932584269662,1.0,0.93,4/10,11.65%,SLCO3A1;SLCO1C1;SLCO2A1;SLC22A6
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5773563417241195,-1.6238848138153865,0.03802281368821293,0.7759238660239772,0.934,9/16,14.21%,PTPRG;PTPRB;PTPRK;PTPRM;PTPRC;PTPRZ1;PTPRO;PTPRU;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5773563417241195,-1.6238848138153865,0.03802281368821293,0.7759238660239772,0.934,9/16,14.21%,PTPRG;PTPRB;PTPRK;PTPRM;PTPRC;PTPRZ1;PTPRO;PTPRU;PTPRT
prerank,anion:anion antiporter activity (GO:0015301),-0.540824375680895,-1.612103605105832,0.01652892561983471,0.7073703291723313,0.95,8/17,28.01%,SLC26A7;SLC26A2;SLC25A4;SLC26A11;SLC4A2;SLC4A3;SLC25A11;SLC25A5
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.708655479641102,1.6101451840446444,0.021739130434782608,0.5072251703150079,0.994,3/14,8.41%,RDH10;RDH11;RDH5
prerank,peptide hormone receptor binding (GO:0051428),0.7585648468656276,1.6080475344611036,0.012893982808022923,0.4794517572378883,0.994,3/11,10.46%,GNRH1;PTHLH;PSMC5
prerank,cysteine-type endopeptidase activity (GO:0004197),0.5470171753410913,1.582593907955322,0.004197271773347324,0.580667519922547,1.0,35/78,19.59%,SFRP1;USP14;USP7;USP30;UCHL1;CASP7;USP1;USP38;CAPN10;USP24;USP47;USP42;CAPN5;USP10;CAPN2;CASP9;USP2;MALT1;USP11;USP15;USP40;USP9X;PIGK;CTSZ;CASP2;USP34;USP35;CTSH;USP48;CAPN15;CAPNS1;USP33;CTSK;CTSO;USP37
prerank,aspartic-type peptidase activity (GO:0070001),-0.6525539675269757,-1.5816277197475923,0.038461538461538464,0.7509225418012959,0.976,3/10,8.71%,BACE2;BACE1;DDI2
prerank,C-C chemokine receptor activity (GO:0016493),0.6548525544544224,1.58000010899614,0.017241379310344827,0.5545120488776262,1.0,3/21,7.14%,CCR9;ACKR2;CXCR4
prerank,amino acid:sodium symporter activity (GO:0005283),0.7288248715711929,1.576040192992187,0.02359882005899705,0.5411716208683407,1.0,6/11,17.80%,SLC6A11;SLC1A3;SLC6A15;SLC6A12;SLC6A13;SLC1A2
prerank,frizzled binding (GO:0005109),0.6000051371851647,1.5744876587055177,0.016374269005847954,0.5176606925092605,1.0,8/34,11.52%,WNT2B;WNT5A;SFRP1;DVL2;DVL1;WNT4;SDCBP;ZNRF3
prerank,vinculin binding (GO:0017166),-0.6060129917778717,-1.572372412022043,0.04294478527607362,0.6984612532443455,0.982,5/11,6.84%,UTRN;SORBS3;PXN;ACTN1;DMD
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7303986435310443,1.5480649265468664,0.03225806451612903,0.6311684308363579,1.0,2/11,4.12%,SLC17A5;SLC5A3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.4460760446551375,-1.5445860134004408,0.010309278350515464,0.7507655968909213,0.991,7/28,11.99%,DAB2IP;CASP8AP2;STAT1;RIPK1;FEM1B;TRAP1;MADD
prerank,cysteine-type peptidase activity (GO:0008234),0.5411173631649515,1.5438491183594958,0.005330490405117271,0.6223108397917829,1.0,34/73,19.59%,OTULINL;SFRP1;ATG4A;USP14;USP7;USP30;UCHL1;CASP7;USP1;USP38;USP24;USP47;USP42;USP10;CAPN2;CASP9;USP2;MALT1;USP11;USP15;GGH;USP40;USP9X;CTSZ;CASP2;USP34;USP35;CTSH;USP48;USP33;CTSK;CTSO;USP50;USP37
prerank,protein phosphatase 2A binding (GO:0051721),-0.4726405308595526,-1.5415940829730093,0.029914529914529916,0.6895315782968731,0.993,8/23,8.90%,MFHAS1;DAB2IP;PPME1;CTTNBP2NL;ENSA;STRN4;SMG5;TP53
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.7367341183299985,1.5375343670677513,0.04599406528189911,0.6261919605693099,1.0,2/10,0.62%,CDKN2D;HEXIM1
prerank,hexosyltransferase activity (GO:0016758),0.5232749204557887,1.5362811889850632,0.004188481675392671,0.6032891913994741,1.0,22/101,12.71%,ALG5;B3GALNT1;TMTC4;A4GALT;B3GLCT;ALG6;GBA2;CHPF;OGT;PIGM;MGAT4B;ALG1;TMTC1;POMGNT1;CHSY3;MGAT4C;POMT2;GBE1;DPY19L1;DPY19L3;ALG9;B4GALT5
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.543484251598845,-1.5325518027821265,0.03571428571428571,0.6676329479444051,0.994,6/14,22.89%,SLC26A7;SLC26A2;SLC26A11;SLC25A14;SLC25A30;SLC25A11
prerank,neuropeptide receptor binding (GO:0071855),0.6923319568654244,1.5304324214706881,0.04103967168262654,0.6084487334684452,1.0,2/14,9.10%,APLN;NMU
prerank,poly(A) binding (GO:0008143),0.6222703019468997,1.5137233747255703,0.03416557161629435,0.6737382094669309,1.0,10/21,15.96%,DDX3X;TIA1;KHDRBS2;PABPC4;RBMS3;PABPC1;ZC3H14;RBMS1;RBMS2;HNRNPDL
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6986211971628008,1.5104319564761515,0.041176470588235294,0.6646789196900408,1.0,6/12,10.08%,IGF1;PIK3R1;ARRB1;YWHAH;GNAS;YWHAG
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.655519814882513,1.5074410085987522,0.05285118219749652,0.6543204697063603,1.0,2/15,3.24%,CCR9;ACKR2
prerank,C-C chemokine binding (GO:0019957),0.6243731750802808,1.5072928601077,0.026737967914438502,0.6298750611097274,1.0,3/22,7.14%,CCR9;ACKR2;CXCR4
prerank,calcium channel inhibitor activity (GO:0019855),0.7109601927425454,1.503055616475202,0.04694167852062589,0.6285830261299766,1.0,4/11,9.62%,TNNI3;ITPR1;PACSIN3;SLC30A1
prerank,dynactin binding (GO:0034452),0.6858002432731287,1.4963580127165377,0.059743954480796585,0.6407019557651615,1.0,7/12,13.93%,SPTBN5;SNX5;SNX6;HOOK3;BICDL1;HTT;MAPT
prerank,symporter activity (GO:0015293),0.7028321353585941,1.4803116695285612,0.05752212389380531,0.7082369458110014,1.0,1/10,0.31%,SLC4A4
prerank,rRNA binding (GO:0019843),-0.3859209443546079,-1.4776093518666045,0.020689655172413793,0.8529024018456721,0.998,30/42,37.35%,CAVIN1;RPL11;MRPS27;RPL5;PTCD3;RPS13;DDX21;RPLP0;ERI1;RPS5;RPL12;MRPS18A;MRPS18C;FASTKD2;NOP53;MTERF4;RPF2;RPS14;ERAL1;EMG1;NGRN;MRPS7;MRPL18;UTP23;MRPL16;MRPS11;RRS1;PPAN;GTF3A;RPL23
prerank,mannosyltransferase activity (GO:0000030),0.6084038872207207,1.4752618601524015,0.05380577427821522,0.7130511476780561,1.0,12/21,21.10%,TMTC4;PIGM;ALG1;ALG8;TMTC1;POMT2;DPY19L1;DPY19L3;ALG9;DPM1;DPY19L4;PIGB
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5391729306258074,-1.4743684575715654,0.058823529411764705,0.8029814703897018,0.999,7/15,22.35%,COX4I1;COX5A;COX8A;NDUFA4;COX7A2L;COX6A1;COX15
prerank,metalloendopeptidase activity (GO:0004222),0.5064011636377214,1.4639258118500804,0.020191285866099893,0.7549135460305679,1.0,13/76,10.62%,ADAMTSL2;MMP12;MMP17;MMP11;ADAMTS7;NRDC;ADAMTS10;ADAMTS20;THOP1;ADAMTS5;ADAMTS6;ADAM33;AFG3L2
prerank,chemokine receptor activity (GO:0004950),0.5892834519833106,1.459458978091699,0.06005221932114883,0.758319588640206,1.0,3/24,7.14%,CCR9;ACKR2;CXCR4
prerank,ribosomal large subunit binding (GO:0043023),0.6751706806925715,1.4592116242096798,0.06734992679355783,0.7365043491267907,1.0,7/11,17.69%,RBM3;DHX33;NEMF;MALSU1;NPM1;MRRF;CPSF6
prerank,transaminase activity (GO:0008483),0.6800715736463278,1.4551179825573983,0.07112970711297072,0.7389286705840503,1.0,4/11,8.15%,PSAT1;BCAT2;ABAT;OAT
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6510099305829751,1.4454749687309976,0.07452574525745258,0.7735540796755184,1.0,5/14,17.19%,CAPN10;CAPN5;CAPN2;CAPN15;CAPNS1
prerank,phosphatase activity (GO:0016791),0.5017696784623978,1.4451186862463548,0.02872340425531915,0.7543048368688036,1.0,24/73,16.22%,DUSP28;DUSP18;DUSP26;APTX;ENOPH1;PTPMT1;LPIN1;HDDC2;ATP1A2;PLPPR2;LPIN3;PRUNE1;PPP1CC;HDHD2;LPIN2;PLPP3;PTPN22;PLPPR5;EPHX2;PPP5C;SACM1L;PLPP4;PLPP5;NUDT16L1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5440378992740698,1.4427953498651511,0.054373522458628844,0.7467068984776489,1.0,15/37,12.81%,FARSB;YARS1;WARS1;YARS2;CARS1;SARS2;GARS1;TARS1;EARS2;AARS1;EPRS1;SARS1;TARS2;NARS1;HARS1
prerank,cation:chloride symporter activity (GO:0015377),-0.5648609597635668,-1.4396824288665977,0.05750798722044728,0.9113300492610837,0.999,6/10,27.28%,SLC12A7;SLC12A4;SLC12A9;SLC12A2;SLC12A8;SLC12A6
prerank,histone deacetylase activity (GO:0004407),0.6110012611977654,1.4394383522165226,0.06719367588932806,0.7453034092854597,1.0,7/19,12.36%,HDAC3;SIRT2;SIRT7;MIER2;HDAC5;HDAC4;HDAC1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6526533385685634,1.4297447646685773,0.08333333333333333,0.7784243803621759,1.0,1/12,1.00%,B3GALNT1
prerank,ion channel inhibitor activity (GO:0008200),0.5424164665788909,1.429611213159321,0.04576659038901602,0.7596665150853928,1.0,16/35,23.39%,TNNI3;ITPR1;PACSIN3;SLC30A1;WNK2;CAMK2D;VTI1B;RACK1;STX8;VAMP8;CALM1;SCN1B;COMMD1;CALM2;WNK3;FKBP1A
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5232755290621994,1.428961247486491,0.04691075514874142,0.7441090147238071,1.0,9/46,10.43%,B3GALNT1;B3GLCT;MGAT3;OGT;MGAT4B;POMGNT1;MGAT4C;EXTL2;PIGA
prerank,pre-mRNA binding (GO:0036002),0.5537094577321593,1.425950759166426,0.06993865030674846,0.7429902829068887,1.0,17/28,22.88%,TARBP2;SLBP;U2AF1;PRPF8;CELF2;CELF1;RBM41;HNRNPL;TRA2B;CELF5;DDX5;RBM22;HNRNPU;PTBP1;RBM7;U2AF2;SRSF6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.49707856773984926,-1.423130299984506,0.07782101167315175,0.9303341160960739,1.0,5/15,20.35%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8
prerank,receptor ligand activity (GO:0048018),0.4626088092105448,1.4195092381016299,0.0,0.7606852218407011,1.0,24/245,10.19%,FGF20;SFRP2;APLN;FGF9;WNT2B;WNT5A;IGF1;IL34;EPHA7;TAFA2;BMP6;NTF3;IL33;EDN3;GNRH1;PTHLH;FGF10;WNT4;LRPAP1;TAFA5;NRG3;EGF;SEMA3D;GDNF
prerank,metallopeptidase activity (GO:0008237),0.47283414368418925,1.4135489325421962,0.02346938775510204,0.7743815534035609,1.0,21/113,11.70%,ADAMTSL2;MMP12;MMP17;MMP11;MPND;ADAMTS7;NRDC;PRPF8;ADAMTS10;ADAMTS20;ANPEP;METAP1;THOP1;ADAMTS5;LAP3;ADAMTS6;ADAM33;METAP1D;AFG3L2;ADAM12;PAPPA
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.6334099375291891,1.4089567750257814,0.08484005563282336,0.7827009093654002,1.0,3/12,7.13%,NQO2;AIFM2;NDUFS7
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5382490117675127,1.4011964341299428,0.08014796547472257,0.8078503261415674,1.0,9/32,20.20%,KCNG2;KCNA4;KCNC1;KCNC2;KCNQ4;KCNA1;KCNQ2;KCNH1;KCNA6
prerank,P-type ion transporter activity (GO:0015662),0.6386635174895048,1.4011406758593752,0.09929078014184398,0.7910208694486512,1.0,3/12,8.60%,ATP2C1;ATP2A2;ATP2B1
prerank,poly-purine tract binding (GO:0070717),0.5539248858512389,1.4004849039018838,0.07026348808030113,0.7782111545481106,1.0,12/27,16.79%,DDX3X;ATXN1;TIA1;KHDRBS2;PABPC4;RBMS3;PABPC1;ZC3H14;RBMS1;RBMS2;HNRNPDL;FMR1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.47869376007245323,1.3991397594837645,0.030818278427205102,0.769213319383665,1.0,36/83,19.63%,MPND;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;TNFAIP3;OTUD7A;USP24;USP47;USP42;UCHL3;USP32;USP10;USP2;USP11;USP15;USP3;USP19;USP40;USP9X;USP4;USP34;USP35;USP48;USP31;TANK;USP33;USP22;USP50;YOD1;VCPIP1;USP37;JOSD1
prerank,G protein-coupled receptor binding (GO:0001664),0.46174873246059633,1.3970599076091452,0.014314928425357873,0.7649792614813646,1.0,29/132,18.07%,S1PR2;WNT2B;WNT5A;SFRP1;DVL2;TUB;ADM;STUB1;PICK1;CXCL12;DVL1;ARRB1;WNT4;PTCH1;TAFA5;GPRC5B;SDCBP;GNAS;PSMC5;GRK3;ZNRF3;USP4;TULP3;GRK2;AGTR1;USP33;GNAQ;CCL25;PACRG
prerank,mechanosensitive ion channel activity (GO:0008381),0.6461723909378814,1.3930580515945603,0.10826210826210826,0.7702627957641519,1.0,2/12,3.55%,TMC5;TMEM63A
prerank,omega peptidase activity (GO:0008242),0.4745152862354559,1.3924211699673352,0.03727369542066028,0.7589817899360002,1.0,38/89,19.63%,MPND;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;TNFAIP3;OTUD7A;USP24;USP47;USP42;UCHL3;USP32;USP10;ASRGL1;USP2;USP11;USP15;USP3;USP19;GGH;USP40;USP9X;USP4;USP34;USP35;USP48;USP31;TANK;USP33;USP22;USP50;YOD1;VCPIP1;USP37;JOSD1
prerank,vitamin D receptor binding (GO:0042809),0.612173230639364,1.3888437735043286,0.11914893617021277,0.7623051207876949,1.0,7/14,16.84%,MED24;MED12;MED14;MED13;MED4;SNW1;THRAP3
prerank,voltage-gated cation channel activity (GO:0022843),0.469721834111194,1.3874137315225556,0.03433922996878252,0.7551116913577077,1.0,19/97,15.42%,CACNA2D2;KCNG2;KCNA4;KCNC1;CACNG3;CACNB4;CACNA2D3;GRIN1;CATSPER3;KCNMA1;KCNC2;GRIN2A;KCNQ4;CACNB1;KCND3;KCNH5;KCNA1;KCNQ2;CACNG4
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.5952625549270278,1.383389856620819,0.10192837465564739,0.7474521510482945,1.0,5/17,9.20%,EPHA7;EPHB2;EFNB3;EPHA8;EPHA10
prerank,ephrin receptor activity (GO:0005003),0.5952625549270278,1.383389856620819,0.10192837465564739,0.7474521510482945,1.0,5/17,9.20%,EPHA7;EPHB2;EFNB3;EPHA8;EPHA10
prerank,muscle alpha-actinin binding (GO:0051371),0.6093426714467838,1.3790396781779009,0.1037344398340249,0.7555610093073862,1.0,2/15,1.71%,PDLIM2;PDLIM7
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.6483163569072778,1.3779162716773825,0.12349397590361445,0.7476390879376672,1.0,3/10,16.34%,SLC6A11;SLC6A12;SLC6A13
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5259710970847712,-1.3776175429802302,0.11490683229813664,1.0,1.0,6/12,27.20%,SLC6A6;SLC3A2;SLC36A4;SLC38A5;SLC1A4;SLC36A1
prerank,transcription corepressor binding (GO:0001222),0.5320457624210618,1.374967803082133,0.09801488833746898,0.7485298056417697,1.0,9/27,16.05%,HDAC3;RORA;PHF1;EZH2;EHMT2;PER1;USP11;EHMT1;CTBP1
prerank,exonuclease activity (GO:0004527),0.4968615849187446,1.3740586959281833,0.07029478458049887,0.7400052931202883,1.0,15/46,17.40%,EXOSC1;EXOSC3;APLF;EXOSC7;EXOSC2;EXOSC8;ENPP2;AEN;ENPP1;CPSF3;ISG20L2;MRE11;CNOT6;RAD50;REXO1
prerank,adrenergic receptor binding (GO:0031690),0.5949860166007184,1.372020339605752,0.09293193717277487,0.7378584030904786,1.0,5/16,14.61%,APLP1;UCHL1;GNAS;MAGI2;GRK2
prerank,neuropeptide binding (GO:0042923),0.5756477820559199,1.3700361146199629,0.11307901907356949,0.7357203164610047,1.0,4/18,17.95%,OPRK1;GPR37;GPR149;SORL1
prerank,growth factor activity (GO:0008083),0.4708426928469326,1.3627150396298524,0.07034632034632035,0.7585919485080044,1.0,7/74,10.19%,FGF20;FGF9;NTF3;FGF10;NRG3;EGF;GDNF
prerank,syntaxin binding (GO:0019905),0.4740633387774427,1.3576882243095787,0.06366630076838639,0.7704419266468878,1.0,19/61,16.55%,SYT3;SYT10;UNC13A;NAPG;STX6;ABL1;VAMP3;STX16;CPLX1;SNAP25;SCFD1;VPS54;SYT1;TMED10;DAPK1;STX8;VPS18;VAMP8;NSF
prerank,deubiquitinase activity (GO:0101005),0.4600928273854167,1.3534605614013293,0.04559915164369035,0.7783523040306608,1.0,37/88,19.63%,MPND;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;TNFAIP3;OTUD7A;USP24;USP47;USP42;UCHL3;USP32;USP10;USP2;USP11;USP15;USP3;USP19;USP40;USP9X;USP4;USP34;USP35;USP48;USP31;EIF3F;TANK;USP33;USP22;USP50;YOD1;VCPIP1;USP37;JOSD1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5023534554756174,-1.352219718123362,0.12459016393442623,1.0,1.0,7/13,19.11%,ERN1;PDGFC;IL1R1;PTPRJ;PDGFA;PDGFD;VEGFA
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.37289350135801563,-1.3504373887813679,0.07262569832402235,1.0,1.0,15/31,27.28%,SLC12A7;KCNK5;ABCC9;TMEM175;TMEM38A;SLC12A4;TMEM38B;SLC12A9;KCNA2;SLC12A2;KCNK9;SLC12A8;KCNK1;HCN1;SLC12A6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.6324508670907371,1.3492928226558547,0.14350453172205438,0.7859093981834474,1.0,3/11,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,NADP binding (GO:0050661),-0.38800872581600987,-1.3437351715914563,0.06748466257668712,1.0,1.0,21/32,39.25%,LBR;ME3;CAT;CRYZL1;NOS3;DECR1;DUS2;NOX1;MTRR;CBR4;NOS1;NNT;SPR;DHFR;KCNAB1;NDOR1;DHCR7;CRYZ;CBR3;TM7SF2;HSD11B1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.45459403385355024,-1.3430911927304545,0.12406015037593984,1.0,1.0,6/16,12.17%,INPP5F;MTMR12;MTMR10;MTMR3;MTMR14;MTMR9
prerank,cardiolipin binding (GO:1901612),0.6294951215610164,1.3422933042964298,0.14992272024729522,0.8083027091905052,1.0,2/10,2.84%,GSDMD;PLEKHN1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.47500952335619884,-1.3422676203612791,0.11785714285714285,0.9989935907622226,1.0,9/14,41.54%,CYB5R4;NOX1;CYBA;MICAL1;NCF2;AIFM1;CYBB;KMO;NOX4
prerank,sodium channel regulator activity (GO:0017080),0.5093756502541553,1.3371123986662343,0.10369487485101311,0.8219351657841084,1.0,13/37,21.46%,GPLD1;GPD1L;YWHAH;SCN2B;FGF12;CAMK2D;PTPN3;FGF14;SCN1B;ATP2B4;SGK3;FGF13;COMMD1
prerank,receptor antagonist activity (GO:0048019),0.5650364088484187,1.3361572586219899,0.15947712418300652,0.8146265458884936,1.0,3/17,14.59%,DKK3;LRPAP1;PXDN
prerank,gated channel activity (GO:0022836),0.5968662784319019,1.3329133307677319,0.15151515151515152,0.8185966385630096,1.0,2/14,3.55%,TMC5;TMEM63A
prerank,FAD binding (GO:0071949),0.5293681766165219,1.3324611073451518,0.14157014157014158,0.8092974140809741,1.0,2/24,1.50%,CYB5R2;NQO2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4572237439081823,1.3307995463323479,0.08565310492505353,0.8059565379407522,1.0,12/75,12.14%,KCNAB2;PRXL2B;ADH5;RDH10;BDH1;RDH11;HADHB;HSD17B4;RDH5;MDH2;AKR1B10;EHHADH
prerank,phospholipase A2 activity (GO:0004623),0.5234772377991614,1.328845177441656,0.1274131274131274,0.8047993809616365,1.0,2/26,5.71%,PLA2G5;PRDX6
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.5502392901724362,1.3254985051780392,0.13400758533501897,0.8096373279260977,1.0,8/22,16.35%,ATP2C1;ATP6V0A2;ATP2A2;ATP6V0E2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.6097632220171461,1.3223745080723441,0.15165165165165165,0.8143462629715064,1.0,3/12,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.4726042278869693,-1.3222301521794781,0.1423728813559322,1.0,1.0,7/14,22.07%,MTMR12;MTMR10;MTMR3;MTMR14;MTMR9;MTMR11;MTMR6
prerank,ubiquitin-specific protease binding (GO:1990381),0.5512887506832846,1.3219952444236849,0.14690721649484537,0.8053695478753948,1.0,7/19,16.38%,SELENOS;SYVN1;CHMP3;VCP;SART3;PARK7;DERL1
prerank,mRNA 3'-UTR binding (GO:0003730),0.4463986924835435,1.3091586970548323,0.10748155953635406,0.8556200035272651,1.0,20/79,14.23%,ILF3;CPEB1;KHSRP;PCBP4;ZFP36L1;IGF2BP2;CELF2;EXOSC8;CELF1;RNF40;PABPC4;RBMS3;DHX36;PABPC1;RBMS1;NUDT21;RBMS2;HNRNPA0;CSDC2;HNRNPA2B1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5923942694036608,1.3073377190592401,0.16690042075736325,0.8531795488651668,1.0,5/13,18.79%,ADH5;ALDH1A2;ALDH4A1;ALDH3A2;ALDH7A1
prerank,gamma-tubulin binding (GO:0043015),0.5462927166292358,1.3061854781899425,0.14966887417218544,0.8474443104775048,1.0,10/21,17.17%,B9D2;DDX3X;ARHGEF7;NDRG1;BRSK1;DIXDC1;BLOC1S2;GIT1;OFD1;TUBGCP2
prerank,retinoic acid binding (GO:0001972),0.5995182820190618,1.3043720621363581,0.18915159944367177,0.8455652850767014,1.0,2/12,12.85%,NR2F2;CYP26B1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.4639637227400148,-1.3027687193473865,0.15925925925925927,1.0,1.0,6/15,10.99%,PICALM;WDFY3;EPB41;SCARB1;ZFYVE9;ZFYVE1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.6176787988148007,1.2988271890306937,0.16040462427745664,0.8615008058301381,1.0,5/11,19.43%,NTHL1;APLF;HMCES;ALKBH1;RPS3
prerank,histone methyltransferase activity (GO:0042054),0.4946820690921176,1.2955685564203523,0.15625,0.866363657668064,1.0,15/32,19.80%,PRMT6;FBL;SETD7;EZH2;EHMT2;PRMT5;NTMT1;NSD3;SUV39H1;PRMT1;EHMT1;PRMT8;PRMT2;KMT5B;CARM1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.5056107359271661,1.2951987627395651,0.15117719950433706,0.8575963227785078,1.0,9/29,18.99%,CDKN2D;HEXIM1;PKIB;CIT;YWHAG;PKIG;SPRY2;PRKAR1A;PRKAG2
prerank,nucleotidase activity (GO:0008252),-0.45763789185477366,-1.2925637343965921,0.14576271186440679,1.0,1.0,4/15,9.08%,NT5C2;BPNT2;NT5E;NT5M
prerank,poly-pyrimidine tract binding (GO:0008187),0.5216370897473918,1.291819343864513,0.15934755332496864,0.8634161040434305,1.0,15/23,26.25%,ATXN1;PABPC4;RBMS3;PABPC1;RBMS1;RBMS2;DIS3L2;FMR1;HNRNPU;PTBP1;U2AF2;KHDRBS1;PNPT1;HNRNPH1;HNRNPC
prerank,E-box binding (GO:0070888),0.4925164887267658,1.2861222355230433,0.15357142857142858,0.8803649038728081,1.0,9/34,16.27%,CIART;SNAI1;TCF4;ZEB1;PER1;PRMT5;TWIST1;TCF3;CLOCK
prerank,carbohydrate kinase activity (GO:0019200),0.6091753306271073,1.284737682280183,0.1884272997032641,0.8765672009792856,1.0,2/11,2.71%,XYLB;GALK1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5281937415121747,1.281033781153393,0.17965653896961692,0.8837345284142596,1.0,9/20,19.20%,OTULINL;USP7;USP47;UFSP2;SENP5;USP9X;EIF3F;USP50;YOD1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.4997664778458002,-1.2800901811587668,0.1702127659574468,1.0,1.0,5/11,22.53%,EGFR;TAOK2;MAP3K13;MAP3K4;MAP3K5
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5345267518438686,1.2799536384806975,0.20341207349081364,0.8785474143779729,1.0,6/20,14.26%,MOGAT3;AGPAT1;AGPAT5;GPAT4;AGPAT3;LCLAT1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.5064931833232257,1.2777481298020488,0.15796178343949044,0.8793936026576554,1.0,4/26,9.21%,B3GALNT1;CHPF;CHSY3;EXTL2
prerank,snRNA binding (GO:0017069),0.47178265985408574,1.2759794205195574,0.16203703703703703,0.8774620649525758,1.0,15/42,21.20%,HEXIM1;LSM7;COIL;TOE1;PRPF8;CDK9;SNRPB2;SART3;RBM41;CCNT1;RBM22;HNRNPU;GEMIN5;CCNT2;RBM7
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4726598276649028,-1.2756738441873443,0.1872791519434629,1.0,1.0,8/13,22.71%,GABRG2;GABRA5;GLRA2;GLRB;GABRA4;GABRG1;GABRA1;GLRA3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4358778548310272,-1.2741488486668,0.1509433962264151,1.0,1.0,10/16,36.93%,ANO4;ANO6;ANO1;ANO3;TTYH3;TTYH1;ANO5;ANO10;ANO8;ANO2
prerank,intracellular chloride channel activity (GO:0061778),-0.4358778548310272,-1.2741488486668,0.1509433962264151,1.0,1.0,10/16,36.93%,ANO4;ANO6;ANO1;ANO3;TTYH3;TTYH1;ANO5;ANO10;ANO8;ANO2
prerank,acylglycerol lipase activity (GO:0047372),-0.49106903473043406,-1.273759345262598,0.20521172638436483,0.987261282225035,1.0,3/11,7.16%,MGLL;ABHD6;ABHD2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.508037105770019,-1.2643635037166245,0.16718266253869968,0.9950150372842254,1.0,5/10,21.34%,GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,NF-kappaB binding (GO:0051059),0.5113654561305945,1.2639072256414654,0.18441558441558442,0.9241112395915995,1.0,8/24,17.71%,HDAC3;COMMD6;CDK5RAP3;NPM1;HDAC1;FAF1;MTDH;ANXA4
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5396472216138377,1.2633252546829248,0.18818681318681318,0.9169080832308752,1.0,3/17,5.66%,THEM4;ACOT9;ACOT11
prerank,hexosaminidase activity (GO:0015929),-0.46743277682228357,-1.2610646371013994,0.18840579710144928,0.9768320834379897,1.0,5/12,26.04%,OGA;CEMIP2;HEXD;HYAL1;NAGA
prerank,MAP-kinase scaffold activity (GO:0005078),0.5859760047917776,1.2577587910117174,0.22466960352422907,0.9329420848726582,1.0,6/11,19.09%,MAPK8IP1;IQGAP1;MAPK8IP3;AKAP13;MAP2K2;KSR1
prerank,chloride channel inhibitor activity (GO:0019869),0.6020680639620637,1.2550007376898973,0.20821114369501467,0.9366633655864889,1.0,7/10,26.38%,WNK2;VTI1B;STX8;VAMP8;WNK3;STX7;STX1A
prerank,voltage-gated potassium channel activity (GO:0005249),0.4307116040896657,1.254877785159431,0.145610278372591,0.9274053989054881,1.0,13/80,15.40%,KCNG2;KCNA4;KCNC1;KCNK2;KCNT2;KCNMA1;KCNC2;KCNJ10;KCNQ4;KCND3;KCNH5;KCNA1;KCNQ2
prerank,poly(U) RNA binding (GO:0008266),0.5225798300905568,1.253989209047336,0.20492866407263294,0.9219223500476137,1.0,8/20,16.79%,ATXN1;PABPC4;RBMS3;PABPC1;RBMS1;RBMS2;DIS3L2;FMR1
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.34809844197135054,-1.25168209909887,0.17721518987341772,0.984311271783463,1.0,20/33,30.23%,PCF11;WAC;ERCC5;WDR43;AGO2;URI1;RRN3;RPRD1B;SCAF8;PAF1;SMYD2;SPTY2D1;CCAR2;ERBB2;SUPT4H1;CTR9;ELP4;MAF1;DHX9;RPRD1A
prerank,G protein-coupled receptor activity (GO:0004930),0.40649865401568824,1.2511015556488705,0.050200803212851405,0.9258836379823304,1.0,29/239,14.70%,FSHR;S1PR2;MRGPRF;LTB4R2;MRGPRE;VIPR2;OPRK1;GPR22;GPR63;CXCR4;HCRTR2;ADGRV1;GPR37;BDKRB2;GPR149;GPR4;TPRA1;GPR45;ELOVL4;LGR4;PTH1R;HCRTR1;ADGRG1;LANCL1;GPR161;GABBR1;LPAR1;LPAR6;PDGFRL
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.46612049681638384,-1.2476288158846445,0.19519519519519518,0.9706632509747083,1.0,7/12,25.44%,DAB2IP;VEGFC;CADM4;VEGFA;VEGFB;PGF;ITGB3
prerank,kinase inhibitor activity (GO:0019210),0.473525466964587,1.243137355134236,0.19781553398058252,0.9551393648360434,1.0,7/33,8.79%,HEXIM1;GSKIP;SH3BP5;PRKRIP1;WARS1;MAPK8IP1;SH3BP5L
prerank,endopeptidase activity (GO:0004175),0.407157964766432,1.242834219253343,0.05,0.9468165320938342,1.0,53/257,17.62%,ADAMTSL2;MMP12;MMP17;SFRP1;MMP11;ADAMTS7;RHBDL3;USP14;NRDC;USP7;USP30;UCHL1;CASP7;ADAMTS10;PCSK5;USP1;USP38;ADAMTS20;PCSK2;USP24;USP47;THOP1;PSMB10;USP42;HTRA3;ADAMTS5;ADAMTS6;USP10;PLAT;MBTPS1;CASP9;ADAM33;USP2;MALT1;AFG3L2;USP11;USP15;PRSS12;USP40;USP9X;ADAMTS3;CTSZ;F3;RHBDF1;CASP2;USP34;USP35;CTSH;USP48;ADAMTS1;PARL;USP33;OMA1
prerank,potassium channel regulator activity (GO:0015459),0.4410953462722079,1.2404896487208685,0.16666666666666666,0.9488358924897592,1.0,3/49,4.12%,AMIGO1;KCNAB2;SLC5A3
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.35134896348326294,-1.2369247481547379,0.16292134831460675,0.9849724094309582,1.0,14/29,38.21%,SLC26A7;SLC25A13;SLC26A2;SLC25A14;SLC25A30;SLC25A11;SLC1A4;SLC25A22;SLC26A6;SLC25A21;SLC25A18;SLC13A5;SLC1A6;SLC26A8
prerank,kinesin binding (GO:0019894),0.48198441007875176,1.2362285379125064,0.19651741293532338,0.9600460313743463,1.0,7/27,12.38%,SPTBN5;ARHGEF10;MAPK8IP1;NEFH;TOR1B;PLEKHM2;MAPK8IP3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5118495537387522,1.2349263478378933,0.20948616600790515,0.9566507758005819,1.0,8/20,18.75%,CASK;AK4;AK3;AK6;MAGI3;DLG2;CMPK1;MPP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4486750885894998,1.2349087943806174,0.16216216216216217,0.9474356802925914,1.0,12/54,13.47%,HDAC3;GLS2;SIRT2;SIRT7;MIER2;NGLY1;HDAC5;ASRGL1;HDAC4;NTAN1;HDAC1;NIT1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5698167041594534,1.231840703010004,0.22126436781609196,0.9527680167555608,1.0,7/12,22.48%,POU2F1;TBP;HDAC1;TBPL1;H3-3A;TAF1;GTF2B
prerank,hexose transmembrane transporter activity (GO:0015149),0.5732144964539564,1.2271149484799877,0.24477611940298508,0.9655393420639258,1.0,3/12,11.24%,SLC5A3;MFSD4A;SLC2A3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.43627028761373543,1.2248085129095216,0.20951302378255945,0.9674357202102146,1.0,6/53,6.76%,CYB5R2;GFER;NQO2;AIFM2;SDHA;POR
prerank,protein kinase C binding (GO:0005080),0.4457643289755502,1.2243283996823844,0.19090909090909092,0.9606097700620153,1.0,16/43,23.20%,DACT2;PICK1;NELL1;TIRAP;ABL1;SQSTM1;HDAC5;YWHAG;RACK1;PRKD2;CCDC88A;ITGAV;TOP2B;PARD6G;PKN1;HINT1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4903666775411297,1.222582041678658,0.21641791044776118,0.9598531868808309,1.0,10/25,18.69%,SIRT2;PARP1;PARP2;PARP14;PARP16;SIRT5;ZC3HAV1;TNKS;TIPARP;PARP11
prerank,retinoid binding (GO:0005501),0.5025963243395979,1.2215269750815947,0.23514538558786346,0.9559986399404972,1.0,4/22,12.85%,NR2F2;ALDH1A2;RBP1;CYP26B1
prerank,outward rectifier potassium channel activity (GO:0015271),0.577374180606261,1.2201516752833867,0.22072072072072071,0.9534067113386905,1.0,4/11,18.02%,KCNK2;KCNT2;KCND3;PKD2
prerank,calcium ion binding (GO:0005509),0.3954170473511169,1.2173507029475261,0.057,0.9574541958096369,1.0,75/323,21.79%,PLA2G5;MMP12;TNNC1;NDUFAB1;SYT3;CLEC3B;SYT10;LPL;LCP1;AIF1L;ANXA7;DNASE1L2;THBS3;CALM3;GRIN1;GJB2;ANXA1;RPH3A;NUCB2;FBLN1;ATP2A2;ITPR1;SLC25A24;TKT;RASGRP2;SPARC;ADGRV1;RCN3;SPOCK1;CRACR2A;CDH11;PITPNM3;ENPP2;MCTP2;BNIP2;IQGAP1;ENPP1;FBN1;SYT1;SPOCK2;PAM;LRP1;CDH18;SLIT1;SLIT3;EFHD1;ANXA2;MAN1C1;CDH20;CDH19;CDH7;MICU2;ANXA4;CDH4;MCTP1;PITPNM2;PKD2;TUBB4A;S100A13;SCUBE1;CALM1;TPM4;EFHD2;S100G;SYT4;PDCD6;CDH9;FKBP9;S100A11;GSN;SYT11;SYT12;CDH10;SDF4;CALM2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.48178791451869096,1.2152398987445394,0.21793275217932753,0.9586518908541483,1.0,6/25,12.91%,CYP27A1;POR;MSMO1;CYP26B1;FMO4;FMO2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4443546964789001,-1.2142767795879237,0.1919191919191919,1.0,1.0,9/14,27.22%,CASP8AP2;BCL2L13;NOD1;EBAG9;MAL;APAF1;BAD;ATP2A3;RPS27L
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4287364130345776,1.213969399447086,0.19889502762430938,0.9559892068767314,1.0,15/60,13.11%,MST1R;EPHA7;EPHB2;FGFRL1;FGFR2;FGFR1;DDR1;NRP1;DDR2;EPHA8;EPHA10;MUSK;PDGFRA;IGF2R;ROR2
prerank,chloride channel regulator activity (GO:0017081),0.5400299960188353,1.210101278491011,0.24271844660194175,0.9654144097559664,1.0,9/14,26.38%,WNK2;VTI1B;STX8;VAMP8;SGK3;WNK3;SGK1;STX7;STX1A
prerank,alkali metal ion binding (GO:0031420),0.5554904258019572,1.2077989059724878,0.25673758865248225,0.967367156047766,1.0,4/13,9.36%,ACAT1;ATP1A2;DRG1;HDAC4
prerank,O-acyltransferase activity (GO:0008374),0.4688367932799821,1.2051572676386475,0.22857142857142856,0.970514017326549,1.0,5/30,9.52%,MOGAT3;PRDX6;GPAT4;SOAT1;GPAM
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5528587591697203,1.2040354230520203,0.2524822695035461,0.967200301081283,1.0,5/13,14.26%,AGPAT1;AGPAT5;GPAT4;AGPAT3;LCLAT1
prerank,pentosyltransferase activity (GO:0016763),0.45973193947211016,1.2035516131205979,0.2099644128113879,0.9610841289122902,1.0,13/36,18.69%,SIRT2;PARP1;PARP2;UPP2;PARP14;PARP16;LACC1;SIRT5;ZC3HAV1;TNKS;TIPARP;QTRT2;PARP11
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5228637405271075,1.2027104582536814,0.25267379679144386,0.9565825354643015,1.0,10/17,24.55%,GRIN1;GRIK5;GRIN2A;GRIA1;GRIA2;PTK2B;GRIA4;GRIK2;GRIN3A;GRIK1
prerank,protein phosphatase activator activity (GO:0072542),0.5421079669485864,1.2026453068107101,0.2647482014388489,0.9488452624128562,1.0,8/13,24.07%,CALM3;PPP2R5E;IGFBP3;PPP2R5D;PPP2R5A;CALM1;CALM2;PPP2R5C
prerank,methyltransferase activity (GO:0008168),0.43712222417522706,1.2008191876595087,0.23344947735191637,0.9489718725307364,1.0,12/46,13.05%,COMTD1;LCMT1;MGMT;BUD23;NNMT;PRMT5;NTMT1;SUV39H1;CARNMT1;COMT;PRMT1;EHMT1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5696921583671473,1.198809975313614,0.26853146853146853,0.9496724269354313,1.0,3/11,19.36%,SLC22A4;SLC25A20;SLC25A47
prerank,copper ion binding (GO:0005507),0.4418935023960729,1.1972140149745363,0.21395348837209302,0.9487770828911344,1.0,12/42,21.53%,GPC1;CUTA;COX17;PARK7;SOD3;PAM;LACC1;HEPH;MOXD1;S100A13;COMMD1;ATOX1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.43792461837498003,1.1969728824616905,0.22544642857142858,0.9421457673985354,1.0,12/49,15.68%,DUSP28;DUSP18;SMPDL3B;GDPD3;ATP1A2;PRUNE1;PPP1CC;HDHD2;PTPN22;EPHX2;PPP5C;SACM1L
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.476005915456063,-1.196408241154439,0.26332288401253917,1.0,1.0,8/10,32.98%,PML;DNAJB2;IDE;ANKRD13D;ANKRD13B;ANKRD13A;LAPTM5;FAAP20
prerank,metalloexopeptidase activity (GO:0008235),0.4308664360216114,1.1928863864371584,0.22356828193832598,0.951744316619053,1.0,16/51,20.34%,MMP17;XPNPEP3;CPXM1;ANPEP;METAP1;LAP3;AGBL3;PEPD;METAP1D;CPXM2;METAP2;AGBL4;DPEP1;AGTPBP1;MMP14;MMP16
prerank,aminopeptidase activity (GO:0004177),0.47223576791595073,1.1927579713202,0.24812967581047382,0.9448005789426718,1.0,8/26,15.68%,MMP17;XPNPEP3;ANPEP;METAP1;LAP3;METAP1D;METAP2;CTSH
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.4349087540310671,-1.1861348052382308,0.2635135135135135,1.0,1.0,9/13,28.90%,TRMT1L;THUMPD3;THUMPD2;TARBP1;FTSJ1;TRMT10B;METTL1;TRMT10A;TRMT5
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5767812926742111,1.1835609648284904,0.2887864823348694,0.9763902540556245,1.0,3/10,12.26%,SIRPA;JUP;CD47
prerank,ribonuclease activity (GO:0004540),0.4237682869375805,1.1826246861621665,0.22355507088331517,0.9729347490749264,1.0,15/56,17.10%,EXOSC1;EXOSC3;EXOSC7;RNASE1;EXOSC2;RNASE7;LACTB2;EXOSC8;RCL1;CPSF3;AGO3;SND1;DIS3L2;CNOT6;ZC3H12C
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.529280084368626,1.1825699263051492,0.26099290780141843,0.9656613689693745,1.0,8/13,24.60%,PIP4K2B;PIK3CB;PIP4K2A;PIP4K2C;PIK3C2B;PIP5K1A;PIKFYVE;PIK3C2A
prerank,phospholipase inhibitor activity (GO:0004859),0.5662938254913822,1.1823801292371436,0.29850746268656714,0.9591485740029276,1.0,3/10,17.71%,ANXA1;ANXA2;ANXA4
prerank,phosphatase activator activity (GO:0019211),0.5296884459785214,1.18233814611221,0.28169014084507044,0.9520127971025395,1.0,8/14,24.07%,CALM3;FRS2;PPP2R5E;PPP2R5D;PPP2R5A;CALM1;CALM2;PPP2R5C
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.4383866261293478,1.182229971748799,0.23971797884841364,0.9452264845379877,1.0,8/38,16.65%,SERPING1;SPOCK1;APP;TFPI;SERPINA2;SERPINE1;SERPIND1;ANXA2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.4556776411652428,1.1819254456509338,0.2712895377128954,0.9394087635465309,1.0,8/33,15.43%,EXOSC3;TOE1;EXOSC7;EXOSC2;USB1;XRN1;DIS3L2;CNOT6
prerank,signal sequence binding (GO:0005048),0.4469739945257839,1.181331892641282,0.26785714285714285,0.9350134378769748,1.0,15/35,20.69%,KDELR3;KPNA3;SEC61A2;BRAP;TOMM20;KPNB1;PEX5;NUP214;TNPO1;CEMIP;NUP153;KPNA1;TIMM22;CABP1;PEX5L
prerank,fibroblast growth factor binding (GO:0017134),0.48869632223200926,1.1811432654347183,0.25,0.9288925317291797,1.0,5/21,9.70%,FGFRL1;FGFR2;FGFR1;GPC1;KL
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.373312648630841,-1.1790917021237364,0.23008849557522124,1.0,1.0,8/23,13.81%,CHRM3;PLCE1;EDNRA;PLCD3;PLCB3;PLCG2;PLCG1;PLCD1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5086751672197667,1.1790861116552662,0.2726027397260274,0.9303782463326572,1.0,1/16,0.55%,HGD
prerank,thyroid hormone receptor binding (GO:0046966),0.4554883675324604,1.1770986959470136,0.2707808564231738,0.9321568822283904,1.0,14/28,22.51%,MED24;MED12;MED13;TACC1;GAS2L1;MED4;BRD8;THRAP3;NSD1;PRMT2;NCOA3;TRIP12;GTF2B;MED17
prerank,ankyrin binding (GO:0030506),-0.3975909878263361,-1.176742684397829,0.2534562211981567,1.0,1.0,6/19,17.94%,CACNA1D;CDH1;PLEC;PTPRC;SPTB;KCTD6
prerank,tubulin binding (GO:0015631),0.38220671960429886,1.1753485274941518,0.12012012012012012,0.9324431441336479,1.0,82/295,20.19%,PSRC1;CFAP157;FSD1;B9D2;ARL4C;CCDC61;CCDC170;REEP4;STMN4;DNM1;WHAMM;MAPRE3;TTLL4;TAOK1;KIF3A;DDX3X;DIP2B;MDM1;RAE1;NEFH;ALMS1;CDK5;TBCA;MTCL1;ARHGEF7;KIF3C;MACO1;TPPP3;GAS2L1;VBP1;RMDN2;PRUNE1;NDRG1;DRG1;ABRAXAS2;GJB6;CLIP3;KATNB1;HOOK3;MAP9;BRSK1;TPGS1;DIXDC1;KIF5C;DAG1;BLOC1S2;GIT1;HTT;RABGAP1;MAPT;UNC5C;MAP1LC3B;EML2;DNM1L;OFD1;VAPB;TBCD;TTLL11;AGBL4;NUMA1;TERF1;TPPP;FMR1;TUBGCP2;KIF5B;MAP4;PACRG;CCDC88A;EML3;ARL8B;PDCD5;KIF20B;KRIT1;MAP6D1;AGTPBP1;RPS3;DNAL1;DLEC1;PAFAH1B1;INO80;KIF6;DCX
prerank,acetyltransferase activity (GO:0016407),-0.3364962005403943,-1.175136733436716,0.21637426900584794,1.0,1.0,11/31,20.27%,SMARCE1;ELP3;NAA15;KAT2B;SAT1;EP300;PAFAH1B2;NAT10;KAT6B;KAT8;NAA80
prerank,mRNA 5'-UTR binding (GO:0048027),0.46720493094807747,1.173819737413935,0.2809278350515464,0.9319703005533201,1.0,5/24,10.48%,GNL3;DDX3X;IGF2BP2;DHX36;MYH10
prerank,cytokine receptor activity (GO:0004896),0.4041976840271808,1.1728224035556758,0.20168067226890757,0.9294896784154378,1.0,14/83,16.37%,IL10RA;IFNAR1;IL10RB;CCR9;ACKR2;IL31RA;IFNGR2;PRLR;GFRA2;LEPR;IFNGR1;F3;IL15RA;IL1RAP
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4750805503294922,1.1725426672826467,0.2664941785252264,0.9240604867543118,1.0,10/24,22.38%,CAMK2B;CAMK1G;CAMK2D;CAMK2G;DAPK1;CAMK1D;PHKA2;PTK2B;MAPKAPK2;EEF2K
prerank,pseudouridine synthase activity (GO:0009982),0.527792206461901,1.1725088756244355,0.29,0.9176915878229688,1.0,3/13,9.92%,TRUB2;PUS10;PUS7
prerank,voltage-gated calcium channel activity (GO:0005245),0.4411817975533353,1.1722911889588685,0.27262313860252,0.9120997657474348,1.0,6/37,10.31%,CACNA2D2;CACNG3;CACNB4;CACNA2D3;CATSPER3;CACNB1
prerank,double-stranded RNA binding (GO:0003725),0.4112095972814332,1.1713468417957664,0.23542116630669546,0.9096893948932594,1.0,20/70,17.09%,ILF3;APTX;TARBP2;DGCR8;PRKRIP1;DDX3X;DHX15;DHX30;DHX58;DHX33;DHX36;RC3H2;AGO3;TLR3;SIDT1;TUBA1B;HSPD1;FMR1;OAS2;MTDH
prerank,retinoic acid receptor binding (GO:0042974),-0.4012686069633093,-1.1654325671975843,0.265625,1.0,1.0,9/17,23.38%,CNOT1;NCOA6;MED1;RARG;ASXL1;MED25;NRIP1;PPARG;NR4A2
prerank,GABA-A receptor activity (GO:0004890),-0.36818112443318357,-1.1629664614898854,0.21991701244813278,1.0,1.0,6/18,21.34%,GABRB1;GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,calcium activated cation channel activity (GO:0005227),0.4982977942206762,1.1626576642317663,0.28753541076487255,0.9377871376544703,1.0,3/17,6.83%,TMEM63A;TMEM63C;KCNMA1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.44806372785356186,-1.1617368357998357,0.31097560975609756,1.0,1.0,6/12,13.66%,ACVR1;ENG;BMPR1A;TGFBR2;LTBP4;BMPR1B
prerank,actin binding (GO:0003779),0.37904262809503236,1.1584860831625428,0.19153225806451613,0.9483132304781045,1.0,32/170,13.93%,FHL3;PDLIM2;TNNI3;SPTBN5;LCP1;PDLIM7;ABITRAM;MYO19;VPS16;CGN;BCL7B;ARPC1A;MRTFA;ABL1;DMTN;DBN1;KCNMA1;CXCR4;GC;PHACTR3;SSH1;DBNL;PLEKHH2;MYH10;CAPZA1;TPM1;MOBP;FLNB;DAG1;ADD2;TLN2;MAPT
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.31906560419298274,-1.1568732013828509,0.2191780821917808,1.0,1.0,11/38,17.58%,PARD3;DAB2IP;DENND1A;ATG2B;ZFYVE26;TECPR1;ZFYVE1;HIP1;BBS5;KIF16B;ZFYVE19
prerank,four-way junction DNA binding (GO:0000400),0.496667391991664,1.156763123358621,0.30529172320217096,0.9487780156858678,1.0,5/17,11.61%,XRCC2;HMGB3;ABL1;FANCM;YY1
prerank,5'-nucleotidase activity (GO:0008253),-0.4241806260824595,-1.1567149907443293,0.25878594249201275,1.0,1.0,3/13,9.08%,NT5C2;NT5E;NT5M
prerank,calcium channel activity (GO:0005262),0.39670449141891084,1.1549720772010172,0.24166666666666667,0.9495720645557818,1.0,11/84,10.31%,CACNA2D2;PKD2L2;SLC24A5;ORAI2;CACNG3;CACNB4;CACNA2D3;GRIN1;CATSPER3;SLC24A4;CACNB1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.37789373302669843,1.154246745300459,0.1676706827309237,0.9461484224664616,1.0,67/232,21.25%,RNF157;RNF138;MSL2;RNF8;STUB1;TRIM7;DTX3;SYVN1;RNF215;TRIM11;BRAP;PDZRN3;COP1;TRIM56;RFFL;TRIM35;MYCBP2;NFX1;XIAP;TRIM62;TRIM9;UBE3B;RNF24;TRIM41;TRIM17;RNF11;UBR3;RC3H2;ZNRF3;RNF152;RNF19A;KCMF1;ANAPC11;NEURL2;RNF19B;RNF220;RNF41;ANKIB1;RNF122;RNF217;CBL;PIAS3;RNF121;UBE2D1;VPS18;HECTD1;ARIH2;UBR5;SMURF1;TOPORS;MDM2;PPP1R11;RNF111;HLTF;TRIM27;BIRC3;ZNRF2;RNF167;PELI2;RNF38;DTX2;PIAS1;FANCL;TRAF3IP2;TRIP12;HECW2;CBLB
prerank,acid-thiol ligase activity (GO:0016878),-0.42332663234184276,-1.1526198715559204,0.27181208053691275,1.0,1.0,4/13,26.04%,AASDH;AACS;ACSS1;ACSS2
prerank,NADPH binding (GO:0070402),-0.4306970578079139,-1.1481341478266296,0.28852459016393445,1.0,1.0,11/13,41.92%,LBR;DECR1;DUS2;MTRR;CBR4;DHFR;KCNAB1;NDOR1;CRYZ;CBR3;GRHPR
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3969651487708983,-1.1473850842241473,0.2571428571428571,0.9959883409549706,1.0,3/16,6.46%,SLC26A7;SLC26A2;CLCN6
prerank,chemokine binding (GO:0019956),0.4468180231131642,1.1460150543819114,0.2945638432364096,0.9726417437714154,1.0,7/30,22.00%,CCR9;ACKR2;CXCR4;ITGAV;ITGB1;FGF2;HMGB1
prerank,ligand-gated anion channel activity (GO:0099095),-0.38482349048935727,-1.1453748064192502,0.284,0.9836830542376388,1.0,9/17,22.71%,GABRB1;GABRG2;GABRA5;GLRA2;GLRB;GABRA4;GABRG1;GABRA1;GLRA3
prerank,steroid hydroxylase activity (GO:0008395),0.4980758936559431,1.1447181651434295,0.3201634877384196,0.9718471825664567,1.0,2/16,6.56%,CYP27A1;CYP7B1
prerank,RNA cap binding (GO:0000339),-0.40099700532644544,-1.144110667054097,0.25650557620817843,0.9684835001853911,1.0,7/16,11.40%,NCBP3;AGO2;DCPS;EIF4E;NCBP1;LSM1;SNUPN
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4210321474546823,1.1433057276797738,0.2978723404255319,0.9709459520754828,1.0,10/40,12.90%,COMTD1;LCMT1;FBL;DPH5;NNMT;SUV39H1;CARNMT1;COMT;METTL2B;METTL2A
prerank,phospholipase C activity (GO:0004629),-0.35280356458482587,-1.1429742038108388,0.2616822429906542,0.953613431530071,1.0,8/25,13.81%,CHRM3;PLCE1;EDNRA;PLCD3;PLCB3;PLCG2;PLCG1;PLCD1
prerank,protein kinase inhibitor activity (GO:0004860),0.419829884909614,1.1419693952770018,0.2982456140350877,0.9700075093132958,1.0,9/42,12.69%,HEXIM1;GSKIP;SH3BP5;PRKRIP1;MAPK8IP1;CIT;SH3BP5L;NPM1;RACK1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.41089795456012,1.1407033088816667,0.30227272727272725,0.9689230606126173,1.0,17/49,23.24%,SYT3;SYT10;ANXA1;RPH3A;CPNE7;MCTP2;SYT1;CPNE8;ANXA2;ANXA4;MCTP1;SYT4;SYT11;SYT12;CPNE2;SYT7;SYT2
prerank,transforming growth factor beta binding (GO:0050431),-0.3500752737994993,-1.1402797664942996,0.26666666666666666,0.94492456005248,1.0,10/23,21.27%,TWSG1;ACVR1;THBS1;ENG;TGFBR2;LTBP4;CD109;NRROS;TGFB3;LRRC32
prerank,GTPase binding (GO:0051020),0.37118892983560686,1.1395444107170085,0.19536757301107754,0.9672722740775556,1.0,65/195,21.18%,UNC13D;CDC42EP5;LCP1;CDC42EP4;MTSS2;TSC2;RAB11FIP4;HSP90AA1;WHAMM;CDKL5;TBC1D7;SGSM3;KIF3A;LZTR1;RAB34;SRGAP2;ATG14;TRIP11;GNB2;MYCBP2;RAP1GAP;CYFIP1;EPRS1;NDRG1;RABGAP1L;RHOBTB3;TBC1D20;USP6NL;PEX5;RTKN;EVI5L;ALS2;MYO5A;IQGAP1;RNF152;BICDL1;DOCK7;RCC1;AKAP13;IFT20;WASF1;PDE6D;RABGAP1;RADIL;STK19;RNF41;DNM1L;SPTBN1;RAB8A;GGA2;USP33;SORL1;SGSM2;RANBP2;AMBRA1;FGD4;RANBP9;RAB3GAP2;EXOC5;EHD1;PEX5L;YBX1;RUSC2;RAB11FIP3;MAPKAP1
prerank,acetylation-dependent protein binding (GO:0140033),0.47857490379826084,1.1387392991899106,0.32118758434547906,0.9581432698580131,1.0,9/20,22.18%,BRD4;BRD3;DPF2;PHIP;KMT2A;BRDT;MLLT3;CARM1;TAF1
prerank,lysine-acetylated histone binding (GO:0070577),0.47857490379826084,1.1387392991899106,0.32118758434547906,0.9581432698580131,1.0,9/20,22.18%,BRD4;BRD3;DPF2;PHIP;KMT2A;BRDT;MLLT3;CARM1;TAF1
prerank,ubiquitin protein ligase activity (GO:0061630),0.371450923821096,1.137499908653831,0.19578313253012047,0.9572562509751391,1.0,65/228,21.25%,RNF157;RNF138;MSL2;RNF8;STUB1;TRIM7;DTX3;SYVN1;RNF215;TRIM11;BRAP;PDZRN3;COP1;TRIM56;RFFL;TRIM35;MYCBP2;NFX1;XIAP;TRIM62;TRIM9;UBE3B;RNF24;TRIM41;TRIM17;RNF11;UBR3;RC3H2;ZNRF3;RNF152;RNF19A;KCMF1;ANAPC11;NEURL2;RNF19B;RNF220;RNF41;ANKIB1;RNF122;RNF217;CBL;RNF121;UBE2D1;VPS18;HECTD1;ARIH2;UBR5;SMURF1;TOPORS;MDM2;PPP1R11;RNF111;HLTF;TRIM27;BIRC3;ZNRF2;RNF167;PELI2;RNF38;DTX2;FANCL;TRAF3IP2;TRIP12;HECW2;CBLB
prerank,adenylate cyclase binding (GO:0008179),0.5421632614238378,1.1361954241071033,0.3307926829268293,0.9561859194604777,1.0,5/10,21.79%,CALM3;AKAP12;ADCY5;CALM1;CALM2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.5044825881162829,1.1360877757739907,0.3119015047879617,0.9505845543877279,1.0,5/15,14.26%,AGPAT1;AGPAT5;GPAT4;AGPAT3;LCLAT1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.40021858205373717,1.1357891893148921,0.2696871628910464,0.9458384482712162,1.0,8/70,9.03%,B3GALNT1;B3GLCT;CHPF;OGT;MGAT4B;POMGNT1;CHSY3;MGAT4C
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.43450288321126246,1.1327989338450954,0.3345280764635603,0.9514752031734636,1.0,5/34,5.02%,EXOSC3;TOE1;EXOSC7;EXOSC2;USB1
prerank,small GTPase binding (GO:0031267),0.36922529129802983,1.12825425360802,0.2292929292929293,0.9633890501008585,1.0,56/170,21.18%,UNC13D;CDC42EP5;CDC42EP4;MTSS2;TSC2;RAB11FIP4;WHAMM;CDKL5;TBC1D7;SGSM3;KIF3A;LZTR1;RAB34;SRGAP2;TRIP11;MYCBP2;RAP1GAP;CYFIP1;NDRG1;RABGAP1L;RHOBTB3;TBC1D20;USP6NL;PEX5;RTKN;EVI5L;ALS2;MYO5A;IQGAP1;RNF152;BICDL1;DOCK7;RCC1;AKAP13;IFT20;WASF1;PDE6D;RABGAP1;STK19;RNF41;DNM1L;RAB8A;GGA2;USP33;SORL1;SGSM2;RANBP2;FGD4;RANBP9;RAB3GAP2;EXOC5;EHD1;PEX5L;RUSC2;RAB11FIP3;MAPKAP1
prerank,protein kinase C activity (GO:0004697),-0.4089366360247505,-1.1266823850908025,0.2775800711743772,0.9746212306709294,1.0,4/14,4.51%,PRKCH;PRKCE;PRKCD;PRKD1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.31523107430042013,-1.126437952881712,0.26506024096385544,0.9574882013393942,1.0,11/34,16.08%,GBF1;PARD3;MYO10;FERMT2;ARAP2;PLEKHB2;ZFYVE1;DAPP1;IQGAP2;ARAP3;KIF16B
prerank,nuclear receptor coactivator activity (GO:0030374),0.39725907143390843,1.1249963275498343,0.3079545454545455,0.9698784544184168,1.0,21/52,22.79%,MED24;MED12;MED14;MED13;TACC1;MED4;SLC30A9;SRA1;CALCOCO1;BRD8;CNOT9;ZMIZ1;CNOT6;THRAP3;USP22;NCOA3;CARM1;FGF2;PKN1;MED17;NCOA1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.37569038715426617,-1.1230245646090637,0.2918287937743191,0.9521466050943248,1.0,7/18,13.66%,ACVR1;ENG;BMPR1A;TGFBR2;ACVR2B;LTBP4;BMPR1B
prerank,histone deacetylase binding (GO:0042826),0.38168424272687407,1.1216691324789476,0.2852664576802508,0.9768911458644151,1.0,16/88,12.36%,CAMTA2;HDAC3;SIRT2;HSP90AA1;USF1;MIER2;NIPBL;RBBP4;AKAP8L;HDAC5;DHX36;HDAC4;NUDT21;NACC2;MTA2;HDAC1
prerank,damaged DNA binding (GO:0003684),0.4065521318378209,1.1204681538275898,0.3052995391705069,0.9759960257192715,1.0,8/44,10.65%,APTX;NTHL1;MPG;SDE2;DDB1;FANCG;CUL4B;DCLRE1A
prerank,ubiquitin binding (GO:0043130),0.38743802062890614,1.1196431932622655,0.2918454935622318,0.9734227951254572,1.0,15/73,9.10%,OTULINL;MVB12A;SIRT2;UBXN2A;USPL1;UCHL1;RAE1;TNFAIP3;FBXO7;UBXN7;SQSTM1;UCHL3;CXCR4;RNF168;AUP1
prerank,ligand-gated calcium channel activity (GO:0099604),0.4695844322395861,1.119503022225049,0.3495400788436268,0.9681473039925775,1.0,3/19,8.22%,GRIN1;ITPR1;GRIN2A
prerank,glucose transmembrane transporter activity (GO:0005355),0.4880238820251039,1.1189606751991577,0.33612273361227335,0.9645642786663021,1.0,3/17,11.24%,SLC5A3;MFSD4A;SLC2A3
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.4377924905595234,-1.118781879846916,0.35542168674698793,0.9501959849568303,1.0,5/11,20.27%,NAA15;NAA40;NAA25;NAA60;NAA80
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3990943180886768,1.118720159813623,0.30363036303630364,0.9598053165765558,1.0,8/55,8.64%,PKD2L2;SLC24A5;ATP2C1;GRIN1;ATP2A2;ITPR1;ATP2B1;SLC24A4
prerank,potassium channel activity (GO:0005267),0.3819583813770807,1.1184905585218397,0.30235042735042733,0.954997904605495,1.0,13/89,15.40%,KCNG2;KCNA4;KCNC1;KCNK2;KCNT2;GRIK5;KCNMA1;KCNC2;KCNQ4;KCND3;KCNH5;KCNA1;KCNQ2
prerank,monocarboxylic acid binding (GO:0033293),0.4739928823498515,1.1154560814142043,0.3617021276595745,0.9607385275903362,1.0,3/18,13.84%,NR2F2;CYP26B1;PSAP
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3141870894065625,-1.1140410752846601,0.25,0.9500050955469257,1.0,11/33,13.99%,PCF11;WAC;ERCC5;AR;WDR43;AGO2;URI1;RPRD1B;SCAF8;PAF1;SMYD2
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.23152136362961842,-1.1131735150498119,0.16666666666666666,0.9358844863812069,1.0,26/134,11.94%,ABCG2;SLCO3A1;ABCC4;SLC6A6;GJA1;SLC25A17;SLC26A7;SLC25A13;ABCC1;SLC3A2;SLC26A2;SLC7A1;SLC35B3;SLC6A9;SLCO1C1;SFXN2;SLCO2A1;SLC16A1;SLC25A32;SLC52A1;SLC36A4;CTNS;SLC39A8;SLC35D1;SLC22A6;SLC16A11
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5313337078475476,1.1127720261166225,0.35196374622356497,0.9653133084662884,1.0,7/10,26.13%,PKIB;PKIG;PRKAR1A;PRKAG2;PKIA;PRKAR1B;PRKAR2A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.4912154126034802,1.1113781482616347,0.33918918918918917,0.9597424829746115,1.0,6/16,16.35%,ATP6V0A2;ATP6V0E2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.4912154126034802,1.1113781482616347,0.33918918918918917,0.9597424829746115,1.0,6/16,16.35%,ATP6V0A2;ATP6V0E2;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4177821460150897,1.1063918053084003,0.3357664233576642,0.9734285333744959,1.0,8/35,13.94%,SMPDL3B;GPLD1;SMPD2;GDPD3;ENPP2;ENPP1;TDP2;SMPD4
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.43688451500394154,-1.1052555546710647,0.3474025974025974,0.947547913668462,1.0,2/11,0.69%,MBD2;LEF1
prerank,phosphatidylglycerol binding (GO:1901611),0.4879716344395834,1.1043364538970013,0.36258992805755397,0.9756789752277122,1.0,2/13,2.84%,GSDMD;PLEKHN1
prerank,fatty acid synthase activity (GO:0004312),0.5212930075069038,1.0975658680438993,0.3728813559322034,0.995717513105098,1.0,3/10,19.11%,ELOVL1;ELOVL4;ELOVL6
prerank,calcium channel regulator activity (GO:0005246),0.4155229193340234,1.095405018659758,0.351288056206089,0.9981794778964818,1.0,14/37,25.76%,TNNI3;ITPR1;PACSIN3;STIMATE;SLC30A1;CACNG4;CALM1;SGK3;CALM2;FKBP1A;SGK1;NRXN2;STIM2;STIM1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.48637722039288867,1.0948115480242273,0.3677685950413223,0.9950910384091465,1.0,4/14,15.38%,AASS;BLVRB;ALDH4A1;QDPR
prerank,GDP binding (GO:0019003),-0.2701319884743186,-1.0940096438857412,0.2755102040816326,0.9716145511473655,1.0,17/63,12.41%,RAB2A;KRAS;RAB18;RAB14;NRAS;RRAGC;RHEB;RAB5C;RALB;RAB27A;ARL3;RAB22A;RAB9A;RIT1;RASL12;GNAI3;MIEF1
prerank,metalloaminopeptidase activity (GO:0070006),0.4770633496628643,1.0938136431164904,0.3814147018030513,0.9934965696969976,1.0,3/16,5.44%,MMP17;XPNPEP3;ANPEP
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3979143268754667,1.0923831208240224,0.3664804469273743,0.9934795603654087,1.0,10/49,9.82%,UBQLN1;PSMD4;PRPF8;TNFAIP3;OTUD7A;SQSTM1;ZFAND6;RNF168;ABRAXAS2;VCP
prerank,DNA replication origin binding (GO:0003688),-0.3402805347295281,-1.0916971238432178,0.27,0.9643177706052667,1.0,19/23,50.35%,KAT7;ORC4;ORC5;MCM6;MCM4;DDX11;DHX9;ORC1;MCMDC2;MCM8;CDC45;MCM3;MCM2;MCM7;MCM5;MCM10;GRWD1;ORC3;CDC6
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.38325417426147546,-1.091154699805033,0.32857142857142857,0.9504387591150661,1.0,10/15,51.52%,P2RY14;P2RX7;P2RY12;P2RY1;GPR34;P2RX4;PTAFR;P2RX5;P2RX3;P2RX6
prerank,exopeptidase activity (GO:0008238),0.3952520049807481,1.0911400883961078,0.34875846501128666,0.992684470091686,1.0,13/50,16.81%,XPNPEP3;DPP9;ANPEP;METAP1;LAP3;METAP1D;CNDP2;GGH;METAP2;DPP10;CTSZ;CTSH;DPEP1
prerank,3'-5' exonuclease activity (GO:0008408),0.4010530778900071,1.0885681173438813,0.36152954808806487,0.9971176803504909,1.0,6/45,5.02%,EXOSC3;TOE1;APLF;EXOSC7;EXOSC2;USB1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5198134106815807,1.0847101965577453,0.3922734026745914,1.0,1.0,4/10,14.75%,HADHB;HSD17B4;EHHADH;ECHDC1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.40993231936709373,-1.0837647749996726,0.37282229965156793,0.9597965993961546,1.0,6/12,21.34%,GABRB1;GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,lipid phosphatase activity (GO:0042577),0.4852324223926754,1.0836003601335191,0.3946629213483146,1.0,1.0,4/14,14.72%,PLPPR2;PLPP3;PLPPR5;EPHX2
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4124172416882051,1.0822841984969769,0.38323353293413176,1.0,1.0,14/34,21.79%,INCENP;CALM3;TAOK1;DDX3X;ALS2;IQGAP1;PARP16;MAP2K2;CCNT1;SPRY2;CAB39L;CALM1;CCNT2;CALM2
prerank,pyridoxal phosphate binding (GO:0030170),0.45042623987493347,1.081087130492197,0.39477124183006534,1.0,1.0,3/20,8.15%,PSAT1;ABAT;OAT
prerank,carboxy-lyase activity (GO:0016831),0.4402969677395897,1.079283054568402,0.37626262626262624,1.0,1.0,3/23,2.69%,AZIN2;MLYCD;UROD
prerank,phospholipase activator activity (GO:0016004),0.5085013664452352,1.0789695943138673,0.4015151515151515,1.0,1.0,1/10,2.08%,PDPK1
prerank,ion channel activity (GO:0005216),0.3739436130023657,1.0787669355109804,0.35089567966280294,0.9966900029762642,1.0,9/80,8.77%,TMC5;NALCN;LRRC8A;TMEM63A;GRIN1;GRIK5;CALHM2;GRIN2A;TRPM3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.49530812098079363,1.0785549200304188,0.3941717791411043,0.9922797361355088,1.0,6/11,19.80%,PRMT6;PRMT5;PRMT1;PRMT8;PRMT2;CARM1
prerank,protein phosphatase regulator activity (GO:0019888),0.3816365074571984,1.078107265268984,0.36414253897550114,0.9888133247920339,1.0,22/53,24.31%,DMPK;CALM3;RCAN2;PPP2R2C;RCAN3;PPP1R2;PPP1R9B;PPP2R5E;PPP6R3;PPP1R16A;PPP2R5D;PPP2R5A;CALM1;ARPP19;IGBP1;PPP2R2B;CALM2;PPP2R2A;PPP4R4;PPP2R5C;PPP4R1;PPP2R2D
prerank,disordered domain specific binding (GO:0097718),0.42441291271165077,1.0767619513909399,0.3793103448275862,0.9886283137310442,1.0,11/23,21.79%,HSP90AA1;CALM3;DFFB;KCNA1;FKBP8;NUMA1;MDM2;CALM1;NCOA3;SMAD2;CALM2
prerank,lipase activator activity (GO:0060229),0.5048082082346171,1.0764580223860802,0.4020771513353116,0.9846924258918494,1.0,1/10,2.08%,PDPK1
prerank,transcription coregulator binding (GO:0001221),0.38545826406056016,1.0736234213418407,0.376271186440678,0.9896359796664548,1.0,11/50,13.05%,HDAC3;RORA;CDK9;PHF1;EZH2;CHD6;CIT;EHMT2;PER1;USP11;EHMT1
prerank,deoxyribonuclease activity (GO:0004536),0.47916982474674474,1.0717655754041324,0.3906911142454161,0.9913473762698151,1.0,3/14,6.72%,DNASE1L2;APLF;DFFB
prerank,protein tyrosine kinase activity (GO:0004713),0.36064782900146664,1.070695772009919,0.3485952133194589,0.9901358634218643,1.0,16/108,11.29%,AATK;MST1R;EPHA7;EPHB2;FGFR2;FGFR1;DDR1;DDR2;ABL1;SRMS;WEE1;EPHA8;TEC;EPHA10;MUSK;PDGFRA
prerank,glutathione transferase activity (GO:0004364),0.4428314456280845,1.0704326271883542,0.39397741530740277,0.9860313795719736,1.0,2/23,4.08%,ALOX5AP;GSTT1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4076752167425337,1.0677856006338189,0.39203860072376356,0.9904758307326144,1.0,11/35,19.88%,DTWD1;TRDMT1;GATB;PUS10;AARS1;TARS2;NT5C3A;QTRT2;FTO;ALKBH1;MTFMT
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.44309144038147064,1.0646765588926141,0.4091503267973856,0.9964144040817035,1.0,8/21,18.87%,PDE7B;PDE4A;PDE1A;PDE8B;PDE10A;PDE4B;PDE1C;PDE9A
prerank,protein tyrosine kinase activator activity (GO:0030296),0.44097777615008704,1.0640812685351884,0.38917525773195877,0.9936339586738663,1.0,5/19,17.61%,CD24;NRG3;EGF;NRG1;ABI1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4602564371989175,1.0639438399136334,0.41360544217687073,0.9891730883213415,1.0,6/18,18.94%,PRDX5;XIAP;RPS6KA3;RPS6KA1;DPEP1;BIRC3
prerank,ribosome binding (GO:0043022),0.38794236800233856,1.0626305503900726,0.3993055555555556,0.9892112585624904,1.0,9/46,13.42%,SRP19;CPEB1;SEC61A2;NCLN;SHFL;YTHDF3;RACK1;SRP68;YTHDF1
prerank,AMP binding (GO:0016208),-0.4123291256485164,-1.062266737391802,0.39274924471299094,1.0,1.0,9/11,42.69%,MPPED2;PRKAG1;PFKM;ACSS2;PRKAG3;PFKL;APRT;PFKP;PYGL
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.48862163851499935,1.0618120549199626,0.4054834054834055,0.9873019406845541,1.0,3/12,5.87%,CDK13;CDK9;BRD4
prerank,myosin II binding (GO:0045159),-0.41972786349704544,-1.0607297051480353,0.38285714285714284,1.0,1.0,6/10,30.85%,STXBP5;SHROOM4;TRIOBP;STXBP5L;SHROOM1;LLGL2
prerank,endopeptidase inhibitor activity (GO:0004866),0.36324119617281464,1.0606473002534687,0.395987328405491,0.9865073499056101,1.0,17/82,20.46%,BIN1;USP14;RENBP;SERPING1;CARD16;SPOCK1;UBE2Z;APP;TFPI;SERPINA2;SPOCK2;SERPINE1;SERPIND1;ANXA2;TIMP2;PROS1;SERPINF1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.40694450292477663,-1.0601457287812055,0.37254901960784315,0.9958689602738546,1.0,5/11,13.16%,ATP8B1;ATP10A;ABCA4;ATP11C;ATP11A
prerank,leak channel activity (GO:0022840),0.4540005935406688,1.0592881480190988,0.40272108843537413,0.9860644528324378,1.0,2/18,5.33%,NALCN;KCNK2
prerank,GABA receptor activity (GO:0016917),-0.3237600582142327,-1.0575238406411076,0.36771300448430494,0.9905791767893938,1.0,7/21,21.34%,GABRB1;GABRG2;GPR156;GABRA5;GABRA4;GABRG1;GABRA1
prerank,nuclease activity (GO:0004518),0.38010996098174943,1.0535342811652912,0.422680412371134,1.0,1.0,12/52,15.16%,DNASE1L2;NTHL1;RNASE1;RNASE7;DFFB;N4BP2;AEN;ENPP1;SND1;ISG20L2;DIS3L2;MRE11
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3417928499420262,1.0534675491527696,0.357,0.9970853475859036,1.0,94/346,21.26%,RNF157;CDC23;RNF138;MSL2;RNF8;UBE2S;STUB1;TRIM7;DTX3;UBE2E2;UBE2QL1;SYVN1;RNF215;TRIM11;BRAP;FBXL14;PDZRN3;TNFAIP3;FBXO7;COP1;BARD1;TRIM56;RFFL;TRIM35;MYCBP2;RMND5A;NFX1;XIAP;TRIM62;TRIM9;UBE3B;RNF24;RNF40;RNF168;RNF103-CHMP3;TRIM41;TRIM17;CUL4B;RNF11;CHFR;UBE2Z;MALT1;UBR3;RC3H2;ZNRF3;RNF152;RNF19A;KCMF1;UBE2A;ANAPC11;ANAPC4;NEURL2;UBE2J1;CUL5;RNF19B;RNF220;RNF41;ANKIB1;RNF122;RNF217;CBL;KLHL13;UBE2E1;RNF121;UBE2D1;VPS18;HECTD1;ARIH2;UBE2L3;UBR5;FBXO22;SMURF1;TOPORS;TTC3;MDM2;FBXO9;PPP1R11;KLHL20;RNF111;HLTF;TRIM27;BIRC3;ZNRF2;RNF167;PELI2;RNF38;DTX2;FANCL;TRAF3IP2;KLHL9;TRIP12;HECW2;CBLB;CNOT4
prerank,transcription cis-regulatory region binding (GO:0000976),0.34173361875304364,1.0514085957943857,0.331,0.9994986204881652,1.0,87/406,18.54%,MMP12;HSF2;FOXM1;ZBTB48;NFKB1;ZNF25;ZBTB46;ZNF568;CREBZF;MLXIP;NKX2-2;GLIS2;STAT6;XBP1;RORA;TFDP1;PSPC1;MXI1;TAF4;RFX5;SNAI1;MTERF3;TCF7L2;PRDX5;TFCP2;IRF1;TBP;ZNF35;CASZ1;ARNT;ZBTB7B;TEAD1;HDAC5;ZBTB5;DBP;NFX1;SOX9;DDIT3;XRCC6;PER1;DHX36;ATMIN;HDAC4;ARID4A;SOX11;TWIST1;CALCOCO1;RBL2;HOXB8;ATF2;ZBTB20;SUV39H1;FOXN3;YY1;E2F3;PARK7;PEG3;SOX6;NPM1;HDAC1;CREB3;SETX;HNRNPL;TRPS1;SMAD6;SOX5;KMT2D;RFX3;NR2C2;SATB1;TCF3;FOXC2;CIC;HOXC8;TIPARP;ZFP37;SOX13;OSR1;ZFP90;TCF7;NFXL1;GABPB1;GABPB2;TBL1XR1;ZNF177;CUX1;NONO
prerank,CoA-ligase activity (GO:0016405),-0.3827677027850221,-1.0499738689269962,0.375,1.0,1.0,6/14,44.27%,AACS;ACSS1;ACSS2;ACSBG1;SLC27A2;ACSF3
prerank,phosphatase inhibitor activity (GO:0019212),-0.34101983348818193,-1.0496488900920204,0.3706896551724138,0.9887708475511346,1.0,6/20,12.59%,PPME1;ENSA;URI1;STYX;LMTK2;ANP32E
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.47269300898994904,1.0482844999654848,0.41359773371104813,1.0,1.0,2/13,10.98%,DNASE1L2;ENDOV
prerank,5'-3' exonuclease activity (GO:0008409),0.4657400605498905,1.0473543209358853,0.43366619115549215,1.0,1.0,4/14,15.16%,DCLRE1A;CPSF3;XRN1;MRE11
prerank,alpha-actinin binding (GO:0051393),0.42029091582791467,1.041895862287942,0.43291139240506327,1.0,1.0,2/24,1.71%,PDLIM2;PDLIM7
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.39431090889104325,-1.040855343321901,0.422360248447205,1.0,1.0,7/12,27.22%,CASP8AP2;BCL2L13;NOD1;APAF1;BAD;ATP2A3;RPS27L
prerank,syntaxin-1 binding (GO:0017075),0.42138712262061,1.0407992987116663,0.4241645244215938,1.0,1.0,7/22,16.55%,UNC13A;VAMP3;CPLX1;SNAP25;SYT1;DAPK1;NSF
prerank,growth factor receptor binding (GO:0070851),0.35104246434823644,1.0388367626315822,0.4282722513089005,1.0,1.0,10/95,11.48%,FGF20;FGF9;FGF10;PIBF1;SDCBP;FRS2;EGF;KL;PDGFRA;CNOT9
prerank,death receptor binding (GO:0005123),-0.36103949688043324,-1.0362252437264676,0.38926174496644295,1.0,1.0,6/15,13.17%,DAB2IP;CASP8AP2;RIPK1;FEM1B;MADD;NGF
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.41409805578536407,-1.0355267850867997,0.40752351097178685,0.9797627331569154,1.0,5/10,32.76%,DUSP10;DUSP1;DUSP7;DUSP8;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.41409805578536407,-1.0355267850867997,0.40752351097178685,0.9797627331569154,1.0,5/10,32.76%,DUSP10;DUSP1;DUSP7;DUSP8;DUSP6
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3873390616168559,1.0353265829606584,0.4418604651162791,1.0,1.0,3/42,4.67%,CDKN2D;HEXIM1;CCNC
prerank,protein kinase activator activity (GO:0030295),0.36337578866685166,1.0333691908932152,0.4189636163175303,1.0,1.0,18/60,18.99%,INCENP;CALM3;TAOK1;DDX3X;STK11;CD24;GPRC5B;ALS2;IQGAP1;PARP16;NRG1;MAP2K2;DAXX;SPRY2;ABI1;CAB39L;CALM1;PRKAG2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.39192259630254844,1.0328916462700457,0.43162901307966706,1.0,1.0,8/35,12.36%,MMP12;TAF4;POU2F1;TBP;SMARCB1;PARK7;NPM1;HDAC1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3016529647354123,-1.0320373672171737,0.39893617021276595,0.9782307335143822,1.0,10/26,20.83%,ABCG2;SLC6A6;SLC16A2;SLC16A6;SLC16A1;SLC16A11;SLC5A6;SLC16A9;SLC16A4;SLC16A7
prerank,nucleosomal DNA binding (GO:0031492),0.42362411732187244,1.029610962188488,0.4481865284974093,1.0,1.0,6/21,12.64%,SMARCC2;RBBP4;SMARCB1;MTA2;HDAC1;RCC1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.40255127937377083,1.029537205545722,0.43842364532019706,1.0,1.0,9/30,18.94%,CARD16;PRDX5;XIAP;SPOCK1;UBE2Z;RPS6KA3;RPS6KA1;DPEP1;BIRC3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.46877557493778543,1.0293996473816924,0.4157973174366617,1.0,1.0,2/12,2.24%,KDM4D;KDM7A
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4106155083136102,-1.029393000333295,0.4110032362459547,0.9740699542701767,1.0,9/10,56.86%,NOX1;CYBA;NCF2;CYBB;NOX4;NCF1;NOX3;NCF4;DUOX1
prerank,I-SMAD binding (GO:0070411),0.4661849991559557,1.0285768406239075,0.45244956772334294,1.0,1.0,8/13,22.11%,SMAD9;TGFB1I1;SMAD6;SMURF1;TGFBR1;SMAD7;SMAD2;SMAD3
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3626716325821614,1.0277250446501927,0.4564498346196251,1.0,1.0,12/60,13.11%,MST1R;EPHA7;EPHB2;FGFR2;FGFR1;DDR1;DDR2;EPHA8;EPHA10;MUSK;PDGFRA;ROR2
prerank,epidermal growth factor receptor binding (GO:0005154),-0.31453693564716656,-1.0251616125330678,0.4063926940639269,0.9748648595905782,1.0,7/25,14.84%,TGFA;FER;TNK2;SNX2;PLSCR1;ARF4;HIP1
prerank,CARD domain binding (GO:0050700),-0.37416860207924674,-1.0246815586534865,0.39649122807017545,0.9637130882959583,1.0,7/14,22.71%,NOD1;CASP4;MAVS;CARD10;IRGM;CARD14;BCL10
prerank,microtubule binding (GO:0008017),0.33509906928251515,1.0244392860262437,0.4568273092369478,1.0,1.0,57/222,21.52%,PSRC1;CFAP157;FSD1;CCDC61;CCDC170;REEP4;DNM1;WHAMM;MAPRE3;KIF3A;MDM1;RAE1;NEFH;ALMS1;CDK5;MTCL1;KIF3C;MACO1;CAMSAP2;GAS2L1;RMDN2;NDRG1;DRG1;ABRAXAS2;GJB6;CLIP3;KATNB1;HOOK3;MAP9;TPGS1;KIF5C;MAPT;MAP1LC3B;EML2;DNM1L;VAPB;NUMA1;TERF1;TPPP;FMR1;TUBGCP2;KIF5B;MAP4;CCDC88A;EML3;KIF20B;KRIT1;MAP6D1;RPS3;PAFAH1B1;KIF6;DCX;MAP6;MAP4K4;FGF13;CLASP2;MID2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.49559812740857745,1.0235063787949996,0.4650817236255572,1.0,1.0,5/10,19.05%,SQSTM1;GNAS;IGSF11;NSF;SHANK1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3464429966236576,1.0218432058268903,0.44667370644139387,1.0,1.0,11/85,11.46%,LPL;LYPLAL1;PON2;PON3;PRDX6;GDPD3;AARS1;ENPP2;PGAP1;APMAP;TARS2
prerank,protease binding (GO:0002020),0.3444215929113143,1.0197951177467646,0.4751552795031056,1.0,1.0,27/99,20.98%,SELENOS;BIN1;ATP9A;SYVN1;CCBE1;TNFAIP3;CARD16;RFFL;BDKRB2;CHMP3;VCP;SART3;BCL2;COL1A2;PARK7;PSAP;F3;DERL1;TRIP4;SERPINE1;ANXA2;FLOT1;TIMP2;NFRKB;ITGAV;NTRK2;ITGB1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.37656212827591057,1.0196100392603917,0.4676674364896074,1.0,1.0,14/42,21.53%,ANXA1;SIRPA;DSCAM;JAM3;BAIAP2;RAB10;CD47;NPTN;ANXA2;PLXNB3;CNTN2;NEXN;S100A11;PDLIM1
prerank,sialyltransferase activity (GO:0008373),0.4237558967968146,1.0177244771074967,0.4607190412782956,1.0,1.0,5/20,8.55%,ST8SIA3;ST3GAL2;ST3GAL3;ST6GAL2;ST3GAL5
prerank,cytokine activity (GO:0005125),0.3394507022288117,1.0165326002972388,0.48057259713701433,1.0,1.0,11/131,14.44%,WNT2B;WNT5A;IL34;BMP6;IL33;CXCL12;WNT4;BMP5;NRG1;TGFB1;SLURP1
prerank,serine-type endopeptidase activity (GO:0004252),0.35523079755327874,1.0158812226920373,0.4765957446808511,1.0,1.0,10/80,17.07%,RHBDL3;PCSK5;PCSK2;PLAT;MBTPS1;PRSS12;F3;RHBDF1;CTSH;PARL
prerank,GTPase regulator activity (GO:0030695),0.3301564809585132,1.0152690023491502,0.4763819095477387,1.0,1.0,69/212,21.96%,ELMOD1;MTSS2;TSC2;TBC1D7;SGSM3;RUNDC1;RAP1GDS1;RGS10;NRP1;TBC1D13;FLCN;SYDE2;ARHGAP20;ERRFI1;SMAP1;ARHGAP19;SRGAP2;THY1;RANBP3L;SIRPA;RAP1GAP;ARRB1;ARHGAP42;RAP1GAP2;RABGAP1L;GPSM1;ARHGAP24;TBC1D20;RIC8B;USP6NL;RTKN;GPSM2;BNIP2;EVI5L;ALS2;IQGAP1;ARHGEF10L;ARAP1;ADAP1;PDE6D;RABGAP1;ARHGAP29;IPO7;DNM1L;TBCD;ARHGEF6;ITGB1BP1;GNAQ;TBC1D9B;TBC1D22B;CCDC88A;SGSM2;GPS2;ADGRB3;RANBP2;RANBP3;KRIT1;RALGAPB;DLC1;STARD13;RAB3GAP2;RALGDS;CHN1;NPRL2;PREX1;ARHGAP26;LLGL1;ARHGAP35;ARFGAP3
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.46963489398339264,1.0147008239215622,0.45180722891566266,1.0,1.0,4/12,15.76%,PDE7B;PDE4A;PDE8B;PDE4B
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.4324542018793569,1.0140576329279107,0.46174863387978143,1.0,1.0,5/18,16.83%,FAR2;ALDH1A2;AKR1B10;FAR1;ALDH3A2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.3889630209716822,-1.014013154516133,0.4290657439446367,0.9863285892206916,1.0,2/12,8.80%,STAT1;TRAP1
prerank,neuropeptide hormone activity (GO:0005184),-0.317174456555367,-1.0124359153135576,0.4312796208530806,0.9794442645289578,1.0,19/22,65.04%,PPY;ADCYAP1;PENK;CCK;SPX;GRP;NPY;NPFF;PNOC;NMB;VIP;CRH;GAL;CALCB;UCN;NPPA;GHRH;HCRT;QRFP
prerank,ATP hydrolysis activity (GO:0140603),0.3793145460243696,1.0117892699152737,0.47264260768335276,1.0,1.0,8/41,12.16%,HSP90AA1;MYO19;DDX3X;ATP2B1;TOR1B;VCP;RHOBTB3;VPS4B
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2716277067311823,-1.0115635870107904,0.4378698224852071,0.9701056729699666,1.0,16/37,26.40%,SLCO3A1;SLCO1C1;SLCO2A1;COX4I1;COX5A;COX8A;NDUFA4;SLC22A6;COX7A2L;COX6A1;SLC16A7;COX15;UQCR10;ATP13A3;UQCRQ;UQCR11
prerank,single-stranded RNA binding (GO:0003727),0.37071750688326177,1.011348419432857,0.4540162980209546,1.0,1.0,8/43,12.58%,ILF3;DDX3X;CNBP;DHX58;LACTB2;SRA1;ENDOV;AGO3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.40007966577003595,-1.0113413333601415,0.44554455445544555,0.9589377619699375,1.0,5/12,8.02%,NCBP3;AGO2;DCPS;EIF4E;NCBP1
prerank,Toll-like receptor binding (GO:0035325),-0.3948763037782448,-1.0081196306502533,0.41324921135646686,0.9575831019711755,1.0,3/11,10.17%,DAB2IP;UNC93B1;TOLLIP
prerank,nucleotidyltransferase activity (GO:0016779),-0.3237349045326505,-1.0045928120193257,0.44206008583690987,0.956931172967733,1.0,12/19,41.83%,NUDT5;TENT2;REV1;PAPSS2;TUT1;TUT4;TERT;YRDC;CGAS;TUT7;CRPPA;MOCS3
prerank,histone acetyltransferase activity (GO:0004402),-0.2950233301171641,-1.0039868046176428,0.44148936170212766,0.94731947902137,1.0,11/30,19.34%,EPC1;KAT7;BAZ1A;KAT2B;MCM3AP;NAA40;EP300;KAT6B;BRCA2;KAT8;NAA60
prerank,sterol binding (GO:0032934),0.35710775750259616,1.003639802124645,0.4856194690265487,1.0,1.0,12/56,13.54%,SCAP;RORA;STARD5;ERLIN2;VDAC2;OSBPL11;SOAT1;INSIG1;PTCH1;STARD3;VDAC1;SIDT1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4189098518176867,1.00259605400287,0.4803664921465969,1.0,1.0,8/21,20.37%,CDK13;CDK5;CDK9;CDK7;CDK10;CDKL2;CDK11B;CDK14
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4189098518176867,1.00259605400287,0.4803664921465969,1.0,1.0,8/21,20.37%,CDK13;CDK5;CDK9;CDK7;CDK10;CDKL2;CDK11B;CDK14
prerank,titin binding (GO:0031432),0.46239000901888916,1.0025305662805286,0.4841040462427746,1.0,1.0,4/13,21.79%,CALM3;CAMK2D;CALM1;CALM2
prerank,metal ion binding (GO:0046872),0.3237993481525429,1.0007830698383995,0.519,1.0,1.0,106/477,21.80%,PLA2G5;MMP12;TNNC1;NDUFAB1;SYT3;CLEC3B;SYT10;LPL;LCP1;AIF1L;ANXA7;DNASE1L2;THBS3;HMGCLL1;CALM3;GRIN1;GJB2;ANXA1;RPH3A;NUCB2;NUAK2;FBLN1;ATP2A2;ITPR1;SLC25A24;TKT;ABL1;PPA2;RASGRP2;STK11;BRSK2;SPARC;RAP2A;ADGRV1;RCN3;SIK1;SPOCK1;CRACR2A;DHX36;CDH11;NUDT12;PITPNM3;ENPP2;BRSK1;NUDT3;IGFBP3;ENDOV;MCTP2;BNIP2;IQGAP1;ENPP1;TDP2;FBN1;SYT1;SPOCK2;HPRT1;GCLC;PAM;LRP1;EYA2;CDH18;EPHX2;SLIT1;SLIT3;DIS3L2;EFHD1;NT5C3A;ANXA2;TPPP;MAN1C1;OXSR1;APOE;CDH20;CDH19;CDH7;MICU2;ANXA4;CDH4;MCTP1;PITPNM2;PKD2;TUBB4A;S100A13;SRPK1;SCUBE1;CDC42BPB;TRIM27;CALM1;MTPAP;TPM4;IMPA1;EFHD2;S100G;SYT4;PDCD6;CDH9;FKBP9;S100A11;EXD2;GSN;SYT11;SYT12;CDH10;SDF4;CALM2;TRIM26
prerank,cadherin binding (GO:0045296),-0.2702287295159423,-1.0,1.0,0.9482431459791926,1.0,110/315,17.70%,NIBAN2;WASF2;COBLL1;PTPRB;CD2AP;CAST;DAB2IP;PICALM;EXOC3;CTNNA3;RDX;EGFR;CD46;EIF3E;PPME1;BAIAP2L1;DOCK9;YWHAZ;VAPA;EPS15L1;ITGA6;FLNA;MARK2;ARHGAP18;MB21D2;PARVA;MAPRE1;EIF2A;BSG;PTPRM;PDLIM5;BAG3;TJP1;SWAP70;STAT1;SLC3A2;PKP4;CEMIP2;CTTN;NOTCH3;UBAP2;CDH6;HSP90AB1;NCK1;TRIM25;ANLN;NUMB;EZR;ERC1;ARVCF;SNX2;EEF2;USP8;ACVR1;RPL6;RPL24;CDH1;IDH1;CNN2;F11R;PROM1;PLCB3;PACSIN2;LRRFIP1;EHD4;GLOD4;EPN2;CHMP5;RAB1A;PLEC;ARHGAP1;KDR;TBC1D10A;GIGYF2;RPL34;RARS1;VASP;PKM;SLK;EPS15;PTPRO;RANGAP1;TRPC4;FNBP1L;RPL15;RPS2;CDC42EP1;PTPRT;HCFC1;CHMP2B;GIPC1;PTPRJ;TLN1;TWF2;PFN1;ESYT2;SRC;PCBP1;DIAPH3;TAGLN2;ARFIP2;RPS26;ATIC;UBFD1;ALDOA;EIF5;TWF1;EEF1D;HSPA5;RPL7A
prerank,nuclear localization sequence binding (GO:0008139),0.4234106179415391,0.9994066723117977,0.47657295850066933,1.0,1.0,8/18,20.31%,KPNA3;BRAP;KPNB1;NUP214;TNPO1;NUP153;KPNA1;CABP1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4107866662384839,0.9991123889645167,0.4853503184713376,1.0,1.0,5/22,8.82%,PRPF8;TNFAIP3;OTUD7A;SQSTM1;RNF168
prerank,phosphate ion binding (GO:0042301),0.4785205695313325,0.9965776452355591,0.49925925925925924,1.0,1.0,1/10,3.77%,RPH3A
prerank,RNA methyltransferase activity (GO:0008173),0.41854028626207007,0.9953399636321921,0.48322147651006714,1.0,1.0,2/19,3.32%,TRDMT1;FBL
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.4017268056324267,0.9946671238717391,0.49049429657794674,1.0,1.0,8/23,18.87%,PDE7B;PDE4A;PDE1A;PDE8B;PDE10A;PDE4B;PDE1C;PDE9A
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.44050239901696475,0.994008014470677,0.4822190611664296,1.0,1.0,4/14,21.60%,SLC7A11;SLC1A3;SLC1A2;SLC38A7
prerank,RNA polymerase II complex binding (GO:0000993),-0.2794598273994779,-0.9927718687935638,0.44805194805194803,0.9578544061302682,1.0,11/32,15.15%,PCF11;WAC;ERCC5;WDR43;AGO2;URI1;RPRD1B;SCAF8;PAF1;SMYD2;PCIF1
prerank,leucine zipper domain binding (GO:0043522),0.46194014123367444,0.991561735088871,0.4875,1.0,1.0,3/10,15.37%,MRTFA;DDIT3;PAWR
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.4400311603976584,0.9911248935935004,0.49232914923291493,1.0,1.0,5/15,23.01%,ALDH1A2;ALDH4A1;ALDH3A2;ALDH7A1;ALDH2
prerank,potassium ion antiporter activity (GO:0022821),0.4378370787969642,0.9910978613413873,0.4936708860759494,1.0,1.0,4/15,15.90%,SLC24A5;SLC24A4;SLC9A7;SLC9A6
prerank,mRNA binding (GO:0003729),0.3240625195858317,0.9908912969937285,0.5255255255255256,1.0,1.0,74/249,21.45%,CPEB1;KHSRP;GNL3;SLBP;RBM4B;RBM47;PCBP4;ZFP36L1;DDX3X;SRSF5;IGF2BP2;FUBP1;SF3B1;CNBP;DCP1B;CELF2;CELF1;HNRNPK;DHX33;KHDRBS2;SRSF1;RNF40;PABPC4;RBMS3;DHX36;PUM3;HNRNPM;PABPC1;MYH10;HDLBP;RBFOX2;CSTF2T;SHFL;RC3H2;RBMS1;NUDT21;EIF4G2;RBMS2;YTHDF3;PARK7;HNRNPA0;MYEF2;HNRNPL;YTHDF1;TRA2B;LUC7L2;CSDC2;NOVA1;HNRNPA2B1;MRPL13;HNRNPLL;CELF5;DDX5;GRSF1;YTHDC1;EIF4G3;FMR1;ZC3H12C;LUC7L3;CPSF6;PCBP2;RSL1D1;SAMD4B;YTHDF2;RPS3;CSTF3;CIRBP;HNRNPU;GEMIN5;TPR;PTBP1;RPL7;ANGEL2;SRRM2
prerank,semaphorin receptor activity (GO:0017154),0.4733369578303438,0.9892317132493289,0.5080291970802919,1.0,1.0,3/11,8.09%,PLXNA2;NRP1;PLXNA1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.45362984230369235,0.9877071988039257,0.501412429378531,1.0,1.0,3/13,17.77%,DDT;EHHADH;ECH1
prerank,translation initiation factor activity (GO:0003743),-0.2684376302655558,-0.9872919866142897,0.46710526315789475,0.9635653067051939,1.0,17/36,26.78%,EIF3E;EIF2S2;EIF2A;AGO2;EIF4E;EIF4A2;EIF2D;EIF3B;EIF5;EIF3K;EIF3I;EIF2B5;EIF2B2;EIF3D;EIF3L;EIF2B4;MTIF3
prerank,platelet-derived growth factor binding (GO:0048407),-0.38482429355358383,-0.9836620021157154,0.4583333333333333,0.9636829923259289,1.0,5/11,19.78%,COL5A1;COL6A1;COL4A1;PDGFA;COL1A1
prerank,histone acetyltransferase binding (GO:0035035),-0.3154686483858259,-0.9827608980129087,0.4495798319327731,0.9558824550513193,1.0,5/21,8.90%,MEF2A;KANSL1L;STAT1;HIF1A;TP53
prerank,LRR domain binding (GO:0030275),0.4272787235544502,0.9819374641340793,0.4935437589670014,1.0,1.0,4/14,15.37%,MRTFA;DDIT3;ROBO1;PAWR
prerank,iron ion binding (GO:0005506),0.3533067833521128,0.9817414391867273,0.511520737327189,1.0,1.0,14/48,20.47%,KDM7A;ISCA2;AGMO;ALKBH3;EGLN2;ETHE1;DNAJC24;HEPH;FTO;ABCE1;ALKBH1;TET1;NFU1;FTH1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.38560040173247123,-0.9815439059212444,0.48011363636363635,0.9485436493222923,1.0,9/11,61.46%,HCN2;HCN1;CNGB1;HCN4;CNGB3;AQP1;CNGA2;CNGA4;CNGA3
prerank,ATPase activator activity (GO:0001671),-0.30890816393305315,-0.9809239201883101,0.4824561403508772,0.939899304749138,1.0,8/20,22.76%,ATP1B3;DNAJC15;DNAJC1;ATP1B1;DNAJA2;DNAJB2;DNAJA1;AHSA1
prerank,phospholipase activity (GO:0004620),0.34049517846424737,0.9807747705691573,0.5288985823336968,1.0,1.0,15/67,21.23%,LPL;GPLD1;SMPD2;LYPLAL1;PRDX6;GDPD3;PITPNM3;ENPP2;SMPD4;DDHD2;PNPLA7;GDE1;SMPD1;ABHD16A;PLCL1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.3069761013710065,-0.9772542432625484,0.4646017699115044,0.940484059045746,1.0,6/21,9.65%,WASF2;PRRC1;EZR;PRKACA;AKAP9;AKAP7
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.4753078381229071,0.9770148531859657,0.511177347242921,1.0,1.0,3/10,15.46%,CASP7;CASP9;CASP2
prerank,methylated histone binding (GO:0035064),0.3433300950104427,0.9765925710160845,0.5124593716143012,1.0,1.0,15/62,18.61%,CBX8;KDM7A;CHD8;PHF1;CHD5;DPF2;CDYL;ATRX;PYGO1;CHD1;MORC4;CBX5;FMR1;SGF29;MPHOSPH8
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.37381995168737875,0.9742130661995091,0.5266418835192069,1.0,1.0,9/31,16.82%,UBE2S;UBE2E2;UBE2QL1;UBE2Z;UBE2A;UBE2J1;UBE2E1;UBE2D1;UBE2L3
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.37273240851170675,-0.9729880210630862,0.4934640522875817,0.9426908698500789,1.0,9/11,62.75%,CHRNA7;CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,amyloid-beta binding (GO:0001540),0.3322657791246652,0.9724196020911708,0.5284640171858217,1.0,1.0,18/79,18.62%,FCGR2B;PFDN4;EPHB2;GRIN1;ATP1A3;VBP1;GRIN2A;LRPAP1;PFDN1;GRIA1;LRP1;GRIA2;HSPG2;ITM2B;APOE;PFDN2;SORL1;ITM2C
prerank,transition metal ion binding (GO:0046914),0.3151657421330399,0.9716418714083567,0.5895895895895896,1.0,1.0,96/397,21.53%,GALT;MMP12;ADH5;XPNPEP3;SMPDL3B;NQO2;SIRT2;KDM7A;ISCA2;RNF8;ZNF8;RPH3A;KMT2B;ZNF205;ANPEP;GALNT4;TIMM13;DHX58;LACTB2;ABL1;ZEB1;TARS1;GPC1;TK1;KPNB1;MYCBP2;ZKSCAN5;GRIN2A;EPRS1;POMGNT1;FAM20C;MDM4;HDAC4;RNF11;SAP30L;NUDT12;ADAM33;AGMO;ENPP2;CUTA;KDM2B;COX17;ZCCHC4;PAPPA;ENPP1;PARK7;SOD2;SOD3;LANCL1;TDP2;ZMYM2;PAM;ADAMTS3;ETHE1;DNAJC24;BBOX1;GLRA1;LACC1;PPM1M;HEPH;SIRT5;ARIH2;TNKS;MBD1;DPEP1;SLC30A5;CHORDC1;ZFP37;MOXD1;USP33;NSD1;MDM2;S100A13;KMT2A;SEC24D;ABCE1;SLC11A2;SMPD1;TIMP2;TET1;MTPAP;KLF4;IMPA1;NFU1;MMP16;FTH1;CTCF;PTGR2;ZBTB32;TAB3;EXD2;TES;CBLB;ME1;COMMD1;ATOX1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.39554023381305764,0.971005275506348,0.5269086357947435,1.0,1.0,1/22,0.41%,DUSP18
prerank,metallocarboxypeptidase activity (GO:0004181),0.38597856301619626,0.963019083350281,0.5200974421437271,1.0,1.0,6/26,19.23%,CPXM1;AGBL3;PEPD;CPXM2;AGBL4;AGTPBP1
prerank,MHC protein binding (GO:0042287),-0.3055282578942274,-0.9629912621588668,0.5384615384615384,0.9622722383946438,1.0,8/20,31.85%,TAPBP;TAP2;ATP5F1B;ABCB9;CD81;TAP1;TUBB4B;CD74
prerank,triglyceride lipase activity (GO:0004806),0.40277056457038346,0.961845579967845,0.5283783783783784,1.0,1.0,1/20,0.96%,LPL
prerank,hyaluronic acid binding (GO:0005540),0.4583476050386255,0.9594403132000263,0.5381231671554252,1.0,1.0,1/10,1.16%,LYVE1
prerank,estrogen receptor binding (GO:0030331),-0.27820959572258314,-0.958442726052393,0.518918918918919,0.9649578153764091,1.0,6/32,5.09%,CNOT1;LATS1;LEF1;NCOA6;MED1;DCAF1
prerank,U6 snRNA binding (GO:0017070),0.4323153079384946,0.9568506466531399,0.5297450424929179,1.0,1.0,3/14,11.06%,LSM7;PRPF8;SART3
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.428831807045262,0.9560670336607037,0.539568345323741,1.0,1.0,2/13,11.52%,BMP6;BMP5
prerank,MAP kinase phosphatase activity (GO:0033549),-0.36006162040404177,-0.9545457450735777,0.5017543859649123,0.9665446174762081,1.0,5/12,32.76%,DUSP10;DUSP1;DUSP7;DUSP8;DUSP6
prerank,acetylcholine receptor activity (GO:0015464),-0.29405776643769865,-0.9535230494147934,0.5173913043478261,0.9596764637302234,1.0,3/22,14.43%,CHRM3;CHRFAM7A;CHRNA7
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.28857347952723766,-0.9533844737024678,0.5054945054945055,0.9501360796450579,1.0,9/27,15.29%,SLC26A7;SLC39A14;SLC26A2;ANO1;SLC39A8;SLC22A6;SLC26A11;SLC25A14;SLC5A5
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.45274700169653315,0.9533747596034524,0.5453194650817236,1.0,1.0,3/11,15.46%,CASP7;CASP9;CASP2
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.3181386240170077,-0.9530920695883808,0.5287356321839081,0.9413502220324614,1.0,4/17,5.50%,ATP8B1;ATP10A;PITPNA;PITPNC1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.3233030724860999,-0.9524209037666125,0.5433070866141733,0.9338153503893214,1.0,9/16,36.90%,SLC25A13;SLC25A14;SLC25A30;SLC25A11;SLC1A4;SLC25A22;SLC25A18;SLC13A5;SLC1A6
prerank,endodeoxyribonuclease activity (GO:0004520),0.3909428457148004,0.9506474753303378,0.5158730158730159,1.0,1.0,6/20,19.43%,APLF;ENDOV;MRE11;RAD50;RBBP8;RPS3
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3823269275723381,-0.9498923142943242,0.5028409090909091,0.9316549007514767,1.0,6/10,19.34%,NAA40;EP300;MSL3;BRCA2;KAT8;NAA60
prerank,TBP-class protein binding (GO:0017025),-0.3007281458815342,-0.949400638080419,0.5158371040723982,0.924096248312698,1.0,10/21,23.64%,THRA;TAF12;PSMC2;PSMC1;AHR;ESR1;DR1;TAF13;RUVBL1;TAF11
prerank,thioesterase binding (GO:0031996),0.44814906890081496,0.9488972210537622,0.5548872180451128,1.0,1.0,1/11,2.78%,RAC1
prerank,clathrin adaptor activity (GO:0035615),-0.3363100359288417,-0.9466812155372606,0.5275862068965518,0.9226120836648176,1.0,5/15,18.44%,AP2A2;HIP1;AP1M1;AP2M1;LDLRAP1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.30412284536020984,0.9460186068738844,0.749,1.0,1.0,168/831,20.84%,TEAD3;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SP7;ZNF23;CIART;FOXM1;ZBTB48;POU5F2;NFKB1;ZNF25;ZBTB46;ZNF568;PKNOX2;CC2D1B;ZEB2;USF1;NR2F2;MLXIP;TEF;NKX6-1;NKX2-2;MAFG;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;ZNF8;ZFP82;XBP1;RORA;TFDP1;NFKB2;CARF;MXI1;ZNF205;POU2F1;RFX5;SNAI1;ZNF692;TCF4;TCF7L2;TFCP2;IRF1;TBP;ZNF35;ZIC3;CASZ1;ARNT;ZBTB7B;ZEB1;TEAD1;HDAC5;MXD1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ZKSCAN5;DBP;NFX1;SOX9;DDIT3;PGBD1;ZFHX2;PER1;DHX36;ZSCAN20;HDAC4;SOX11;TWIST1;CALCOCO1;PRRX1;NKRF;RBL2;HOXB8;ATF2;POU6F2;TOP1;ZBTB20;ZNF445;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SARS1;BACH2;MAZ;NFAT5;IRF3;ZNF471;YY1;NACC2;E2F3;NFIX;BACH1;PEG3;SOX6;HDAC1;CEBPG;ZFP2;CREB3;CREB3L4;ZNF383;PROX2;FOXJ3;EBF1;ZIC2;TRPS1;ESRRG;BCL6;SOX5;RFX3;NR2C2;SATB1;TCF7L1;TCF3;FOXC2;CIC;GTF2IRD1;MAF;HOXC8;CLOCK;KDM6B;THRAP3;ZFP37;SOX13;ZBTB41;OSR1;ZFP90;TCF7;NFXL1;NSD1;MEIS2;RELB;ZNF177;CUX1;BCL11B;CHD2;FOXD1;KLF13;SOX4;ZIC4;RPS3;KDM6A;MITF;KLF4;GABPA;NFIA;PRDM15;DNMT3A;E2F6;PKNOX1;GLIS3;TBPL1;HDX;HNRNPU;CTCF;ZNF219;CREB5;ZBTB32;MYNN
prerank,GTPase activator activity (GO:0005096),0.3055189876974977,0.9456434963756128,0.655,1.0,1.0,79/313,18.77%,ELMOD1;MTSS2;TSC2;SH3BP5;TBC1D7;SGSM3;RUNDC1;NUCB2;RAP1GDS1;RGS10;ARHGEF10;NRP1;GAPVD1;TBC1D13;FLCN;SYDE2;ARHGAP20;ERRFI1;SMAP1;ARHGAP19;SRGAP2;THY1;ARHGEF7;ARHGEF4;RASGRP2;RASGEF1A;RANBP3L;KALRN;MYCBP2;RAP1GAP;ARRB1;ARHGAP42;DOCK8;RAP1GAP2;SH3BP5L;RCC1L;EGF;RALGPS1;RAPGEF1;RABGAP1L;VAV2;ARHGAP24;TBC1D20;DENND4C;DENND5A;RIC8B;USP6NL;BNIP2;EVI5L;ALS2;IQGAP1;ARHGEF10L;MON1A;ARAP1;RCC1;LAMTOR5;AKAP13;RASGEF1B;FARP1;ADAP1;EEF1B2;RABGAP1;ARHGAP29;DNM1L;CYTH1;FARP2;DNMBP;TBCD;ARHGEF6;EPS8L1;DENND6A;GNAQ;TBC1D9B;TBC1D22B;CCDC88A;SGSM2;ADGRB3;RANBP2;RANBP3
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.30444623585660247,0.9455137311563361,0.736,1.0,1.0,100/731,12.66%,TEAD3;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SP7;ZNF23;CIART;ZBTB48;POU5F2;NFKB1;ZNF568;PKNOX2;CC2D1B;ZEB2;USF1;NR2F2;MLXIP;TEF;NKX6-1;NKX2-2;MAFG;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;ZNF8;ZFP82;XBP1;RORA;NFKB2;CARF;MXI1;ZNF205;POU2F1;RFX5;SNAI1;ZNF692;TCF4;TCF7L2;TFCP2;IRF1;ZIC3;ARNT;ZBTB7B;ZEB1;TEAD1;HDAC5;MXD1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ZKSCAN5;DBP;SOX9;DDIT3;PGBD1;ZFHX2;PER1;DHX36;PRMT5;ZSCAN20;HDAC4;SOX11;TWIST1;CALCOCO1;PRRX1;NKRF;ATF2;POU6F2;TOP1;ZBTB20;ZNF445;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SARS1;BACH2;MAZ;NFAT5;IRF3;ZNF471;YY1;NACC2;E2F3;NFIX;BACH1;SOX6;HDAC1;CEBPG;ZFP2;CREB3;CREB3L4;ZNF383
prerank,BMP receptor binding (GO:0070700),0.4288390386017093,0.9451051058704774,0.5552367288378766,1.0,1.0,2/12,11.52%,BMP6;BMP5
prerank,RNA binding (GO:0003723),0.3035200243615362,0.9448060558140803,0.786,1.0,1.0,305/1321,18.55%,ILF3;FASN;SRP19;NHP2;KHSRP;HEXIM1;AFF2;BICC1;RAVER2;LSM6;EXOSC1;CDC42EP4;EXOSC3;APTX;GNL3;TARBP2;YARS1;DHX40;ANXA7;DGCR8;DDX17;NOP9;PSMD4;LSM7;DNM1;TRMT2A;DDX18;TBRG4;TOE1;SUGP2;CHERP;HMGB3;DDX19B;SLBP;EBNA1BP2;RBM4B;PARP1;FAM50A;HSP90AA1;EXOSC7;EXOSC2;RBM3;PRKRIP1;TRUB2;FBL;U2AF1;SRSF2;DIMT1;RBM47;PCBP4;LRRC47;ANP32A;NOP56;RPL22L1;ZFP36L1;PRPF8;ZCCHC8;SRSF12;DDX3X;PSPC1;YARS2;DHX15;RAE1;POLR2B;CDK13;SRSF5;SLTM;SPATS2;TBCA;IGF2BP2;FUBP1;DRG2;SF3B2;SF3B1;DHX30;STIP1;DCN;CNBP;MTCL1;RBM39;DCP1B;CELF2;DHX58;LACTB2;PUS10;ARL6IP4;CARS1;DHX8;SARS2;BARD1;ZC3H4;NOL12;SRSF3;CELF1;TRIM56;HNRNPK;AKAP8L;FUS;MPHOSPH10;TIA1;RTF1;SRSF9;DHX33;CCT6A;CKAP4;HADHB;IFIT3;SF3A1;WRAP53;AARS1;KPNB1;KHDRBS2;DDX46;PEF1;RCAN3;NFX1;PRPF6;SRSF1;FNDC3B;SRP9;TBL2;EIF1B;UBA1;GCN1;BUD23;MDH2;WDR6;USP10;EPRS1;RBM18;XRCC6;PABPC4;KIN;RCC1L;HNRNPD;RBMS3;DHX36;PPP1CC;PPIB;MRPL21;PUM3;MRPL10;RBM34;LIN28B;CPSF7;HNRNPM;VCP;NOL7;ANKHD1;PUS7;PABPC1;PSIP1;NKRF;ZC3H7B;YWHAG;MRPL1;ESF1;RPL35A;RPS25;MTREX;MYH10;TOP1;RBM10;HDLBP;RBFOX2;ZC3H14;ENDOV;SART3;CSTF2T;SHFL;SARS1;RC3H2;MAZ;RPS15;EIF4E2;RBMS1;MYO5A;YY1;TRMT1;JAKMIP1;NUDT21;EIF4G2;DYNC1LI1;RBMS2;ATXN2L;NEMF;PTCD2;YTHDF3;DHX16;FLNB;PARK7;EIF1AX;EIF1;NPM1;CPSF3;TIAL1;HNRNPA0;CFAP20;RPL9;AGO3;PEG10;RACK1;MYEF2;HNRNPH3;PRMT1;DHX57;SETX;SRP68;RBM45;HNRNPL;MRPL3;GSPT1;TLR3;METAP2;YTHDF1;TRA2B;LUC7L2;SIDT1;RPP30;C1D;LRP1;SUCLG1;RPL4;SND1;SCAF4;KHDC4;FAM98A;TUBA1B;MAPT;CSDC2;BMS1;NOVA1;ROCK2;CHCHD1;HNRNPA2B1;RBM26;PRPF40A;HELB;USO1;BCLAF1;XRN1;MRPL13;RP9;ISG20L2;HNRNPLL;NUCKS1;CELF5;SPTBN1;TNPO1;HSPD1;RPL7L1;CCDC9;TFB1M;DDX5;GRSF1;AHNAK;SAFB2;HNRNPDL;ZC3HAV1;YTHDC1;NUDT16L1;SNW1;LAS1L;DDX19A;EIF4G3;ANXA2;DNAJC21;FMR1;UBE2L3;THRAP3;RPL23A;OAS2;MSI1;TOP3B;ZC3H7A;MTDH;ZC3H12C;MRPL15;DHX34;PTCD1;SON;DHX29;SRRM1;PNISR;BCCIP;NSA2;FASTKD1;PRPF40B;LUC7L3;CPSF6;RBM27;ZC3H18;PCBP2;MAP4;TENT5A;SMG7;ASS1;BRIX1;MECP2;RBM22;HLTF;NOL4;SRPK1;NONO;BAG4
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3030303626990779,0.9416179027019558,0.752,1.0,1.0,99/732,12.66%,TEAD3;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SP7;ZNF23;CIART;ZBTB48;POU5F2;NFKB1;ZNF568;PKNOX2;CC2D1B;ZEB2;USF1;NR2F2;MLXIP;TEF;NKX6-1;NKX2-2;MAFG;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;ZNF8;ZFP82;XBP1;RORA;NFKB2;CARF;MXI1;ZNF205;POU2F1;RFX5;SNAI1;ZNF692;TCF4;TCF7L2;TFCP2;IRF1;ZIC3;ARNT;ZBTB7B;ZEB1;TEAD1;HDAC5;MXD1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ZKSCAN5;DBP;SOX9;DDIT3;PGBD1;ZFHX2;PER1;DHX36;ZSCAN20;HDAC4;SOX11;CALCOCO1;PRRX1;NKRF;ATF2;POU6F2;TOP1;ZBTB20;ZNF445;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SARS1;BACH2;MAZ;NFAT5;FOXN3;IRF3;ZNF471;YY1;NACC2;E2F3;NFIX;BACH1;SOX6;HDAC1;CEBPG;ZFP2;CREB3;CREB3L4;ZNF383
prerank,ephrin receptor binding (GO:0046875),0.38376116992139103,0.940261229770269,0.5348837209302325,1.0,1.0,6/21,20.59%,ABL1;EFNB3;EFNB2;CBL;LYN;CHN1
prerank,androgen receptor binding (GO:0050681),0.37074941123116234,0.9396226053429599,0.5651612903225807,1.0,1.0,9/25,19.08%,WIPI1;TGFB1I1;PRPF6;PARK7;DDX5;SNW1;DAXX;NSD1;PRMT2
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.39063175973121617,0.93803112379738,0.5589005235602095,1.0,1.0,6/20,16.89%,SLC30A10;SLC39A1;SLC30A1;SLC39A6;SLC30A3;SLC30A5
prerank,zinc ion binding (GO:0008270),0.30646677779382403,0.9372798630134189,0.6773547094188377,1.0,1.0,67/293,21.25%,GALT;MMP12;ADH5;SMPDL3B;NQO2;SIRT2;KDM7A;RNF8;ZNF8;RPH3A;KMT2B;ZNF205;ANPEP;TIMM13;DHX58;LACTB2;ZEB1;TARS1;TK1;KPNB1;MYCBP2;ZKSCAN5;GRIN2A;EPRS1;MDM4;HDAC4;RNF11;SAP30L;NUDT12;ADAM33;ENPP2;KDM2B;ZCCHC4;PAPPA;ENPP1;LANCL1;ZMYM2;PAM;ADAMTS3;DNAJC24;BBOX1;GLRA1;SIRT5;ARIH2;TNKS;MBD1;DPEP1;SLC30A5;CHORDC1;ZFP37;USP33;NSD1;MDM2;S100A13;KMT2A;SEC24D;SMPD1;TIMP2;TET1;KLF4;MMP16;CTCF;PTGR2;ZBTB32;TAB3;TES;CBLB
prerank,GABA receptor binding (GO:0050811),0.4386037530834989,0.9355305285802498,0.5597579425113465,1.0,1.0,3/11,15.81%,PLCL2;JAKMIP1;TRAK1
prerank,voltage-gated anion channel activity (GO:0008308),0.40230308128818604,0.9345723344256971,0.5447042640990372,1.0,1.0,4/15,13.34%,CLCN2;VDAC2;CLCN4;VDAC1
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.2461784081730623,-0.9345677859958896,0.5675675675675675,0.9471468773470999,1.0,12/38,18.44%,SORBS1;IRS1;NCK1;LRRK2;SPAG9;AXIN1;SHANK3;SHANK2;CARD10;GRIP1;SH2B3;LDLRAP1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3463617890623826,-0.9318490632479408,0.5392156862745098,0.9455538487796551,1.0,3/12,9.74%,SLC9A2;LETM1;SLC9B2
prerank,serine-type peptidase activity (GO:0008236),0.32043251361920017,0.9312735135179095,0.6234177215189873,1.0,1.0,11/96,17.07%,RHBDL3;PCSK5;PCSK2;HTRA3;PLAT;MBTPS1;PRSS12;F3;RHBDF1;CTSH;PARL
prerank,GTPase activity (GO:0003924),0.30509535475855937,0.9297695584980142,0.6424974823766365,1.0,1.0,42/192,18.38%,GPN2;ATL1;GBP3;DNM1;RAC1;GPN3;SAR1A;RAB24;DDX3X;ENTPD7;DNAJC27;DRG2;GBP7;MFN1;RRAGA;RAP2A;RHOD;GNB2;MFN2;RAP1GAP;RAB5B;GNAS;DRG1;RHOBTB3;RAB3B;GSPT1;TBC1D24;BMS1;GBP6;DNM1L;RAB31;RAB8A;RAB8B;MTG2;RIT2;TPPP;RAB21;GNAQ;MRAS;RRAS2;RAB6A;ARL8B
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.30407724184538226,0.9297563282286686,0.6649848637739657,1.0,1.0,42/181,19.94%,HDAC3;TEAD3;DUSP26;BBS10;SMARCD3;COMMD6;MIER2;TAF4;TCF7L2;BBS7;TBP;TACC1;ARNT;SMARCB1;HDAC5;TTC8;CDK5RAP3;HDAC4;PRRX1;RBL2;ATF2;TAF6;JUP;RBPJ;MTA2;NPM1;TADA3;HDAC1;PIAS3;TCF3;FAF1;SNW1;TRIP4;MTDH;ANXA4;RBBP8;ATN1;NCOR2;NCOA3;KLF4;PIAS1;MIER1
prerank,ATP binding (GO:0005524),0.30255428170115517,0.9269815096811358,0.6923847695390781,1.0,1.0,60/266,19.61%,STK36;PIP4K2B;HSP90AA1;GALK1;DMPK;CDKL5;TAOK1;ATP1A3;YARS2;ABCA2;NUAK2;MINK1;MAP4K5;CHD8;MYO1B;ABL1;CARS1;SARS2;STK11;N4BP2;BRSK2;TARS1;ATP1A2;AARS1;SIK1;DHX36;PRAG1;RHOBTB3;WNK2;MTREX;MYH10;TOP1;BRSK1;PEX1;ABCF3;TLK1;ENPP1;ABCF2;HARS1;PRKCI;DAPK1;AK6;PPP5C;ACVR1B;ABCD2;SYN2;MLKL;OAS2;OXSR1;LANCL2;SRPK1;TGFBR1;ABCC6;ABCE1;CDC42BPB;PGK1;PRKAG2;KSR1;MTPAP;CDK11B
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.3765176169620261,-0.9269081744411477,0.5621301775147929,0.9497508295963603,1.0,4/10,20.27%,NAA15;NAA25;NAA60;NAA80
prerank,lipoprotein particle binding (GO:0071813),0.37860988317703337,0.9218271577599356,0.5766710353866317,1.0,1.0,4/20,17.95%,LPL;MAPT;HSPD1;SORL1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.29873690148263615,0.9217854127193347,0.701,1.0,1.0,67/269,18.55%,PTPRN;UQCRC1;HSP90AA1;RNF8;STUB1;USP7;SLC22A18;UCHL1;FBXO7;UBXN7;PRDX6;SLF2;SQSTM1;ERLIN2;BAG1;RRAGA;HGS;CXCR4;RFFL;WRAP53;MFN2;GPR37;ARRB1;HM13;RNF40;PER1;JKAMP;AUP1;CCDC50;CDK5RAP3;CUL4B;NDUFS2;VCP;USP2;BCL2;EIF4E2;AXIN2;UBE2A;UBE2J1;PTPN22;CUL5;TUBA1B;MAP1LC3B;TUBB;SMAD6;DNM1L;PSMD1;ACVR1B;FAF1;HSPD1;CKB;CHEK2;UBE2D1;TXNIP;DERL1;TRIP4;NEDD8;DAXX;UBE2L3;TANK;MDM2;PCBP2;JAK1;PACRG;PRKAR1A;HLTF;BAG4
prerank,cGMP binding (GO:0030553),-0.3622538143850451,-0.9213847118051949,0.563076923076923,0.9558792104299574,1.0,1/11,0.78%,PDE5A
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4285930011351611,0.9207292808758619,0.5829662261380323,1.0,1.0,3/12,14.04%,PIK3R1;FRS2;BLNK
prerank,tau protein binding (GO:0048156),0.34182417158948003,0.9197675711931503,0.6054181389870436,1.0,1.0,12/40,18.71%,BIN1;HSP90AA1;STUB1;TAOK1;CDK5;BRSK2;BRSK1;ROCK2;PPP5C;PPP2CB;APOE;PRKAA1
prerank,mRNA methyltransferase activity (GO:0008174),0.4275420726275175,0.9192989593980347,0.5813609467455622,1.0,1.0,1/12,0.77%,TRMT61B
prerank,Tat protein binding (GO:0030957),-0.3725451454792664,-0.9179761017324738,0.5795795795795796,0.9562522601701938,1.0,3/10,8.04%,MDFIC;ACTB;CTDP1
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.35227871893244644,-0.9166104853795292,0.5639344262295082,0.9511871271624718,1.0,3/12,8.71%,BACE2;BACE1;DDI2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.34180768018409524,-0.9160083867285952,0.5413533834586466,0.944303996584308,1.0,6/13,22.30%,SLC7A1;SLC7A6;SLC7A7;SLC15A4;SLC66A1;SLC38A5
prerank,GTPase inhibitor activity (GO:0005095),-0.33416538131830337,-0.9148132403049051,0.5760517799352751,0.9388587697820179,1.0,8/13,24.32%,SLIT2;TNK2;CPEB2;IPO5;IQGAP2;CDC42SE1;ARL2;RHOH
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.32452351267472285,-0.9146773087855808,0.5759717314487632,0.9306968059748927,1.0,6/15,12.36%,KMT2C;WDR82;RBBP5;SETD1B;SETD3;WDR5
prerank,protein heterodimerization activity (GO:0046982),0.29789745329330053,0.9142016686533413,0.6726907630522089,1.0,1.0,38/178,17.71%,LSM6;BAX;BMP6;USF1;XBP1;SAE1;FZD9;FBXO7;TENM3;TCF4;BARD1;ARNT;RRAGA;GTF2A2;ATP1A2;PEF1;BUD23;BDKRB2;DDIT3;SDCBP;YWHAH;PRMT5;KATNB1;TPM1;PIK3R2;BCL2;ADD2;RCC1;ZHX2;TENM4;TCF3;VAPB;AGTR1;FMR1;EXT2;MICU2;MTTP;QTRT2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3302925597323646,0.913806709035049,0.6290143964562569,1.0,1.0,7/51,10.92%,SLC4A4;SLC35D2;SLC22A4;ANKH;SLC20A2;CLCN4;SLC22A8
prerank,chemorepellent activity (GO:0045499),0.3638888114841994,0.9137935784641138,0.6128205128205129,1.0,1.0,6/25,15.56%,EPHA7;NRG3;SEMA3D;NRG1;SEMA3E;SEMA3A
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3440589823177131,-0.912343996160421,0.5637583892617449,0.9285527566409962,1.0,6/12,22.25%,CNOT1;NOCT;PARN;CNOT8;CNOT7;CNOT2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4328816491656008,0.9116048167224969,0.5848484848484848,1.0,1.0,2/10,8.00%,RENBP;GALE
prerank,calcium:sodium antiporter activity (GO:0005432),0.4363588915355948,0.911594024477485,0.5849624060150376,1.0,1.0,2/10,8.64%,SLC24A5;SLC24A4
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.34498550439634557,0.9107128586391164,0.6063569682151589,1.0,1.0,9/34,16.82%,UBE2S;UBE2E2;UBE2QL1;UBE2Z;UBE2A;UBE2J1;UBE2E1;UBE2D1;UBE2L3
prerank,cell adhesion mediator activity (GO:0098631),0.36375589200648933,0.910594455338338,0.5994930291508238,1.0,1.0,8/24,20.32%,SIRPA;DSCAM;JAM3;CD47;NPTN;PLXNB3;CNTN2;NEXN
prerank,SH3 domain binding (GO:0017124),-0.21208594503814449,-0.9104375942728066,0.7529411764705882,0.9252862721629187,1.0,12/62,12.24%,WASF2;CD2AP;DAB2IP;REPS1;SOCS7;AFAP1L2;SGIP1;PLSCR1;ABI2;ADAM15;VASP;SHANK3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4153426585224204,0.9088571444597249,0.5915697674418605,1.0,1.0,2/11,10.86%,RDH11;AKR1B10
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3302762349086453,-0.9087147993446755,0.5723684210526315,0.9215607250138372,1.0,3/13,9.74%,SLC9A2;LETM1;SLC9B2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.3567886510576862,-0.908521731571221,0.5522388059701493,0.9141809332634387,1.0,10/11,64.35%,DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;DDAH1;PADI3;PADI6
prerank,N-methyltransferase activity (GO:0008170),0.3773189545555547,0.9084926528634385,0.5934959349593496,1.0,1.0,7/20,18.42%,DIMT1;NNMT;ZCCHC4;TRMT1;PRMT1;TFB1M;METTL5
prerank,retinoid X receptor binding (GO:0046965),-0.3648357279659041,-0.9084239667246243,0.5661538461538461,0.9066103838072692,1.0,7/11,28.03%,NCOA6;RARG;MED25;NRIP1;PPARG;NR4A2;ARID5A
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.2506353270258647,-0.9075180710737145,0.6553398058252428,0.9014200754552558,1.0,12/32,28.23%,SLC6A6;SLC3A2;SLC6A9;SFXN2;SLC36A4;SLC43A2;SLC38A5;SLC1A4;SFXN3;SLC36A1;SLC43A1;SLC6A7
prerank,proton transmembrane transporter activity (GO:0015078),-0.24509848728628383,-0.906346933317896,0.6415094339622641,0.8966908973452191,1.0,16/39,28.72%,SLC33A1;CLCN3;COX4I1;COX5A;COX8A;CTNS;NDUFA4;COX7A2L;COX6A1;DMAC2L;COX15;UQCR10;UQCRQ;UQCR11;NNT;COX5B
prerank,phosphatase binding (GO:0019902),0.30679831137220315,0.9051569633909624,0.6673575129533679,1.0,1.0,34/105,22.66%,TSC2;EIF2AK3;STAT6;KIF3A;ANK1;PIK3R1;DLG3;SIRPA;RCAN3;MVP;VCP;PPP6R3;JUP;PIK3R2;AP3B1;IQGAP1;MAGI2;RACK1;ANAPC4;TRPC4AP;STX17;MTMR4;JAK1;TERF2IP;ANAPC5;KIFAP3;SYTL2;SPTBN4;SMAD2;TRAF2;CNST;SMAD3;ITGA1;MAP2K7
prerank,adenyl ribonucleotide binding (GO:0032559),0.29448138014979003,0.9050381389620155,0.7327327327327328,1.0,1.0,64/291,19.61%,STK36;PIP4K2B;HSP90AA1;GALK1;DMPK;CDKL5;TAOK1;ATP1A3;YARS2;ABCA2;NUAK2;PDE4A;MINK1;MAP4K5;CHD8;MYO1B;ABL1;CARS1;SARS2;STK11;N4BP2;BRSK2;TARS1;ATP1A2;AARS1;SIK1;DHX36;PRAG1;RHOBTB3;WNK2;MTREX;MYH10;TOP1;BRSK1;PEX1;ABCF3;TLK1;ENPP1;ABCF2;HARS1;GCLC;PRKCI;DAPK1;AK6;PPP5C;ACVR1B;ABCD2;PDE10A;PDE4B;SYN2;MLKL;OAS2;OXSR1;LANCL2;SRPK1;TGFBR1;ABCC6;ABCE1;CDC42BPB;PGK1;PRKAG2;KSR1;MTPAP;CDK11B
prerank,Wnt-activated receptor activity (GO:0042813),0.40173018578716707,0.904289161804964,0.6095890410958904,1.0,1.0,2/15,4.16%,FZD9;FZD3
prerank,MAP kinase kinase activity (GO:0004708),0.3998763207265662,0.9041360311089904,0.5865384615384616,1.0,1.0,6/15,23.75%,PAK3;MAP2K2;MAP2K7;MAP2K3;MAP2K1;MAP2K6
prerank,methylation-dependent protein binding (GO:0140034),0.3204643962326652,0.9036193376727011,0.6395604395604395,1.0,1.0,13/57,18.61%,CBX8;KDM7A;CHD8;PHF1;CDYL;ATRX;PYGO1;CHD1;MORC4;CBX5;FMR1;SGF29;MPHOSPH8
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.38862645085248515,0.9030489872338294,0.5734265734265734,1.0,1.0,3/15,9.16%,HS2ST1;NDST2;HS6ST2
prerank,channel activity (GO:0015267),0.33296570299115985,0.9015945931049189,0.6268656716417911,1.0,1.0,4/41,14.55%,BAX;SLC14A1;BCL2;AQP4
prerank,bHLH transcription factor binding (GO:0043425),-0.2972896103983677,-0.901408592084139,0.60546875,0.9008878177398756,1.0,6/19,11.70%,TCF12;SIRT1;MAP3K10;LMO2;USF2;PSMD9
prerank,phospholipase binding (GO:0043274),0.4130543313159576,0.8996469629138375,0.6014084507042253,1.0,1.0,4/13,20.16%,PDPK1;BLNK;PAFAH1B1;ARHGAP6
prerank,cation channel activity (GO:0005261),0.30475353235601216,0.8993823261171411,0.6691176470588235,1.0,1.0,10/94,9.53%,PKD2L2;NALCN;SLC24A5;TMEM63A;GRIN1;TMEM63C;CALHM2;SLC24A4;TRPM3;KCNQ4
prerank,transmitter-gated ion channel activity (GO:0022824),-0.2581371296120743,-0.899048953674749,0.6645161290322581,0.8991318790085094,1.0,11/29,22.71%,GABRB1;GABRG2;GABRA5;GLRA2;GABRA4;GRIK3;GRIN2D;GABRG1;GABRA1;GRIK4;GLRA3
prerank,protein homodimerization activity (GO:0042803),0.28812223851434277,0.8982126525750467,0.844,1.0,1.0,107/589,16.99%,TNNC1;XPNPEP3;LPL;CAMK2B;NQO2;BAX;TARBP2;CACYBP;DGCR8;GBP3;TSC2;CLN6;DCK;PIP4K2B;RAB11FIP4;HSP90AA1;RNF8;STUB1;PAXX;USF1;NR2F2;FGFR2;FGFR1;WARS1;ERP29;GLIPR2;MAD2L1;GLB1;FZD9;YARS2;ST3GAL2;PON3;SNF8;TKT;TENM3;MTCL1;SRGAP2;SRM;BARD1;SNX6;ARNT;ZBTB7B;RRAGA;GTF2A2;ZBTB38;ZDHHC3;HSD17B4;RAP1GAP;GALE;HM13;RDH5;DDIT3;TRIM9;EPRS1;RNF40;GNPTG;GDNF;TPM1;JUP;DPY30;PTH1R;BCL2;SARS1;PDGFRA;IRF3;ALS2;TARS2;CNOT9;CAMK2D;NUDT21;NACC2;CARNMT1;ENPP1;PARK7;VPS4B;CAMK2G;SOX6;STARD3;NPM1;ADD2;RACK1;HARS1;FBLN5;PIP4K2A;PEX7;PSAP;ZHX2;NRBP1;ACSL6;EPHX2;ABCB7;DNM1L;DPYD;TENM4;TCF3;VAPB;ABCD2;PRMT8;CHEK2;NUDT16L1;MAPK4;TERF1;TPPP;FMR1;ALDH3A2;STK25;EXT2
prerank,DNA binding (GO:0003677),0.2882939990619023,0.8980080518739344,0.859,1.0,1.0,130/694,18.35%,ILF3;CAMTA2;MMP12;POU6F1;SP7;APTX;DNASE1L2;MYRF;RNF138;HMGB3;NTHL1;ZEB2;CREBZF;USF1;NR2F2;AIFM2;ZNF8;XBP1;RORA;CARF;DDX3X;TAF4;MPG;CHD8;SDE2;POU2F1;RFX5;SLTM;FUBP1;CDK9;PALB2;TCF4;TCF7L2;TFCP2;FBH1;CNBP;IRF1;MLH1;SPO11;ABL1;DDB1;PHF1;ZNF35;TDP1;ZIC3;ARNT;RTF1;ZNF711;SMARCB1;TEAD1;SNAPC4;FANCG;TSHZ2;SOX9;DDIT3;XRCC6;KIN;DHX36;HDAC4;APLP2;ARID4A;CUL4B;RNF11;SAP30L;CALCOCO1;PSIP1;TOP1;DCLRE1A;KDM2B;APP;TAF6;RBPJ;ENDOV;BCL2;RC3H2;RPS15;IRF3;RBMS1;YY1;SMARCA1;E2F3;BRIP1;PARK7;SOX6;CEBPG;TDP2;PMS2;SETX;CBFB;CENPC;C1D;FOXJ3;MAPT;ZIC2;CAMTA1;BCL6;BCLAF1;ZNF292;XRN1;KMT2D;NUCKS1;MRE11;RFX3;NR2C2;SATB1;TCF7L1;TCF3;NUPR1;SSBP2;FOXC2;HSPD1;SAFB2;BCLAF3;CLOCK;RAD50;CCNT1;TERF1;MBD1;THRAP3;SOX13;HP1BP3;TOPORS;NABP2;TOP3A;PCBP2;MEIS2;HMCES;RBBP8;MECP2;CUX1
prerank,RNA stem-loop binding (GO:0035613),0.40931874817965574,0.8978265095701454,0.5934379457917262,1.0,1.0,5/12,16.79%,DDX3X;EPRS1;MYH10;RC3H2;FMR1
prerank,ferrous iron binding (GO:0008198),0.36764572085795677,0.8971622896766527,0.6036269430051814,1.0,1.0,7/21,20.47%,ALKBH3;EGLN2;DNAJC24;HEPH;FTO;ALKBH1;FTH1
prerank,receptor tyrosine kinase binding (GO:0030971),0.32100020468368107,0.8957898764548133,0.64340239912759,1.0,1.0,12/56,14.97%,PIK3R1;SQSTM1;FRS2;NRG3;PITPNM3;SHC4;PIK3R2;RACK1;BLNK;NRG1;RNF41;CBL
prerank,sulfuric ester hydrolase activity (GO:0008484),0.4207502683361088,0.8956278000749215,0.6059322033898306,1.0,1.0,3/12,14.45%,SULF1;ARSG;ARSB
prerank,phosphatidic acid binding (GO:0070300),0.37119991083669596,0.8948256403288236,0.6111888111888112,1.0,1.0,2/19,2.84%,GSDMD;PLEKHN1
prerank,ubiquitin protein ligase binding (GO:0031625),0.2905050788764732,0.8947822650010948,0.7597597597597597,1.0,1.0,63/254,18.55%,UQCRC1;HSP90AA1;RNF8;STUB1;USP7;SLC22A18;UCHL1;FBXO7;UBXN7;PRDX6;SLF2;SQSTM1;ERLIN2;BAG1;RRAGA;CXCR4;RFFL;WRAP53;MFN2;GPR37;ARRB1;HM13;RNF40;PER1;JKAMP;AUP1;CCDC50;CUL4B;NDUFS2;VCP;USP2;BCL2;EIF4E2;AXIN2;UBE2A;UBE2J1;PTPN22;CUL5;TUBA1B;MAP1LC3B;TUBB;SMAD6;DNM1L;PSMD1;ACVR1B;FAF1;HSPD1;CKB;CHEK2;UBE2D1;TXNIP;DERL1;NEDD8;DAXX;UBE2L3;TANK;MDM2;PCBP2;JAK1;PACRG;PRKAR1A;HLTF;BAG4
prerank,nuclear receptor binding (GO:0016922),0.29608483725124946,0.8946800915417333,0.6892596454640251,1.0,1.0,35/111,22.79%,WBP2;MED24;SMARCD3;MED12;MED14;WIPI1;TCF7L2;MED13;TACC1;TGFB1I1;GAS2L1;MED4;PRPF6;YWHAH;BRD8;JUP;PARK7;TADA3;MMS19;DDX5;SNW1;TRIP4;DAXX;THRAP3;NSD1;NCOR2;PRMT2;NCOA3;TRIP12;SMAD3;TAF1;GTF2B;PKN1;MED17;NCOA1
prerank,MAP kinase activity (GO:0004707),0.3920554698376678,0.893317766692,0.6201117318435754,1.0,1.0,3/14,16.36%,MAPK9;MAPK6;MAPK4
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.27019321910316124,-0.8925960304173755,0.6138613861386139,0.9068363755721293,1.0,8/25,23.25%,PLEK;ZFYVE1;DAPP1;HIP1;ARAP3;KIF16B;AKT1;FCHSD2
prerank,SUMO transferase activity (GO:0019789),0.38845772818133284,0.8925954932842586,0.6086956521739131,1.0,1.0,6/16,19.91%,HDAC4;PIAS3;TOPORS;MDM2;RANBP2;PIAS1
prerank,ribosomal small subunit binding (GO:0043024),0.3820170987283703,0.8922361366945918,0.6206896551724138,1.0,1.0,6/17,18.76%,DDX3X;EIF1B;EIF1;NPM1;DHX29;ABCE1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.341596562193935,0.8911857980461687,0.6420927467300832,1.0,1.0,11/34,20.73%,NDUFA7;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;NDUFB4;NDUFA6;NDUFA2;NDUFB3;NDUFA12
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.341596562193935,0.8911857980461687,0.6420927467300832,1.0,1.0,11/34,20.73%,NDUFA7;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;NDUFB4;NDUFA6;NDUFA2;NDUFB3;NDUFA12
prerank,cholesterol transfer activity (GO:0120020),-0.3096900256028093,-0.8897144469657654,0.6135458167330677,0.9068592725230182,1.0,3/16,6.39%,OSBPL2;GRAMD1B;GRAMD1C
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.25822980880510193,-0.8895340434463453,0.6945812807881774,0.8999944183302037,1.0,11/27,32.09%,SLC9A2;SLC3A2;SLC8B1;SLC9B2;SLC4A8;SLC9A8;KCNK1;CNNM4;SLC8A1;SLC9A5;SLC8A2
prerank,transferrin receptor binding (GO:1990459),-0.35899722165898446,-0.8893681589511051,0.6195965417867435,0.8931998516870597,1.0,3/10,10.78%,IKBKB;SNX2;IKBKG
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.2888894219236201,-0.8889378552806735,0.6398104265402843,0.8869251156978262,1.0,3/21,14.43%,GRM1;CHRFAM7A;CHRNA7
prerank,nucleoside-triphosphatase activity (GO:0017111),0.28981015373695945,0.8887339393151167,0.7570281124497992,1.0,1.0,52/248,18.76%,GPN2;ATL1;GBP3;DNM1;HSP90AA1;MYO19;RAC1;GPN3;SAR1A;RAB24;DDX3X;ENTPD7;DNAJC27;DRG2;GBP7;MFN1;KIF3C;RRAGA;RAP2A;RHOD;GNB2;MFN2;RAP1GAP;RAB5B;ATP2B1;GNAS;DRG1;TOR1B;VCP;RHOBTB3;RAB3B;VPS4B;GSPT1;TBC1D24;BMS1;GBP6;DNM1L;RAB31;ABCD2;RAB8A;RAB8B;MTG2;RIT2;TPPP;RAB21;DHX29;GNAQ;MRAS;RRAS2;RAB6A;ARL8B;KIF20B
prerank,galactosyltransferase activity (GO:0008378),0.40773759878703986,0.8883585541305948,0.6003062787136294,1.0,1.0,2/11,12.71%,A4GALT;B4GALT5
prerank,ligand-gated ion channel activity (GO:0015276),0.34386069162131344,0.8876305014279392,0.6165680473372781,1.0,1.0,5/30,14.09%,GRIN1;GRIK5;GRIN2A;GRIA1;GRIA2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3787535983386854,0.8871014015358665,0.6396761133603239,1.0,1.0,6/18,21.53%,ANXA1;BAIAP2;RAB10;ANXA2;S100A11;PDLIM1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.4185097565666263,0.8852346219132002,0.6119186046511628,1.0,1.0,2/10,14.64%,DPP9;DPP10
prerank,MHC class I protein binding (GO:0042288),-0.3335021688695925,-0.8846936232956599,0.5889967637540453,0.8899457645658585,1.0,6/13,29.56%,TAPBP;TAP2;ATP5F1B;ABCB9;TAP1;TUBB4B
prerank,nuclear export signal receptor activity (GO:0005049),-0.3474439654542751,-0.8839973543915547,0.5893416927899686,0.8845283339513038,1.0,3/11,10.53%,EIF4ENIF1;XPO5;NUP42
prerank,cytokine receptor binding (GO:0005126),0.3041006396765368,0.8838985005613674,0.6796628029504742,1.0,1.0,19/83,24.48%,IL34;DDT;CXCL12;IL22;PIBF1;SDCBP;PRLR;USP15;PXDN;IL1RAP;CCL25;JAK1;TGFBR3;SMAD2;SMAD3;IL18;FKBP1A;JAK2;TRAF6
prerank,actinin binding (GO:0042805),-0.2777042981904644,-0.8834628509779342,0.6359832635983264,0.8790511804196259,1.0,5/21,9.42%,CACNA1D;PDLIM5;CACNA1C;PROM1;RARA
prerank,ligand-gated channel activity (GO:0022834),0.3456008534430775,0.883426204721783,0.6327751196172249,1.0,1.0,5/29,14.09%,GRIN1;GRIK5;GRIN2A;GRIA1;GRIA2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.2808016977762767,-0.8830121990751068,0.647887323943662,0.873249479478623,1.0,17/21,62.75%,CHRNA7;GLRB;P2RX7;CHRNB1;P2RX4;CHRNA4;CHRNB2;P2RX5;P2RX3;P2RX6;CHRNA9;CHRNA5;CHRNA3;P2RX1;CHRNB4;TRPV1;CHRNA1
prerank,alpha-tubulin binding (GO:0043014),0.3462023669130618,0.8811789210595288,0.6666666666666666,1.0,1.0,9/31,19.92%,ARL4C;TAOK1;DIP2B;OFD1;PACRG;ARL8B;DNAL1;DLEC1;INO80
prerank,pyrophosphatase activity (GO:0016462),0.31622556424994663,0.8800523815256784,0.6548571428571428,1.0,1.0,12/50,18.34%,DDX3X;ENTPD7;PPA2;PRUNE1;NUDT3;BNIP2;ENPP1;PLPP4;PLPP5;NUDT16L1;DHX29;ATCAY
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2846125214267225,0.8786628319783721,0.856,1.0,1.0,93/431,19.61%,ARL4C;STK36;GNL3;ATL1;GBP3;PIP4K2B;HSP90AA1;GALK1;RAC1;DMPK;CDKL5;TAOK1;ATP1A3;YARS2;ABCA2;NUAK2;MINK1;MAP4K5;CHD8;MYO1B;DRG2;TUBB2A;ABL1;CARS1;SARS2;GBP7;STK11;N4BP2;RRAGA;BRSK2;TARS1;RAP2A;RHOD;ATP1A2;AARS1;TUBD1;SIK1;TUBA1A;DHX36;DRG1;RAB10;ARL5B;PRAG1;RHOBTB3;WNK2;MTREX;MYH10;TOP1;BRSK1;PEX1;ABCF3;DYNC1LI1;TLK1;ENPP1;ABCF2;HARS1;RAB13;PRKCI;DAPK1;AK6;TUBA1B;BMS1;GBP6;TUBB;RAB31;PPP5C;ACVR1B;ABCD2;RAB8A;SYN2;MTG2;RIT2;MLKL;OAS2;RAB21;OXSR1;LANCL2;MRAS;RRAS2;TUBB4A;RAB6A;ARL8B;SRPK1;TGFBR1;ABCC6;ABCE1;CDC42BPB;PGK1;PRKAG2;KSR1;RABL6;MTPAP;CDK11B
prerank,N-acyltransferase activity (GO:0016410),0.33390593877832225,0.8785111062668202,0.6415094339622641,1.0,1.0,5/32,12.73%,SIRT7;CERS2;GNPNAT1;NMT1;TLCD3B
prerank,voltage-gated chloride channel activity (GO:0005247),0.41275704205116315,0.8784186241999471,0.6274509803921569,1.0,1.0,2/10,8.19%,CLCN2;CLCN4
prerank,glycine binding (GO:0016594),0.3913268420976462,0.8781308042992554,0.6273653566229985,1.0,1.0,2/11,14.46%,GRIN1;GLRA1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.25850868177296205,-0.8775509037226535,0.7012195121951219,0.8789711686059622,1.0,8/28,21.63%,GABRG2;GABRA5;CHRNA7;GABRA4;GRIK3;GABRG1;GABRA1;GRIK4
prerank,ATPase binding (GO:0051117),0.30911448417098625,0.8765475103738627,0.6772082878953108,1.0,1.0,12/71,12.68%,TMTC4;SELENOS;FBL;ATP6V0A2;SYVN1;ANK1;SNX10;BRSK2;ATP6V1G1;TCIRG1;PTPN3;ATP6V0A4
prerank,microtubule plus-end binding (GO:0051010),-0.2845404016429795,-0.8735760208811766,0.6106194690265486,0.8809264315382226,1.0,5/20,13.15%,DST;CLIP1;MAPRE1;TTBK2;DCTN1
prerank,tRNA binding (GO:0000049),-0.22570586928455805,-0.8724726971619953,0.7226890756302521,0.8769513698967478,1.0,15/43,18.56%,EIF2AK4;EIF2A;XPOT;MRPS27;NSUN6;TRNAU1AP;AIMP1;DARS2;EEF1A1;TRNT1;TYW5;NAT10;ELP5;DALRD3;TRMT10B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36967490154620924,-0.8715704364262943,0.6181818181818182,0.8721686340267516,1.0,2/10,7.61%,ADARB2;APOBEC1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4061695855230543,0.8714720183458121,0.6337817638266069,1.0,1.0,5/11,18.57%,HNRNPA2B1;RAD50;TERF1;NABP2;TERF2IP
prerank,Hsp90 protein binding (GO:0051879),0.3318676860101968,0.8712450360515354,0.6593939393939394,1.0,1.0,12/33,21.94%,UNC45A;TSC2;STUB1;STIP1;USP19;MAPT;PPP5C;CHORDC1;PACRG;RPS3;NPAS2;TELO2
prerank,phospholipid transfer activity (GO:0120014),-0.27062398360742634,-0.8712013114209521,0.6405529953917051,0.8664496903280737,1.0,4/21,5.50%,OSBPL2;PITPNA;CERT1;PITPNC1
prerank,kinase binding (GO:0019900),0.27909433197068884,0.8691970701659751,0.867,1.0,1.0,86/434,17.12%,CDKN2D;TNNI3;UBQLN1;FOXM1;GSKIP;DNM1;RNF138;FAM83H;PARP1;RAC1;STUB1;USF1;PRAM1;CALM3;PRKRIP1;MAPRE3;WARS1;IL31RA;NEFH;SNAI1;NEK9;FBXO7;CARD16;TCF7L2;ERRFI1;DLG3;SQSTM1;THY1;FBXO5;BARD1;ARHGEF7;DVL1;RHOD;RFFL;FBXW5;CD24;CDC25A;TBL2;SIK1;CIT;GPRC5B;PER1;PPP1CC;CDK5RAP3;MVP;CASP9;SHC4;SRCIN1;ATF2;JTB;RHOBTB3;PGAM1;ATG13;CNOT9;IQGAP1;PARK7;NPM1;HNRNPA0;LRRC14;ADD2;SUFU;VDAC1;TNS2;PTPN22;EMP2;PARP16;HTT;MAPT;BLNK;UNC5C;KIZ;SV2A;IL15RA;AP1B1;FAF1;CHEK2;SNAP91;MAP3K1;MAPK4;TRIP4;NSF;TPRKB;DAXX;DLG2;SPRY2;OXSR1
prerank,telomerase RNA binding (GO:0070034),0.3523190199090348,0.8684842945993733,0.6752910737386805,1.0,1.0,6/22,20.48%,NHP2;WRAP53;DHX36;XRN1;SMG7;HNRNPU
prerank,protein serine/threonine kinase activity (GO:0004674),0.2817788086721904,0.8679437515009407,0.844,1.0,1.0,86/335,21.36%,MAPK9;CAMK2B;CAMK1G;STK36;ARAF;PDPK1;CSNK2A2;MAP3K14;EIF2AK3;DMPK;CDKL5;CASK;HUNK;TAOK1;HTATIP2;NUAK2;MINK1;MAP4K5;CDK13;PRKCA;CDK5;CDK9;MAST3;BRD4;NUAK1;SQSTM1;PAK3;STK11;BRSK2;KALRN;SBK1;SIK1;CIT;FAM20C;NRBP2;WNK2;TOP1;BRSK1;GRK3;MAPK6;CAMK2D;TLK1;CAMK2G;ATR;RPS6KA3;PRKCI;DAPK1;CSNK1D;STK19;NEK3;NRBP1;ROCK2;GRK2;CSNK1A1;ACVR1B;RPS6KA1;TRIO;CHEK2;MAP3K1;MAPK4;CAMK1D;TP53RK;CLK4;CDK7;OXSR1;ILK;PRKD2;CDK10;SRPK1;TGFBR1;PRKAA1;CDC42BPB;PIK3R4;NRK;CDKL2;CDK11B;PRKCZ;CDK14;PTK2B;MAPKAPK2;PAK5;ACVR2A;SGK3;MAP4K4;STK35;SMG1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.294248586774722,-0.8623749866835534,0.6117216117216118,0.8789450151584549,1.0,4/16,22.44%,SCARB1;THBS1;SCARF1;STAB1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.300106465149136,0.8618681414773113,0.6928879310344828,1.0,1.0,12/71,13.92%,DUSP18;ACP1;PTPRN;DUSP26;CDC14B;CDC25A;PTPN5;PTPRF;PTPN3;TNS2;PTPN22;EYA2
prerank,beta-tubulin binding (GO:0048487),0.33288780060568873,0.8609340592912043,0.6650426309378806,1.0,1.0,12/31,23.60%,TAOK1;GJB6;HTT;VAPB;TBCD;PACRG;ARL8B;PDCD5;DLEC1;FGF13;TTLL7;EML4
prerank,insulin-like growth factor I binding (GO:0031994),-0.317018259796244,-0.8599367167221794,0.6576271186440678,0.8778339815258371,1.0,2/13,2.38%,IGF1R;ITGA6
prerank,GTP binding (GO:0005525),0.2826106815476361,0.8585994705694266,0.7937310414560161,1.0,1.0,35/172,18.38%,ARL4C;GNL3;ATL1;GBP3;PIP4K2B;RAC1;DRG2;TUBB2A;GBP7;RRAGA;RAP2A;RHOD;TUBD1;TUBA1A;DRG1;RAB10;ARL5B;RHOBTB3;DYNC1LI1;RAB13;TUBA1B;BMS1;GBP6;TUBB;RAB31;RAB8A;MTG2;RIT2;RAB21;LANCL2;MRAS;RRAS2;TUBB4A;RAB6A;ARL8B
prerank,single-stranded DNA binding (GO:0003697),0.293663647879413,0.8581844895986678,0.7250786988457503,1.0,1.0,25/93,20.54%,APTX;RNF138;FUBP1;FBH1;MLH1;TDP1;RTF1;DHX36;TOP1;RBMS1;PARK7;TDP2;PMS2;MAPT;NUCKS1;SSBP2;HSPD1;NABP2;TOP3A;PCBP2;HMCES;RBBP8;NUP35;HNRNPU;SUB1
prerank,general transcription initiation factor binding (GO:0140296),-0.2588024337074334,-0.8562885087211243,0.7081339712918661,0.8790138980688866,1.0,11/25,23.64%,THRA;AR;TAF12;PSMC2;PSMC1;AHR;ESR1;DR1;TAF13;RUVBL1;TAF11
prerank,histone demethylase activity (GO:0032452),0.3303899360192468,0.8556312163426975,0.6569620253164556,1.0,1.0,7/27,19.43%,KDM4D;KDM7A;JARID2;KDM2B;KDM6B;KDM3B;KDM6A
prerank,motor activity (GO:0003774),-0.2134117522981135,-0.8550662986371833,0.8089887640449438,0.8752953143603026,1.0,23/60,31.84%,KIF13B;KIF26B;MYL6;KLC1;KIF1C;KIF13A;MYO6;KIFC3;DYNLRB1;KIF16B;KIF24;KIF2A;KIF18A;DNAH2;KIF26A;KIF9;DYNC1I1;APPBP2;DNAH8;KIFC2;KIF7;KIF21A;KIF23
prerank,cAMP binding (GO:0030552),0.3957827881586497,0.8548252722338949,0.6656716417910448,1.0,1.0,3/11,15.76%,PDE4A;PDE10A;PDE4B
prerank,guanyl ribonucleotide binding (GO:0032561),0.2796371671191699,0.8540244763536474,0.8088978766430738,1.0,1.0,40/196,18.38%,ARL4C;GNL3;ATL1;GBP3;PIP4K2B;RAC1;DRG2;TUBB2A;GBP7;RRAGA;RAP2A;RHOD;RAB12;TUBD1;TUBA1A;RAB5B;DRG1;RAB10;ARL5B;RHOBTB3;RAB3B;DYNC1LI1;RAB13;TUBA1B;BMS1;GBP6;TUBB;RAB31;RAB8A;PDE10A;RAB8B;MTG2;RIT2;RAB21;LANCL2;MRAS;RRAS2;TUBB4A;RAB6A;ARL8B
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.28751634311749086,0.8538685950691476,0.7400835073068893,1.0,1.0,27/91,23.33%,GSDMD;RPH3A;WIPI1;TIRAP;SNX14;MYO1B;FRMPD4;SDCBP;ADAP2;SVIL;MAPT;TULP3;VILL;SNAP91;ANXA2;SNX21;KRIT1;KCNH1;SYTL2;MAPKAP1;GSN;COMMD1;PFN2;SNX18;WIPI2;SYT7;SH3PXD2B
prerank,Hsp70 protein binding (GO:0030544),0.33285264759338656,0.8536604818236444,0.6658566221142163,1.0,1.0,9/31,23.86%,IQCG;STUB1;GPR37;DNAJC10;PACRG;RPS3;DNAJC2;DNAJB12;TSC1
prerank,palmitoyltransferase activity (GO:0016409),-0.2540834437925118,-0.8535627793206559,0.7314285714285714,0.872062432685347,1.0,12/28,26.75%,ZDHHC20;ZDHHC5;ZDHHC15;HHAT;GOLGA7;ZDHHC13;ZDHHC8;ZDHHC7;YKT6;ZDHHC16;ZDHHC4;ZDHHC24
prerank,histone methyltransferase binding (GO:1990226),0.40177862420332966,0.8511811494468893,0.6666666666666666,1.0,1.0,2/11,6.32%,NOP56;PHF1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2766037554436752,0.8496209075540485,0.8263052208835341,1.0,1.0,35/254,12.60%,HSF2;SP7;NFKB1;SMARCD3;MLXIP;NKX2-2;GLIS2;STAT6;TFDP1;NFKB2;RFX5;TCF4;TFCP2;IRF1;ZIC3;CASZ1;DBP;SOX9;SMARCD1;DDIT3;MDM4;ATMIN;SOX11;PRRX1;NKRF;ATF2;ZNF445;RBPJ;RFX4;NFAT5;IRF3;YY1;E2F3;CEBPG;CREB3
prerank,CoA hydrolase activity (GO:0016289),0.36803765220075635,0.8486640288409389,0.6717877094972067,1.0,1.0,2/16,5.66%,ACOT9;ACOT11
prerank,actin monomer binding (GO:0003785),0.3430798402412917,0.8466900637714817,0.6896103896103896,1.0,1.0,3/22,6.07%,ABITRAM;MRTFA;ABL1
prerank,manganese ion binding (GO:0030145),0.3099702839164464,0.8466104161762766,0.7124711316397229,1.0,1.0,12/48,21.34%,XPNPEP3;GALNT4;ABL1;POMGNT1;FAM20C;SOD2;TDP2;PPM1M;MTPAP;IMPA1;EXD2;ME1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2790313368309002,0.8462737821184068,0.8155241935483871,1.0,1.0,47/188,22.16%,ZBTB48;NFKB1;ZNF568;CREBZF;GLIS2;PSPC1;MTERF3;TCF7L2;IRF1;TBP;HDAC5;DDIT3;XRCC6;PER1;DHX36;ATMIN;HDAC4;ARID4A;SOX11;CALCOCO1;ZBTB20;SUV39H1;YY1;SOX6;HNRNPL;SMAD6;SOX5;KMT2D;RFX3;FOXC2;SOX13;TCF7;GABPB1;GABPB2;TBL1XR1;NONO;SOX4;KLF4;CARM1;GABPA;CTCF;TAF2;CREB3L2;HMGB1;ZBED4;SMAD3;ERBB4
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.38606403013182694,0.8432331939357346,0.6622613803230544,1.0,1.0,12/12,61.42%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW;OPN1MW3;RRH;GPR52;GPR88;OPN3
prerank,phosphotyrosine residue binding (GO:0001784),0.31847559913486184,0.8431453799193551,0.7147846332945286,1.0,1.0,7/37,11.84%,PIK3R1;ABL1;VAV2;PTPN5;PIK3R2;SHF;PTPN3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.27771515131508706,0.8427481097900389,0.8054711246200608,1.0,1.0,34/147,16.51%,SH3BP5;NUCB2;ARHGEF10;GAPVD1;ARHGEF7;ARHGEF4;RASGRP2;RASGEF1A;KALRN;MYCBP2;DOCK8;SH3BP5L;RCC1L;EGF;RALGPS1;RAPGEF1;VAV2;DENND4C;DENND5A;RIC8B;ALS2;MON1A;RCC1;LAMTOR5;AKAP13;RASGEF1B;FARP1;EEF1B2;CYTH1;FARP2;DNMBP;ARHGEF6;EPS8L1;DENND6A
prerank,lysophospholipase activity (GO:0004622),0.35051795664829866,0.8411856723801993,0.6901408450704225,1.0,1.0,6/20,20.14%,LYPLAL1;GDPD3;ENPP2;PNPLA7;GDE1;ABHD16A
prerank,neurexin family protein binding (GO:0042043),0.4040472061969391,0.8406959003554607,0.6686567164179105,1.0,1.0,3/10,19.83%,NLGN3;NLGN2;SYTL2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4064784899727165,0.8384483104202853,0.675187969924812,1.0,1.0,5/10,19.44%,EHMT2;SUV39H1;EHMT1;ASH1L;SETD5
prerank,"DNA binding, bending (GO:0008301)",0.37223629132332664,0.8380903497138072,0.6835443037974683,1.0,1.0,5/14,22.00%,HMGB3;SAP30L;TERF1;FOXD1;HMGB1
prerank,ion gated channel activity (GO:0022839),0.3322755881221548,0.837894463190335,0.6878109452736318,0.9976786061368411,1.0,4/24,12.53%,TMEM63A;KCNT2;TMEM63C;TTYH2
prerank,protein tyrosine kinase binding (GO:1990782),0.2895110706662109,0.8345808481382677,0.7513397642015005,1.0,1.0,12/71,14.97%,HSP90AA1;SQSTM1;SIRPA;NRG3;PITPNM3;SHC4;PIK3R2;RACK1;BLNK;NRG1;RNF41;CBL
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.38883620327909485,0.8340539051779483,0.6628407460545194,0.9987903992215674,1.0,2/11,4.91%,RPH3A;ITPR1
prerank,protein kinase binding (GO:0019901),0.2666311315651505,0.8320114192830699,0.93,0.9996867706778889,1.0,92/479,18.28%,CDKN2D;TNNI3;DACT2;FOXM1;GSKIP;DNM1;RNF138;FAM83H;PARP1;HSP90AA1;RAC1;USF1;PRAM1;CALM3;PRKRIP1;MAPRE3;WARS1;PICK1;NELL1;TIRAP;IL31RA;NEFH;NEK9;FBXO7;TCF7L2;ERRFI1;ABL1;SQSTM1;THY1;FBXO5;ARHGEF7;DVL1;RHOD;RFFL;HDAC5;SIRPA;FBXW5;CD24;CDC25A;TBL2;SIK1;CIT;SOX9;GPRC5B;PPP1CC;CDK5RAP3;MVP;CASP9;SHC4;YWHAG;SRCIN1;ATF2;JTB;RHOBTB3;PGAM1;ATG13;IQGAP1;NPM1;MAPK8IP3;HNRNPA0;ADD2;RACK1;ROR2;SUFU;VDAC1;EMP2;MAPT;BLNK;UNC5C;KIZ;SV2A;IL15RA;AP1B1;TCF3;FAF1;CHEK2;SNAP91;MAP3K1;MAPK4;TRIP4;NSF;TPRKB;DAXX;SPRY2;OXSR1;TNIP1;CAMK2N1;ILK;PRKD2;RELB;CCDC88A;PRKAR1A
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.2641906687526261,-0.8279393163427344,0.7317073170731707,0.916437228651746,1.0,7/19,21.63%,GABRG2;GABRA5;GABRA4;GRIK3;GABRG1;GABRA1;GRIK4
prerank,sterol transfer activity (GO:0120015),-0.2829726146960585,-0.8273138067713933,0.6926229508196722,0.9112803131979369,1.0,3/17,6.39%,OSBPL2;GRAMD1B;GRAMD1C
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.24826504211327577,-0.824540924776362,0.7867298578199052,0.9103787079315444,1.0,7/26,17.61%,PPME1;PPP1R1A;ENSA;PPP1R14C;LMTK2;PPP1R8;BOD1L1
prerank,sodium channel activity (GO:0005272),0.3089431048622912,0.8226409484103333,0.7329479768786127,1.0,1.0,4/37,10.99%,ASIC1;SCN7A;GRIK5;SCN1A
prerank,SH2 domain binding (GO:0042169),0.3157231605628731,0.8222597166994706,0.7,1.0,1.0,12/31,24.19%,ABL1;SQSTM1;DAG1;RACK1;BLNK;RUFY1;AFAP1;CCDC88A;DLC1;SH3PXD2B;KHDRBS1;JAK2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.3304080076193374,-0.8213068297879528,0.6906906906906907,0.9102277564921243,1.0,4/10,13.99%,SETD2;NSD2;SETD3;SMYD2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3164247541778417,0.8208792779177634,0.7182926829268292,1.0,1.0,8/30,18.90%,SLC30A10;SLC39A1;SLC30A1;SLC39A6;SLC30A3;SLC30A5;SLC25A37;SLC11A2
prerank,endopeptidase regulator activity (GO:0061135),0.3059817410540852,0.8205800610194306,0.7361111111111112,1.0,1.0,5/40,12.13%,USP14;ABCA2;RENBP;PSME2;TFPI
prerank,lysine N-methyltransferase activity (GO:0016278),0.3451019167199424,0.81955104699176,0.7010443864229765,1.0,1.0,5/20,15.49%,ETFBKMT;SETD7;EHMT2;EHMT1;ATPSCKMT
prerank,ligand-gated cation channel activity (GO:0099094),0.2874067043938538,0.8190388556590666,0.7752928647497338,1.0,1.0,7/75,14.09%,ASIC1;GRIN1;GRIK5;KCNJ10;GRIN2A;GRIA1;GRIA2
prerank,telomeric DNA binding (GO:0042162),0.3105710001951164,0.8188913727544666,0.7296969696969697,1.0,1.0,11/32,21.94%,ZBTB48;XRCC6;HNRNPD;HNRNPA2B1;RAD50;TERF1;UPF2;SMG7;TERF2IP;SMG1;TELO2
prerank,adenylyltransferase activity (GO:0070566),0.3433179487525144,0.8187737644139833,0.704630788485607,1.0,1.0,10/21,26.89%,ABL1;FLAD1;COASY;OAS2;MTPAP;SELENOO;PAPOLA;TENT4A;PAPOLG;TENT4B
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2826364609169939,0.8185617256003602,0.7648327939590076,0.9983218116422647,1.0,20/72,22.30%,GSDMD;RPH3A;TIRAP;MYO1B;FRMPD4;SDCBP;ADAP2;SVIL;TULP3;VILL;SNAP91;ANXA2;SNX21;KRIT1;SYTL2;MAPKAP1;GSN;COMMD1;PFN2;SNX18
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.2964483243476032,0.8183486322745489,0.7337807606263982,0.9960029946809371,1.0,8/48,18.02%,NALCN;MMGT1;CALHM2;SLC39A1;TRPM3;SLC41A1;ATP6V1B2;PKD2
prerank,DNA secondary structure binding (GO:0000217),0.31422337919798654,0.8136351292137003,0.7271634615384616,1.0,1.0,10/31,22.00%,XRCC2;HMGB3;ABL1;FANCM;YY1;MAPT;RBBP8;KMT2A;RAD18;HMGB1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.28775061714079725,0.8120697148767778,0.7842278203723987,1.0,1.0,21/60,24.09%,PPM1B;CDC14B;PPP1CC;PPM1H;CTDSPL2;CAMK2G;PPM1E;CTDSP2;PPP5C;PPM1M;PPP2CB;TAB1;PHLPP2;PPP4C;PPM1A;LRRK1;PPM1F;RPAP2;PTEN;PPP3CB;PPM1D
prerank,snoRNA binding (GO:0030515),0.31252257529371236,0.8075756007409592,0.7243107769423559,1.0,1.0,2/30,3.94%,NHP2;NOP56
prerank,microtubule motor activity (GO:0003777),-0.20174720138633842,-0.8062297108723184,0.8839285714285714,0.9326667774751852,1.0,27/51,38.90%,KIF13B;KIF26B;KIF1C;KIF13A;KIFC3;DYNLRB1;KIF16B;KIF24;KIF2A;KIF18A;DNAH2;KIF26A;KIF9;DYNC1I1;APPBP2;DNAH8;KIFC2;KIF7;KIF21A;KIF23;KIF11;KIF1B;KIF15;KIF21B;KIF17;CENPE;DNAH3
prerank,3'-5' DNA helicase activity (GO:0043138),0.3469028980085692,0.8037430678061581,0.7192052980132451,1.0,1.0,3/16,11.55%,HELQ;FBH1;FANCM
prerank,DNA polymerase binding (GO:0070182),-0.2700475492396978,-0.8029810691929482,0.7605042016806722,0.9320181564836966,1.0,9/18,26.42%,PTGES3;HSP90AB1;NAT10;SMG6;RTEL1;FANCI;CDK2AP1;POLG2;PCNA
prerank,protein phosphorylated amino acid binding (GO:0045309),0.2978795098422725,0.8016867626166712,0.7938144329896907,1.0,1.0,7/42,11.84%,PIK3R1;ABL1;VAV2;PTPN5;PIK3R2;SHF;PTPN3
prerank,chemoattractant activity (GO:0042056),0.32057709349930646,0.7996540869624322,0.7604562737642585,1.0,1.0,3/26,10.19%,NTF3;FGF10;GDNF
prerank,antiporter activity (GO:0015297),0.32999844862285505,0.7964257297689208,0.741222366710013,1.0,1.0,3/20,8.19%,SLC35D2;ATP1A3;CLCN4
prerank,phosphatidylinositol binding (GO:0035091),0.2700896914326773,0.7959864230405223,0.8046462513199577,1.0,1.0,21/91,18.25%,PLEKHN1;RPH3A;SNX5;ITPR1;PIGU;THY1;SNX10;SNX24;SNX11;PIGK;MAPT;TULP3;NUMA1;SNAP91;DPEP1;PARD3B;SNX4;PITPNM2;PHF12;CCDC88A;ZFYVE16
prerank,tau-protein kinase activity (GO:0050321),0.3270863142024707,0.7921000104808107,0.7218628719275549,1.0,1.0,5/20,14.18%,TAOK1;CDK5;BRSK2;BRSK1;ROCK2
prerank,peptidase inhibitor activity (GO:0030414),0.3062080683019393,0.7919349274113234,0.7684964200477327,1.0,1.0,6/33,19.60%,USP14;RENBP;TFPI;SERPIND1;TIMP2;PROS1
prerank,glutamate receptor activity (GO:0008066),-0.25737886383830105,-0.7912450050543413,0.7565217391304347,0.9465291492941263,1.0,3/19,4.76%,GRM7;GRM1;GRM3
prerank,peptidoglycan binding (GO:0042834),-0.32867466330613265,-0.7911015184376101,0.6920731707317073,0.9403090520999309,1.0,2/10,4.72%,HK1;NOD1
prerank,endonuclease activity (GO:0004519),0.28799556891307665,0.7907865920562602,0.7818383167220376,1.0,1.0,10/49,17.10%,NTHL1;APLF;LACTB2;N4BP2;RCL1;CPSF3;AGO3;SND1;MRE11;ZC3H12C
prerank,DNA-binding transcription factor binding (GO:0140297),0.2594660716041398,0.7906360695968985,0.8800403225806451,1.0,1.0,47/189,22.39%,TEAD3;DUSP26;BBS10;CRTC1;USF1;MIER2;TCF7L2;BBS7;TBP;HDAC5;SIK1;DDIT3;CRTC3;TTC8;HDAC4;TWIST1;PRRX1;RBL2;ATF2;PSMC5;RBPJ;BCL2;MTA2;PARK7;NPM1;HDAC1;RUNX1T1;PIAS3;TCF3;CTBP1;CBX5;MTDH;TLE5;RBBP8;ATN1;KLF4;GABPA;PIAS1;MIER1;SMAD2;TCERG1;HMGB1;SMAD3;MTA1;TAF1;IFI27;ID2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.2969822357296039,-0.7887146959531871,0.7438271604938271,0.9381954761235245,1.0,5/12,19.85%,NUDT5;ENTPD1;ENTPD6;SLC25A42;CANT1
prerank,solute:anion antiporter activity (GO:0140323),0.3593853733705274,0.7876940558346587,0.7320441988950276,1.0,1.0,1/14,1.47%,SLC7A11
prerank,double-stranded DNA binding (GO:0003690),0.254728726453828,0.786333512083235,0.98,1.0,1.0,98/531,22.00%,CAMTA2;HSF2;POU6F1;ZNF23;APTX;ZBTB48;HMGB3;PKNOX2;NTHL1;USF1;TEF;MAFG;GLIS2;NR1D2;XBP1;NFKB2;RFX5;SNAI1;TCF4;TFCP2;FBH1;ZNF276;ABL1;TDP1;ZIC3;ARNT;ZBTB7B;TEAD1;ZNF32;DBP;SOX9;XRCC6;KIN;LIN28B;PSIP1;HOXB8;ATF2;TOP1;ZBTB20;ZNF445;GLIS1;RFX4;BACH2;NFAT5;IRF3;RBMS1;YY1;E2F3;NFIX;PARK7;CEBPG;CREB3;CREB3L4;FOXJ3;MAPT;ESRRG;CAMTA1;BCL6;NUCKS1;MRE11;RFX3;NR2C2;SATB1;TCF7L1;FOXC2;MAF;HOXC8;CLOCK;RAD50;TERF1;MBD1;OSR1;TCF7;MEIS2;ZNF177;RBBP8;MECP2;CUX1;BCL11B;KLF13;SOX4;ZIC4;RPS3;KLF4;GABPA;PKNOX1;HNRNPU;YBX1;CREB5;ZBTB32;NFATC3;FOXJ2;GLI3;NPAS2;SMAD2;ETV3;MSH3;HMGB1
prerank,Notch binding (GO:0005112),0.31388570301250523,0.7815780253225815,0.7539473684210526,1.0,1.0,5/22,18.66%,TCIM;SNW1;JAG1;SNED1;NCOR2
prerank,sequence-specific DNA binding (GO:0043565),0.2520624151633011,0.7812199057621347,0.986,1.0,1.0,112/590,22.21%,MMP12;HSF2;POU6F1;ZNF23;MYRF;PKNOX2;ZEB2;USF1;NR2F2;TEF;MAFG;GLIS2;NR1D2;XBP1;RORA;KMT2B;NFKB2;POU2F1;RFX5;SNAI1;SLTM;TCF4;TCF7L2;TFCP2;ZNF276;ABL1;ZNF35;ZIC3;ARNT;ZBTB7B;ZNF711;TEAD1;ZNF32;ZBTB38;DBP;SOX9;XRCC6;HNRNPD;PRMT5;HDAC4;LIN28B;CALCOCO1;HOXB8;ATF2;ZBTB20;KDM2B;RBPJ;GLIS1;RFX4;BCL2;BACH2;NFAT5;IRF3;YY1;E2F3;NFIX;CEBPG;CREB3;CREB3L4;PRMT1;CBFB;FOXJ3;MAPT;ESRRG;BCL6;RFX3;NR2C2;SATB1;TCF7L1;FOXC2;MAF;SAFB2;HOXC8;CLOCK;TERF1;UPF2;MBD1;SOX13;OSR1;TCF7;MEIS2;ZNF177;SMG7;MECP2;CUX1;KMT2A;BCL11B;TERF2IP;FOXD1;KLF13;SOX4;ZIC4;TET1;KLF4;GABPA;PKNOX1;HNRNPU;CTCF;YBX1;CREB5;ZBTB32;NFATC3;FOXJ2;GLI3;SMG1;NPAS2;FOXO1;ETV3;TELO2;SMAD3;TAF1;HOXA7
prerank,glutamate receptor binding (GO:0035254),0.3370494884037736,0.7806626201751375,0.757496740547588,1.0,1.0,5/17,19.05%,SQSTM1;GNAS;IGSF11;NSF;SHANK1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.29874334409020326,0.7784687372339985,0.7882069795427196,1.0,1.0,14/33,24.48%,AUP1;PARK7;RNF19A;ZMYM2;RNF19B;ANKIB1;RNF217;ARIH2;DCUN1D5;RPS3;TCERG1;UBA2;SIAH2;TRAF6
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2995115942177977,0.7781513433797215,0.7686746987951807,1.0,1.0,8/34,15.49%,ETFBKMT;SETD7;EZH2;EHMT2;NSD3;SUV39H1;EHMT1;ATPSCKMT
prerank,calcium-activated potassium channel activity (GO:0015269),0.35991853567417015,0.7759770720494871,0.7455621301775148,1.0,1.0,1/11,6.83%,KCNMA1
prerank,RNA polymerase binding (GO:0070063),0.33235134733429383,0.7758817363083583,0.775,1.0,1.0,6/18,21.94%,BIN1;PPIB;CCNT1;YTHDC2;CCNT2;TCERG1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.300243637115715,-0.775258310274394,0.7507082152974505,0.954772792815062,1.0,4/11,9.10%,UBE2K;RBX1;AMFR;UBOX5
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.33867395012033163,0.773449531785069,0.7583333333333333,1.0,1.0,3/14,19.24%,SPOCK1;SPOCK2;TIMP2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.2419059816884186,-0.7718241448738697,0.8034188034188035,0.9417306246026611,1.0,4/22,14.70%,CHRM3;HTR4;HTR7;HTR1F
prerank,serotonin receptor activity (GO:0099589),-0.2419059816884186,-0.7718241448738697,0.8034188034188035,0.9417306246026611,1.0,4/22,14.70%,CHRM3;HTR4;HTR7;HTR1F
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.2419059816884186,-0.7718241448738697,0.8034188034188035,0.9417306246026611,1.0,4/22,14.70%,CHRM3;HTR4;HTR7;HTR1F
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3036195480458361,0.7698921373867151,0.7796817625458996,1.0,1.0,8/27,17.91%,AUP1;RNF19A;ZMYM2;RNF19B;ANKIB1;RNF217;ARIH2;DCUN1D5
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.25723777397902925,0.7636574057901805,0.8526970954356846,1.0,1.0,15/100,13.93%,GSDMD;PLEKHN1;RPH3A;WIPI1;OGT;MYO1B;PLEKHA3;SNX24;ATG2A;SAP30L;ADAP2;IQGAP1;ARAP1;SNX11;MAPT
prerank,nuclear import signal receptor activity (GO:0061608),0.3357426154270732,0.7629050419433469,0.7833333333333333,1.0,1.0,4/15,18.71%,KPNA3;KPNB1;TNPO1;KPNA1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.31011610801250894,-0.7605498415443201,0.7774294670846394,0.9529507694135059,1.0,5/10,20.78%,STAMBPL1;CYLD;STAMBP;OTUD4;OTUD5
prerank,high voltage-gated calcium channel activity (GO:0008331),0.36652509171426906,0.7596448460263648,0.7603550295857988,1.0,1.0,2/10,10.31%,CACNB4;CACNB1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2786118957815684,0.7595711578001607,0.8105625717566016,1.0,1.0,14/44,19.65%,KMT2B;SETD7;EZH2;EHMT2;SETD1A;NSD3;SUV39H1;EHMT1;KMT2D;ASH1L;NSD1;KMT2A;SETD5;KMT5B
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2716847020938149,0.7589732730163599,0.8320441988950277,1.0,1.0,7/57,9.77%,UQCRC1;NDUFA7;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.24492916920354568,0.7565794121862,0.994,1.0,1.0,113/597,22.21%,HSF2;POU6F1;ZNF23;ZBTB48;NFKB1;ZNF568;PKNOX2;CREBZF;USF1;TEF;MAFG;GLIS2;NR1D2;XBP1;NFKB2;PSPC1;RFX5;SNAI1;MTERF3;TCF4;TCF7L2;TFCP2;ZNF276;IRF1;TBP;ABL1;ZIC3;ARNT;ZBTB7B;DHX33;TEAD1;HDAC5;ZNF32;DBP;SOX9;DDIT3;XRCC6;PER1;DHX36;ATMIN;HDAC4;ARID4A;LIN28B;SOX11;CALCOCO1;HOXB8;ATF2;ZBTB20;GLIS1;RFX4;SUV39H1;BACH2;NFAT5;IRF3;YY1;E2F3;NFIX;SOX6;CEBPG;CREB3;CREB3L4;HNRNPL;CENPC;FOXJ3;ESRRG;BCL6;SMAD6;SOX5;KMT2D;RFX3;NR2C2;TCF7L1;FOXC2;HSPD1;MAF;HOXC8;CLOCK;SOX13;OSR1;TCF7;GABPB1;GABPB2;MEIS2;TBL1XR1;ZNF177;CUX1;BCL11B;NONO;KLF13;SOX4;ZIC4;ZW10;KLF4;CARM1;GABPA;PKNOX1;HNRNPU;CTCF;YBX1;CREB5;ZBTB32;TAF2;NFATC3;CREB3L2;FOXJ2;GLI3;NPAS2;ETV3;HMGB1;ZBED4;SMAD3;ERBB4;HOXA7
prerank,WW domain binding (GO:0050699),0.2992617075691409,0.752857593241736,0.8084832904884319,1.0,1.0,2/26,4.74%,TCEAL5;PMEPA1
prerank,carboxypeptidase activity (GO:0004180),0.28840157727141297,0.751932931171305,0.8169014084507042,1.0,1.0,6/35,16.08%,CPXM1;AGBL3;PEPD;CPXM2;CTSZ;AGBL4
prerank,wide pore channel activity (GO:0022829),0.3009946238793336,0.7504901905842796,0.7977099236641222,1.0,1.0,2/23,9.65%,GJB2;GJB6
prerank,R-SMAD binding (GO:0070412),0.3166879261913352,0.7497347454529856,0.7730978260869565,1.0,1.0,8/18,22.11%,PMEPA1;SMAD6;DDX5;SMURF1;RANBP3;PPM1A;SMAD2;SMAD3
prerank,gap junction channel activity (GO:0005243),0.30399447074145247,0.7494023860872358,0.7941176470588235,1.0,1.0,2/22,9.65%,GJB2;GJB6
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.34080480803358215,0.748979654259444,0.7859154929577464,1.0,1.0,6/12,24.60%,PIK3CB;PIK3C2B;PIK3C3;IPMK;ATM;PIK3C2A
prerank,calcium-release channel activity (GO:0015278),0.3214063120368195,0.7470291124517212,0.7791005291005291,1.0,1.0,4/17,18.02%,ITPR1;TPCN1;RASA3;PKD2
prerank,myosin V binding (GO:0031489),0.328774237658029,0.7461188855252686,0.7748618784530387,1.0,1.0,6/15,25.35%,RAB10;RAB3B;RAB8A;RAB6A;RAB11B;RAB11A
prerank,tRNA methyltransferase activity (GO:0008175),0.3220890159761764,0.7456292746582464,0.7793103448275862,1.0,1.0,3/16,12.90%,TRDMT1;METTL2B;METTL2A
prerank,heme binding (GO:0020037),0.2578971649344865,0.7455688737446953,0.8586839266450917,1.0,1.0,8/65,14.59%,DGCR8;CYP27A1;RSAD1;BACH1;CYP26B1;CYP51A1;PTGS2;PXDN
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.32553360007394594,0.7455208605592717,0.7881844380403458,1.0,1.0,4/14,19.20%,USP7;USP15;USP9X;YOD1
prerank,insulin-like growth factor binding (GO:0005520),-0.2652248323325953,-0.7444477773079191,0.8212927756653993,0.9699108128904675,1.0,2/15,2.38%,IGF1R;ITGA6
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.29966141539870295,0.7442457798017201,0.8066581306017926,1.0,1.0,2/23,5.17%,WIPI1;SNX14
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.3452121847866949,0.7421308320459947,0.7847730600292826,1.0,1.0,3/11,17.75%,PPP1R2;PPP1R14A;PPP1R11
prerank,semaphorin receptor binding (GO:0030215),-0.2226763109543397,-0.7377050819573706,0.8713692946058091,0.9729867627531699,1.0,17/23,43.07%,SEMA6A;SEMA7A;SEMA4D;SEMA4B;SEMA3B;PLXNB1;SEMA5A;SEMA5B;SEMA6C;SEMA3G;SEMA6B;SEMA4C;SEMA6D;SEMA4A;SEMA4G;SEMA3F;SH3BP1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.32554366354674347,0.734242743721018,0.8208744710860366,1.0,1.0,2/14,4.86%,ISCA2;RSAD1
prerank,protein phosphatase binding (GO:0019903),0.24647820119044647,0.7319994188592659,0.9042224510813595,1.0,1.0,32/117,22.66%,EIF2AK3;STAT6;KIF3A;ANK1;PIK3R1;SIRPA;PPP1R9B;MVP;VCP;PPP6R3;JUP;PIK3R2;AP3B1;IQGAP1;RACK1;ANAPC4;PPP1R16A;MAPT;STX17;MTMR4;PPP1R11;JAK1;SMG7;ANAPC5;ARPP19;KIFAP3;IGBP1;ATP2B4;FOXO1;TRAF2;ITGA1;MAP2K7
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.2146410067006688,-0.7316484249175098,0.9044943820224719,0.9748899264496921,1.0,9/29,20.16%,SIRT1;NFATC1;NBR1;DUSP10;PTPRJ;ACE;MAPKAPK3;DUSP1;GCH1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.31023563518949443,0.731500614677155,0.8235294117647058,1.0,1.0,4/17,18.45%,AK4;AK5;AK3;CMPK1
prerank,SUMO binding (GO:0032183),-0.2696081691814659,-0.7312011311493254,0.8169491525423729,0.9693220628014563,1.0,5/13,19.97%,CASP8AP2;PML;TDG;HABP4;CBX4
prerank,amino acid transmembrane transporter activity (GO:0015171),0.2646344414575849,0.7311013854633631,0.8370535714285714,1.0,1.0,7/47,16.34%,SLC7A11;SLC22A4;SLC38A9;SLC7A2;SLC38A10;SLC1A5;SLC6A13
prerank,solute:proton symporter activity (GO:0015295),0.3152561055816159,0.7293673856120287,0.8046647230320699,1.0,1.0,1/16,0.83%,SLC17A5
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2894740272408324,0.7265310777211104,0.8335500650195059,1.0,1.0,2/24,6.60%,GSDMD;PLEKHA3
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.2122298169194263,-0.7230460915572935,0.8689320388349514,0.9734707948656361,1.0,17/27,36.71%,POLR3B;TENT2;POLR3A;CRCP;MED20;POLR1F;POLR3H;TERT;POLR2G;POLR2F;POLR2C;POLR2E;POLR1H;POLR2J;POLR2D;POLRMT;POLR1C
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.26433198352956466,-0.7221053651918911,0.8379310344827586,0.9686070943023112,1.0,3/13,8.34%,EZR;PRKAR2B;CSK
prerank,regulatory RNA binding (GO:0061980),0.27243420088225206,0.7212984016922168,0.8370457209847597,1.0,1.0,10/38,22.96%,TARBP2;ZC3H7B;RBM10;AGO3;HNRNPA2B1;FMR1;ZC3H7A;YBX1;MATR3;AGO4
prerank,death receptor activity (GO:0005035),0.3292461580906302,0.7212858650390319,0.808095952023988,1.0,1.0,2/11,12.49%,EDA2R;TNFRSF25
prerank,DNA polymerase activity (GO:0034061),-0.22803613581055523,-0.7210370930814348,0.8813559322033898,0.9639189621778972,1.0,10/22,30.02%,REV3L;REV1;POLB;PRIMPOL;POLM;TERT;POLE2;POLQ;POLK;POLI
prerank,protein kinase regulator activity (GO:0019887),0.2438681237616658,0.7197394091969289,0.9141949152542372,1.0,1.0,11/95,12.27%,HEXIM1;GSKIP;SH3BP5;PRKRIP1;CCNC;MAPK8IP1;STK11;GPRC5B;SH3BP5L;CCNH;NPM1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.2568047274880143,0.7187000302067569,0.8725055432372506,1.0,1.0,5/55,6.25%,SLC6A11;SLC22A4;SLC16A12;SLC38A9;SLC7A2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.3142671022132886,0.7177157459882451,0.8119891008174387,1.0,1.0,4/17,15.15%,BLVRB;BLVRA;MECR;DPYD
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.33949455130440004,0.7170692494289465,0.8132352941176471,1.0,1.0,5/10,24.60%,PIK3CB;PIK3C2B;PIK3C3;ATM;PIK3C2A
prerank,tropomyosin binding (GO:0005523),-0.24615057822578162,-0.716627680797742,0.8636363636363636,0.9631491170649907,1.0,7/16,40.82%,NEBL;TMOD1;LMOD1;CALD1;TNNT3;S100A6;PYCARD
prerank,anion channel activity (GO:0005253),0.2536667478752577,0.7166151789311852,0.8803046789989118,1.0,1.0,9/61,14.46%,BEST1;LRRC8A;VDAC2;CLCN4;CLIC1;GABRB3;VDAC1;CLCN7;GLRA1
prerank,store-operated calcium channel activity (GO:0015279),0.34456753390493244,0.7157164143515561,0.8172205438066465,1.0,1.0,1/10,2.25%,ORAI2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.31287607663310546,0.7145076113300544,0.8126721763085399,1.0,1.0,8/15,25.25%,PIK3CB;PI4KB;PIK3C2B;PIK3C3;PIKFYVE;ATM;PIK3C2A;PI4KA
prerank,kinase activator activity (GO:0019209),-0.20319216197552414,-0.7145035486806335,0.9375,0.9598030986485779,1.0,3/30,2.43%,CAB39;STRADA;MARK2
prerank,death domain binding (GO:0070513),0.3341874919221379,0.7143955644614329,0.8256333830104322,0.999231379147237,1.0,3/11,12.69%,BAX;BCL2;RACK1
prerank,glucuronosyltransferase activity (GO:0015020),0.30261067405234865,0.7132797752299646,0.8309114927344782,0.9982141436053429,1.0,1/19,3.69%,CHPF
prerank,cation transmembrane transporter activity (GO:0008324),0.25766525341553403,0.712068936486099,0.8652321630804077,0.997197274470902,1.0,7/48,14.36%,SLC38A9;SLC7A2;MMGT1;SLC39A1;SLC25A38;SLC41A1;SLC1A5
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2475604040181538,0.7105714831052103,0.8904555314533622,0.9966161825228558,1.0,14/74,17.28%,XYLB;GALK1;DCAKD;PANK4;COASY;FAM20C;PIK3CB;IPPK;PI4KB;NT5C3A;CHKB;PIK3C2B;PIK3C3;IPMK
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2833895137321635,0.7102475340723448,0.8559218559218559,0.9947259426682727,1.0,2/29,3.42%,ABHD10;GBA2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.2844863948025011,-0.708918956868791,0.8503184713375797,0.9604770130014981,1.0,7/10,32.98%,DNAJB2;IDE;ANKRD13D;ANKRD13B;ANKRD13A;LAPTM5;FAAP20
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.33338371523270544,0.7082018931031405,0.8202764976958525,0.9947756268255312,1.0,2/10,10.68%,KDM7A;KDM2B
prerank,metal ion transmembrane transporter activity (GO:0046873),0.2782713017020761,0.7079160934083958,0.844059405940594,0.9928281478062121,1.0,5/27,14.06%,ITPR1;MMGT1;ATP2B1;KCNA1;SLC41A1
prerank,methyl-CpG binding (GO:0008327),0.289837809955132,0.7068742222502797,0.8253968253968254,0.9918116475793662,1.0,6/22,19.34%,ZBTB38;PRMT5;PRMT1;MBD1;MECP2;TET1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3045252702553738,0.7059063253125565,0.8339973439575034,0.9906161263379039,1.0,9/18,23.39%,USP15;TGFB1;SMAD6;TGFBR1;TGFBR3;SMAD7;SMAD2;SMAD3;FKBP1A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.24665041015293365,-0.6994564056021968,0.8783269961977186,0.9652475814878485,1.0,3/15,7.94%,SOCS7;PIK3R3;SOCS4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.2694587810390192,-0.6958105887207114,0.8485804416403786,0.963252341959607,1.0,1/11,0.75%,DAB2IP
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.22942185692490022,0.6932824559590838,0.9555555555555556,1.0,1.0,32/173,21.03%,POU6F1;NFKB1;ZNF25;ZEB2;MXI1;SNAI1;ZNF692;ZEB1;MXD1;ZBTB5;CC2D1A;NFX1;ZBTB20;YY1;NACC2;BACH1;PEG3;TRPS1;BCL6;SATB1;TCF3;GTF2IRD1;ZFP37;SOX13;ZFP90;ZNF177;MITF;E2F6;CTCF;ZNF219;ZBTB32;NFATC3
prerank,lipase activity (GO:0016298),0.25474425197806466,0.6919125856373239,0.8916083916083916,1.0,1.0,5/43,16.33%,LPL;SMPD2;PITPNM3;DDHD2;LDAH
prerank,cholesterol binding (GO:0015485),0.25336127078037973,0.6912866417263712,0.8961937716262975,0.9998944690449519,1.0,13/47,22.04%,STARD5;ERLIN2;VDAC2;SOAT1;PTCH1;STARD3;VDAC1;SIDT1;SCARB2;OSBPL1A;NPC2;ABCG1;NPC1
prerank,MHC class II protein complex binding (GO:0023026),0.3164537291652649,0.6889689317402344,0.827536231884058,1.0,1.0,1/11,2.67%,HSP90AA1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.30101380946857376,0.6854915847948877,0.8615819209039548,1.0,1.0,3/14,18.45%,AK4;AK5;CMPK1
prerank,chloride channel activity (GO:0005254),0.24209409172638582,0.6842117047547058,0.9060773480662984,1.0,1.0,8/59,14.46%,BEST1;CLCN2;CLCN4;CLIC1;GABRB3;TTYH2;CLCN7;GLRA1
prerank,cAMP response element binding (GO:0035497),-0.27254092922557405,-0.6841261839875059,0.8666666666666667,0.9692295053941061,1.0,5/10,25.65%,E4F1;CREB1;JUN;CREB3L1;HMGA2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.2067408504902894,-0.6826666100470968,0.8952879581151832,0.9648727863410845,1.0,17/27,36.71%,POLR3B;POLR3A;CRCP;PRIMPOL;MED20;POLR1F;POLR3H;PRIM1;POLR2G;POLR2F;POLR2C;POLR2E;POLR1H;POLR2J;POLR2D;POLRMT;POLR1C
prerank,N-acetyltransferase activity (GO:0008080),0.287664831074946,0.6812220146530908,0.8707571801566579,1.0,1.0,2/19,6.77%,ATAT1;GNPNAT1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.3162549747089396,0.6806233371493356,0.8533724340175953,0.9997438455509279,1.0,2/12,12.03%,ISCA2;CISD1
prerank,transcription coactivator binding (GO:0001223),0.28210782974135257,0.6781231666687029,0.869340232858991,0.9999279940375874,1.0,3/20,8.25%,RORA;CDK9;CIT
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3206692940227974,0.6744636189309897,0.8546255506607929,1.0,1.0,2/11,17.73%,ITPR1;RASA3
prerank,mannose binding (GO:0005537),0.3096364483257379,0.6730933283436864,0.8790087463556852,1.0,1.0,1/12,8.24%,LMAN2L
prerank,hydro-lyase activity (GO:0016836),0.24837313061075092,0.6700667583329318,0.886337543053961,1.0,1.0,7/41,14.75%,HADHB;HSD17B4;ENO2;CDYL;PARK7;EHHADH;ECHDC1
prerank,hormone receptor binding (GO:0051427),0.2973711688597809,0.66771639792323,0.8607242339832869,1.0,1.0,1/14,3.71%,PTHLH
prerank,O-methyltransferase activity (GO:0008171),-0.2729722714528887,-0.6641379374203582,0.8832335329341318,0.9760717401685999,1.0,7/10,42.48%,COQ3;CMTR1;MEPCE;FTSJ3;ASMT;BCDIN3D;CMTR2
prerank,NAD+ binding (GO:0070403),0.30264316430881527,0.6615205979194996,0.8755364806866953,1.0,1.0,3/12,15.96%,SIRT2;SIRT5;ZC3HAV1
prerank,amino acid binding (GO:0016597),0.25015809222802493,0.6601765036039251,0.9104477611940298,1.0,1.0,5/31,18.27%,GRIN1;AARS1;GCLC;GLRA1;ASS1
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.2097967947200592,-0.659320810509621,0.9333333333333333,0.9742924236806328,1.0,9/21,30.02%,REV3L;REV1;POLB;PRIMPOL;POLM;POLE2;POLQ;POLK;POLI
prerank,PDZ domain binding (GO:0030165),0.23732396550704513,0.6591607605517181,0.9362637362637363,1.0,1.0,14/61,21.06%,SYNJ2;FZD3;SLC22A4;CIT;ATP2B1;TMEM88B;GRIA1;ARHGAP29;MAP2K2;NSF;PLEKHA1;TGFBR3;FZD2;ATP2B4
prerank,sodium:proton antiporter activity (GO:0015385),-0.25071572028512135,-0.6528979123572778,0.8925373134328358,0.9738132254378377,1.0,2/11,9.74%,SLC9A2;SLC9B2
prerank,nucleotide diphosphatase activity (GO:0004551),0.2904027644949465,0.6527696075356008,0.8884120171673819,1.0,1.0,3/14,12.01%,NUDT12;NUDT3;ENPP1
prerank,ATPase regulator activity (GO:0060590),0.24553427474507977,0.6491141826554997,0.9152148664343787,1.0,1.0,11/38,22.09%,BAG1;BRSK2;KATNB1;HSPH1;DNAJB6;DNAJC24;DNAJC10;BAG4;TOR1AIP2;ATP1B2;SIL1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.28307581462430115,0.6479192301890636,0.8748241912798875,1.0,1.0,6/15,26.36%,SLC1A3;SLC1A5;SLC1A2;SLC38A7;SLC25A12;SLC17A6
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.2836353937964842,0.6472657855995497,0.8846675712347354,1.0,1.0,1/16,2.63%,NTHL1
prerank,NAD binding (GO:0051287),0.25389060426761295,0.6472549999559858,0.916354556803995,1.0,1.0,5/26,16.05%,SIRT2;QDPR;SIRT5;ZC3HAV1;CTBP1
prerank,single-stranded DNA helicase activity (GO:0017116),0.27175879303347156,0.6445772279393525,0.8993377483443709,1.0,1.0,1/19,2.77%,HELQ
prerank,endoribonuclease activity (GO:0004521),0.24815666805282915,0.6421166275241321,0.9182464454976303,1.0,1.0,7/32,17.10%,LACTB2;RCL1;ENDOV;CPSF3;AGO3;SND1;ZC3H12C
prerank,ribonuclease P activity (GO:0004526),0.30555110975364436,0.6415614830345275,0.8875739644970414,1.0,1.0,2/11,13.56%,PRORP;RPP30
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.23541376621521592,-0.6407261110745472,0.897196261682243,0.9772342510915084,1.0,6/14,36.71%,KCNJ2;KCNJ3;KCNQ1;KCNJ8;KCNIP2;KCNE4
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.2903918619538456,0.6397990179185685,0.8841642228739003,1.0,1.0,5/13,21.88%,GPSM1;GPSM2;ITGB1BP1;CCDC88A;GDI2
prerank,ribonuclease P RNA binding (GO:0033204),-0.2649154074842656,-0.6381740153866237,0.9090909090909091,0.9734144053586979,1.0,6/10,37.58%,POP1;RPP14;RPP21;POP5;POP4;RPP38
prerank,peptidase activator activity (GO:0016504),0.2607985602040183,0.6376256002688047,0.9082687338501292,0.999792724052039,1.0,3/22,10.21%,PCOLCE;VCP;PSME2
prerank,carboxylic acid binding (GO:0031406),-0.17189245858505756,-0.6371606651700222,0.9759036144578314,0.9685587931531701,1.0,12/38,29.68%,GRM7;UBR1;NOS3;PHYH;GLRA2;GLRB;SESN2;GLRA3;HIF1AN;NOS1;EPDR1;GLUD1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2695302687766893,0.6369118746656596,0.900398406374502,0.9983165664652001,1.0,18/18,73.08%,RDH5;HSD3B1;HSD17B3;HSD17B6;RDH16;DHRS9;AKR1C1;HSD3B2;SRD5A2;HSD17B1;HSD17B14;HSD3B7;HSD17B2;HSD17B10;HSD11B1;HSD17B8;HSD17B7;DHRS11
prerank,endopeptidase activator activity (GO:0061133),-0.2593062814402791,-0.6338380849596639,0.9240121580547113,0.9651358652470999,1.0,6/10,31.33%,APH1A;VSIR;APH1B;PSME3;PSME1;PSENEN
prerank,cyclic nucleotide binding (GO:0030551),0.25620649727576034,0.6325627272250355,0.9092105263157895,0.9996635961720716,1.0,4/21,19.08%,PDE4A;PDE10A;PDE4B;KCNH1
prerank,water transmembrane transporter activity (GO:0005372),0.28785944892797555,0.6324932854789518,0.884450784593438,0.9976174949931234,1.0,1/11,14.55%,AQP4
prerank,adenyl nucleotide binding (GO:0030554),0.2991518527559106,0.6288575965795479,0.9042709867452136,0.9962772925911693,1.0,4/11,22.09%,BAG1;HSPH1;BAG4;SIL1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.2991518527559106,0.6288575965795479,0.9042709867452136,0.9962772925911693,1.0,4/11,22.09%,BAG1;HSPH1;BAG4;SIL1
prerank,potassium ion leak channel activity (GO:0022841),0.27144008103357414,0.6210922036305427,0.907563025210084,1.0,1.0,1/15,5.33%,KCNK2
prerank,translation elongation factor activity (GO:0003746),-0.22629387249516233,-0.6205238541731045,0.9265734265734266,0.9680860327412052,1.0,7/14,29.73%,EEF2;EEF1A1;GTPBP1;EIF5A;EIF5AL1;TSFM;EIF5A2
prerank,neuropeptide receptor activity (GO:0008188),0.2390407469432872,0.6161343740637943,0.9298029556650246,1.0,1.0,2/29,8.05%,HCRTR2;GPR37
prerank,lipoprotein particle receptor binding (GO:0070325),0.24278866294794058,0.6160278296011871,0.9172749391727494,0.9995806516539113,1.0,6/27,17.19%,LRPAP1;LANCL1;SYT1;LRP1;HSPG2;APOE
prerank,voltage-gated ion channel activity (GO:0005244),0.27249201554488595,0.6155229271344984,0.9231843575418994,0.9978518185453942,1.0,3/14,18.02%,VDAC2;VDAC1;PKD2
prerank,voltage-gated sodium channel activity (GO:0005248),0.24886616499142478,0.6152871982535184,0.9280397022332506,0.9959388863115998,1.0,3/22,10.99%,SCN7A;SCN2B;SCN1A
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2340265212571623,0.6149019383879465,0.935,0.9940845562909439,1.0,8/32,19.34%,KDM7A;KDM2B;ALKBH3;EGLN2;BBOX1;FTO;ALKBH1;TET1
prerank,kinase activity (GO:0016301),0.20468135742180935,0.6037471474669369,0.9824380165289256,0.9996055572117533,1.0,27/109,22.67%,COQ8B;CDKL5;TAOK1;CDK5;DCAKD;ABL1;PANK4;COASY;PIK3CB;IPPK;PI4KB;CHKB;CKB;PIK3C2B;PIK3C3;IPMK;IP6K1;NEK1;PGK1;PAPSS1;DGKI;LYN;MAP4K4;TAF1;PSTK;NADK2;EPHA4
prerank,organic cation transmembrane transporter activity (GO:0015101),0.2620012490682706,0.597554920806621,0.9103260869565217,1.0,1.0,3/16,20.66%,SLC22A4;SLC44A2;SLC44A1
prerank,magnesium ion binding (GO:0000287),0.19951391259289306,0.5957046907223079,0.9846625766871165,1.0,1.0,27/135,20.41%,NUAK2;TKT;ABL1;PPA2;STK11;BRSK2;RAP2A;SIK1;DHX36;NUDT12;BRSK1;NUDT3;ENDOV;TDP2;HPRT1;GCLC;EYA2;EPHX2;DIS3L2;NT5C3A;TPPP;OXSR1;SRPK1;CDC42BPB;MTPAP;IMPA1;PDCD6
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.25742449927795563,0.5947627989002405,0.9287749287749287,0.9990946144274849,1.0,15/15,74.28%,SAP30L;LANCL2;SH3PXD2B;SESTD1;PLEKHA5;PLCZ1;OBSCN;VEPH1;RUBCNL;PHLDA3;SNX3;PLA2G4E;PLA2G4A;JPH2;PLEKHF1
prerank,ADP binding (GO:0043531),0.23664512841110766,0.5943793308084784,0.9371794871794872,0.9972798601564653,1.0,8/25,21.80%,MYH10;GCLC;PPP5C;PGK1;PRKAG2;ME1;ABCG1;MYH9
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.2513778503624695,0.5933584697001212,0.9258777633289987,0.9958400443653097,1.0,3/18,13.07%,PIK3R1;PIK3R2;WDR91
prerank,inward rectifier potassium channel activity (GO:0005242),-0.1848665133015967,-0.5928955164613434,0.9815668202764977,0.9780763588195576,1.0,9/24,35.67%,KCNJ2;ABCC9;KCNJ3;KCNK1;KCNJ12;KCNN3;KCNK6;KCNJ8;KCNJ15
prerank,sulfotransferase activity (GO:0008146),0.22060362363274388,0.5910248347921044,0.955794504181601,0.9951511151474002,1.0,2/33,6.08%,HS2ST1;CHST10
prerank,microtubule minus-end binding (GO:0051011),0.2624579428283734,0.5810615400764334,0.9378531073446328,0.9987092530550747,1.0,4/13,22.15%,CAMSAP2;NUMA1;TUBGCP2;CAMSAP1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.23653840593114792,0.5782977299669252,0.959493670886076,0.998248659998837,1.0,5/22,17.19%,LRPAP1;LANCL1;SYT1;HSPG2;APOE
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.20515252783959254,0.5774607201366599,0.9728813559322034,0.9966086839413998,1.0,6/53,14.36%,SLC7A11;SLC38A9;SLC7A2;SLC25A38;SLC1A3;SLC1A5
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2239342555602162,0.565681676014216,0.9623115577889447,1.0,1.0,9/28,24.25%,PAK3;MAP2K2;RPS6KA1;MAP2K7;MAP2K3;MAP2K1;MAP2K6;SGK1;RPS6KA2
prerank,miRNA binding (GO:0035198),0.21968585958665135,0.5642455515462621,0.9625468164794008,0.9990637738784487,1.0,9/30,22.96%,ZC3H7B;RBM10;AGO3;HNRNPA2B1;FMR1;ZC3H7A;YBX1;MATR3;AGO4
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.21067909201746296,0.5611142409875144,0.9747899159663865,0.9984791107142191,1.0,3/35,8.95%,ABL1;SRMS;TEC
prerank,sequence-specific mRNA binding (GO:1990825),0.27204898056805277,0.5603200460133212,0.9453237410071943,0.9967837765363079,1.0,2/10,16.79%,SHFL;FMR1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.2632351590009079,0.5592244983744721,0.9345661450924608,0.9952237370064111,1.0,4/11,22.60%,DPAGT1;PTDSS1;PTDSS2;SAMD8
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2176015082313906,0.5535019726537944,0.9628252788104089,0.9957230630787635,1.0,5/28,16.22%,PRORP;ENDOV;AGO3;RPP30;NUDT16L1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.22292344104006925,-0.5523545980226886,0.9616519174041298,0.9887807093191352,1.0,2/11,7.18%,NUDT5;DCPS
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.19037780437876634,0.5519503654112874,0.9978540772532188,0.9943934369726847,1.0,5/69,7.58%,MOGAT3;CERS2;NMT1;SOAT1;ZDHHC3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.22084922960364428,0.5508127342230376,0.974937343358396,0.9928738550589982,1.0,6/24,22.95%,ZDHHC3;GLUL;ZDHHC17;ZDHHC2;ZDHHC14;ZDHHC21
prerank,FMN binding (GO:0010181),0.2445835443805541,0.5228785689226771,0.9607293127629734,1.0,1.0,1/11,6.76%,POR
prerank,chemokine activity (GO:0008009),0.20251233669663532,0.5189865755236686,0.9852760736196319,1.0,1.0,1/31,4.50%,CXCL12
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.20193381418567036,0.5087531027093009,0.9846938775510204,1.0,1.0,5/24,18.45%,AK4;AK5;AK3;IP6K1;CMPK1
prerank,myosin binding (GO:0017022),0.18037826837159052,0.5057706265209816,0.9966329966329966,0.9997894225225183,1.0,12/55,22.41%,CXCR4;NCKIPSD;RAB10;RAB3B;MOBP;RAB8A;TRAK1;KIRREL1;RAB6A;GSN;LLGL1;RAB11B
prerank,BMP binding (GO:0036122),-0.1898765260842497,-0.4988251217491838,0.9865319865319865,0.9967623865126366,1.0,1/11,7.62%,ENG
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.1945479063688379,-0.4984928152080547,0.985632183908046,0.9912660157376509,1.0,5/10,40.92%,B4GALT6;B4GALT7;B3GALT2;A3GALT2;B3GALT6
prerank,potassium:proton antiporter activity (GO:0015386),0.23466902876981247,0.4868375767048383,0.9813664596273292,1.0,1.0,4/10,25.79%,SLC9A7;SLC9A6;SLC9A9;SLC9A1
prerank,CCR chemokine receptor binding (GO:0048020),0.18842844371170767,0.474456243066081,0.9924812030075187,1.0,1.0,6/28,26.04%,NARS1;CCL25;NES;CX3CL1;CNIH4;CCL14
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.22068614547033227,0.47395095384028724,0.9891975308641975,1.0,1.0,1/11,12.11%,KCND3
prerank,chemokine receptor binding (GO:0042379),0.18173540905674873,0.4736607953787531,0.9951749095295537,0.9984623318111335,1.0,1/35,4.50%,CXCL12
prerank,protein phosphatase 1 binding (GO:0008157),0.19317767067856026,0.46720731324729076,0.9897959183673469,0.9975887828259533,1.0,3/21,17.75%,PPP1R9B;PPP1R16A;PPP1R11
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.20964638431788218,0.46634059955371576,0.9914893617021276,0.9957559020529534,1.0,2/14,13.56%,PRORP;RPP30
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.19996208307473834,0.43633656243948016,0.9915848527349228,0.9975146639422307,1.0,6/12,26.89%,TENT5A;MTPAP;PAPOLA;TENT4A;PAPOLG;TENT4B
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.19507071088341962,0.4111194008491838,0.9984591679506933,0.9975979257814076,1.0,2/10,21.07%,DCLRE1A;EXD2
